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The innate immune system has drawn interest with its deep evolutionary
conservation and importance in response to infection both in invertebrates, providing
the only reaction to invading microbes, and as a generalized first reaction in
vertebrates, activating the adaptive response. Drosophila has become a useful model
for innate immunity, due to the powerful genetic, genomic and comparative resources
available. Drosophila-based research has uncovered many genes involved in these
pathways, and studies of the population genetics, interspecific divergence, and gene
duplication patterns have revealed evidence for selection acting on immune genes,
with distinct evolutionary pressures inferred to act on different functional groups.
To investigate variation in immune response within a natural D. melanogaster
population, we assayed polymorphism in X-linked immune genes and tested
correlations between these variants and immune phenotypes. This revealed
associations in numerous immune genes with differences in immunocompetence, and
strikingly, many of these genotypes appear to associate with sex differences in
immune phenotype. Beyond this segregating variation, we also examined divergence
between species. In order to quantify regulatory divergence, we have assayed
expression before and after infection in D. melanogaster, D. simulans, and
interspecific hybrids. If immune regulation has diverged between species, we expect
hybrids to display a disrupted immune response, and we do, in fact, observe immune
dysregulation in the hybrids. This was most notable in the downstream pathway
components, indicative of propagation of dysregulation throughout the response.
To further dissect the dysregulation evident in hybrids, we have quantified
immune phenotypes in hybrids bearing mutant melanogaster alleles for genes
throughout the innate immune pathways. Resulting animals are forced to employ only
the simulans allele at the point of the melanogaster mutation. We find that a mutation
in one gene in particular, Dredd, has a detrimental effect in a hybrid background,
indicating that Dredd is likely involved in interactions that have evolved to be specific,
such that combinations of melanogaster + simulans alleles in Dredd interactions lead
to a breakdown in immune activation. Overall, we find strong evidence for immune
response divergence between species, but the degree of functionally relevant
divergence appears to be greatest among signaling molecules.
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1CHAPTER 1
INTRODUCTION
The innate immune pathways have been found to be highly conserved among
taxa throughout the animal kingdom, comprising the only response to infection in
invertebrates and providing a critical activation step of the adaptive immune pathways
in vertebrates (MEDZHITOV and JANEWAY 1997). Due to the evolutionary importance
of this system, it has been investigated in a variety of organisms. The Drosophila
immune response has become a model of particular interest, with extensive resources
available for genetic and comparative analyses.  In recent years, many genetic studies
in Drosophila have clarified the genetic factors and their interactions in the innate
immune response (BRENNAN and ANDERSON 2004; FERRANDON et al. 2007; IRVING et
al. 2004).
The most studied portion of Drosophila immunity, the humoral response,
includes the Toll and imd pathways, which are homologous to those in the mammalian
innate immune response (KIMBRELL and BEUTLER 2001). These pathways involve the
recognition of invading microbes, signal transduction after activation, and
transcription of antimicrobial peptides (AMPs) and other effector molecules as attack
mechanisms. The Drosophila immune response also includes cellular mechanisms,
including melanization and encapsulation or phagocytosis of invading cells, as well as
less well-defined interactions with other pathways involved in stress response.
Despite the constancy of the genes that comprise the main functions of these
pathways in Drosophila and other species, they have been shown to evolve under the
influence of positive selection at higher levels than those seen for non-immune genes
(SCHLENKE and BEGUN 2003). Furthermore, genes involved in different functions
within the immune response appear to show different levels of polymorphism and
divergence within and between species. In some studies examining levels of variation
2in subsets of immune genes, antimicrobial peptides have been found to have low
levels of polymorphism and little evidence of positive selection (CLARK and WANG
1997; DATE et al. 1998; LAZZARO and CLARK 2003; RAMOS-ONSINS and AGUADE
1998), whereas some recognition proteins, including scavenger receptors, have been
found to evolve under positive selection (LAZZARO 2005). In a recent study of
sequence divergence between multiple Drosophila species in genes throughout the
immune system, more evidence was found for distinct patterns of selection acting on
genes belonging to different functional groups. Here, (SACKTON et al. 2007) found
greater signs of positive selection acting on genes encoding recognition proteins than
with genes involved in either signaling or effector functions.
Beyond examinations of sequence-level differences, other investigations have
quantified variation in immune-related genes in natural populations as well as the
functional consequences of such variation (LAZZARO et al. 2006; LAZZARO et al.
2004). These experiments have surveyed flies in natural populations to determine
which autosomal genes harbor variation that can impact phenotype and therefore be
acted on by selection. These studies uncovered polymorphisms in multiple genes
throughout the immune pathways that associate with immunocompetence phenotypes,
indicating that a variety of potential targets for selection may exist in natural
populations.
In order to more fully explore the effects of naturally occurring polymorphisms
on immune response phenotypes, we have assayed variation in X-linked immune
genes and quantified associations between these genotypes and response to infection,
described in Chapter 2. Here, we report that a variety of X-linked genes contain
naturally segregating polymorphisms that correlate with bacterial load phenotypes
after infection, consistent with previous studies, but we have also found that a
substantial number of these variants associate with sex differences in the immune
3response. This presents evidence for sexual dimorphism existing among X-linked
genetic variants, potentially allowing for these to be maintained as segregating alleles
within a population.
Beyond investigations of population level variation in the immune response,
studies of divergence in immune phenotypes between species can provide an
additional perspective on the evolutionary pressures acting upon genes in these
pathways. To this end, we have examined the divergence in regulation of the innate
immune response between Drosophila species by quantifying levels of transcription in
immune-related genes before and after infection in D. melanogaster, D. simulans, and
their F1 hybrids.
Since interspecific F1 hybrids contain genomes of two diverged species in a
single individual, they have the potential to display disrupted phenotypes as a
consequence of incompatibilities between parental alleles (LANDRY et al. 2007; TRUE
and HAAG 2001). Previous investigations have revealed hybrid dysregulation of
developmental and enzyme expression phenotypes (DICKINSON et al. 1984; PARKER et
al. 1985; WHITT et al. 1977), and genome-wide studies have found widespread
patterns of non-additive expression levels in interspecific hybrids (HEGARTY et al.
2005; MICHALAK and NOOR 2003; MOEHRING et al. 2007; RANZ et al. 2004; RENAULT
et al. 2009).
If regulation of the immune response has diverged between D. melanogaster
and D. simulans, we expect that the F1 hybrids of these species should display
dysregulatory immune phenotypes, reflective of the divergence between the parental
species. To investigate this, we quantified expression levels of immune genes in D.
melanogaster, D. simulans, and their F1 hybrids before and after infection using
custom Illumina BeadChips, described in Chapter 3. With this, we do find evidence
for dysregulatory patterns of expression in the F1 hybrids in response to infection.
4Despite overall trends toward additivity in expression levels after infection in the
hybrids, numerous genes appear as outliers from these trends. Furthermore, genes
belonging to recognition, signaling, and effector functional groups show distinct
patterns of dysregulation in the hybrids, providing further evidence for dissimilar
regulatory divergence among these groups of genes.
To examine broader influences of dysregulation in hybrids in response to
bacterial infection, we also quantified transcript abundance in D. melanogaster, D.
simulans, and their F1 hybrids before and after infection using Illumina short-read
sequencing of cDNA sequences (RNA-seq), explained in Chapter 4. Through this, we
were able to quantify genome-wide expression patterns in these flies, revealing
dysregulation in non-immune pathways, as well as in the immune response genes in
response to infection. Furthermore, we were able to quantify allele-specific transcript
levels within the hybrid flies, revealing skewed patterns of expression between the two
parental alleles before and after infection. There was some tendency for genes
downstream of a gene with skewed allelic expression to be similarly skewed, but this
effect was weak.
While regulatory differences in F1 hybrids can reveal divergent portions of the
immune response in the parental species, it does have the limitation of detecting only
interactions with effects dominant to the regulatory phenotypes of the conspecific
alleles, since genes in the F1 hybrids may still be able to maintain normal interactions
with alleles from both parents present for each gene in a complex. In order to further
perturb the immune system, we have examined hybrids bearing mutant D.
melanogaster alleles for genes throughout the innate immune pathways, described in
Chapter 5. With a dysfunctional allele from one parent, genes involved in critical
interactions in the immune response may be less able to interact if the genes involved
have diverged between the parental species such that interspecific interactions are less
5functional.  This investigation pinpointed the protein Dredd, critically important for
imd pathway function, as one in which interactions have evolved between species,
yielding dysfunctional effects of interspecific complexes.
Overall, these studies have clarified patterns of variation in innate immune
response within and between species of Drosophila. Despite largely conserved
structure and function of the immune response, there is increasing evidence for
divergence in gene sequences and regulation in this system. While variation
segregating in natural populations that associates with immune response phenotypes
and sex differences may exist within immune genes, selection to fix diversity between
species appears to act distinctly on different functional groups of immune genes. Even
in the face of dysregulatory patterns of expression, though, the hybrids show a
generally functional immune response, indicating a robustness of the immune response
to some perturbations.
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9CHAPTER 2
X-LINKED VARIATION IN IMMUNE RESPONSE
IN DROSOPHILA MELANOGASTER
Abstract
A fundamental challenge of immune systems is to defend against
unpredictably diverse pathogens. Understanding an immune system’s evolutionary
robustness must begin with analysis of genetic variation in its components, and here
we examine effects of X-linked genetic variation on immunocompetence of
Drosophila. We generated 168 lines of D. melanogaster with X chromosomes
extracted from a natural population into a co-isogenic autosomal background and
genotyped the lines at 88 SNPs in 20 X-linked immune genes. We tested the genotypic
variation among lines for association with bacterial load phenotypes after infection
with Gram-positive Enterococcus faecalis and Gram-negative Serratia marcescens.
We also quantified immune gene expression in a subset of lines to evaluate
associations with induction phenotypes. We find that polymorphisms in many genes
correlate with load and/or expression phenotypes. These results are comparable to
those from experiments testing effects of naturally occurring autosomal
polymorphisms on immune variation. Many of the associations found here, however,
are sex-specific or sexually antagonistic. This supports the theory that sexually
antagonistic variation may be maintained on the X chromosome even in the presence
of selection that typically purges variation in these genes facing regular hemizygosity.
Introduction
The deep evolutionary conservation of many specific genes in innate immunity
underscores the potent forces of natural selection maintaining this vital function.
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While it is widely accepted as the ancestral form of immune response, its role in the
activation of adaptive immune response further motivates investigation into variation
in its function (MEDZHITOV and JANEWAY 1997). Drosophila has been used as a
valuable model organism to identify and characterize functions of the components of
innate immune pathways as well as the evolutionary patterns present among the genes
of these pathways (reviewed in BRENNAN and ANDERSON 2004; FERRANDON et al.
2007; IRVING et al. 2004). The humoral response, resulting in the production of
antimicrobial peptides in response to bacterial or fungal infection, relies mainly on
Toll and imd signal transduction pathways, both of which are homologous to pathways
in mammalian immunity (reviewed in KIMBRELL and BEUTLER 2001). The cellular
component, on the other hand, incorporates both phagocytic engulfment as well as
melanization and encapsulation of infecting particles. While less well defined in the
Drosophila model, portions of other systems also appear to impact the effectiveness of
immune response, including JAK/STAT and JNK signaling pathways, hematopoesis
and iron metabolism.
Population genetic analysis can be used to determine whether sequence
polymorphism and divergence patterns among Drosophila genes in innate immune
pathways are consistent with signatures of selection acting within and between species
of flies. If, for example, the innate immune pathways are involved in an evolutionary
“arms race” with pathogenic organisms, genes in these pathways would be expected to
show signs of positive selection driven by evolutionary pressure to counter virulence
mechanisms of invading microbes. When signs of selection (as inferred by sequence
comparisons within Drosophila simulans populations and between D. simulans and D.
melanogaster) in immune genes and non-immune genes were evaluated, immune
genes as a group were found to have higher KA/KS ratios than non-immune genes,
providing evidence for elevated adaptive evolution (SCHLENKE and BEGUN 2003).
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Since receptor, effector and signaling proteins function in different portions of the
immune response pathways, these may be exposed to differing levels of contact with
invading microbes and may display non-uniform levels of functional redundancy or
pleiotropy. Thus, genes from different functional groups may be exposed to distinct
selective pressures. Antimicrobial peptides, which might be expected to encounter
unique selective pressures due to their direct interactions with invading microbes, have
shown little sign of positive selection, bearing low levels of amino acid divergence
(CLARK and WANG 1997; DATE et al. 1998; LAZZARO and CLARK 2003; RAMOS-
ONSINS and AGUADE 1998). Furthermore, sequence analyses of immune-related
receptors have shown evidence for purifying selection in peptidoglycan recognition
proteins (PGRPs), while others, including some scavenger receptors (SRs), appear to
be rapidly evolving under pressures consistent with positive selection (JIGGINS and
HURST 2003; LAZZARO 2005). On a deeper evolutionary timescale, sequence
comparisons between immune genes in multiple Drosophila species (based on full-
genome sequence data) have shown striking differences among functional groups of
immune genes, with recognition molecules showing much more positive selection than
either signaling or effector genes (SACKTON et al. 2007).
Beyond using sequence data and the analysis of polymorphism and divergence
to infer levels and modes of selection that have previously acted on immune genes
(both individually or in groups), other studies have investigated correlations between
autosomal variation in genotype and immune response phenotype in naturally
occurring populations of Drosophila (LAZZARO et al. 2006; LAZZARO et al. 2004;
SACKTON et al., submitted). These experiments tested associations between naturally
occurring genetic variation in immune-related genes and post-infection bacterial load.
In these studies, genetic variation in many of the immune genes was found to associate
significantly with one or more of the bacterial load phenotypes. Specifically, many
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polymorphisms in autosomal genes encoding recognition and signaling proteins (but
not antimicrobial peptides) associate consistently with bacterial load phenotypes,
suggesting that not all functional classes of immune-related genes harbor equally
influential genetic variation.
The focus of this study is X-linked immune genes, which may be under unique
regulatory and selective pressures simply because they are hemizygous in males, are
dosage compensated, and face elevated influence of random genetic drift due to their
smaller effective population size. As a consequence, the X chromosome should favor
the more rapid fixation of beneficial recessive alleles and more rapid loss of harmful
recessive alleles compared to autosomes (CHARLESWORTH et al. 1987; SINGH et al.
2008). Thus, with different selective pressures compared to autosomal genes, X-linked
immunity genes are expected to maintain different standing levels of variation, and
segregating polymorphisms in these genes may have different impacts on phenotype.
Different exposures of X-linked genes to selection in males and females can
also contribute to sexual dimorphism. (RICE 1984) suggested that X-linked sexually
antagonistic alleles may more freely impact sexually dimorphic traits than can those
on autosomes. In fact, the X chromosome appears to favor the maintenance of sexually
antagonistic variation (GIBSON et al. 2002). The presence of sexually antagonistic
selection among X-linked genes may be able to preserve polymorphism; if a given
allele is slightly deleterious in one sex, it may be maintained in the population by
being beneficial to the other sex. Immune-related genes may be particularly prone to
displaying sexual dimorphism in Drosophila, since males and females have been
shown to have different evolutionary optima for energetic expenditure on immune
response, and thus their respective immune responses may differ based on other
conditions such as food or reproductive resource availability (MCKEAN and NUNNEY
2001; MCKEAN and NUNNEY 2005). If sexually antagonistic traits are responsible for
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some of the observed sexual dimorphism, variation in X-linked genes could contribute
to phenotypic differences, and so X-linked variation in immune genes could face
distinct selective pressures.
In this report we investigate the standing levels of variation in X-linked
immune genes in natural populations of D. melanogaster and quantify the impacts of
that variation on immune response phenotypes. We genotyped 168 lines at single
nucleotide polymorphisms (SNPs) across 20 X-linked immunity loci and quantified
post-infection bacterial load and immune gene expression phenotypes. We found
significant variation across the lines for bacterial load after infection, and we were
able to identify polymorphisms in immune-related genes that associate with immune
response phenotypes individually and in interacting pairs of SNPs. Additionally, some
of the genetic variation was found to associate with a sex difference in immune
competence, with alleles acting either in a sex-specific or sexually antagonistic
manner. This provides evidence for X-linked genetic variation in immune-related loci
associating with both phenotypic variation among lines and sex differences in these
phenotypes.
Materials and Methods
Construction of Lines: D. melanogaster females were collected from apple
orchards near Ithaca, NY by Todd Schlenke and Brian Lazzaro in 2004. Isofemale
lines were established and kept under laboratory conditions for fewer than five
generations prior to isogenization. X chromosomes were isogenized in these lines, by
individually mating males from each line to females of the highly inbred balancer
stock FM7a, B1 sc8 vOf wa y31d. From each of these crosses, three female offspring
were individually mated to FM7a males. Since the balancer chromosome bears the co-
dominant marker Bar, heterozygous female offspring could be selected for the crosses
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each generation. The crossing scheme was repeated for each line in triplicate for a
total of seven generations to replace the background autosomes from the natural
population. This resulted in 168 lines, each homozygous (or hemizygous) for a unique
X chromosome from nature and all co-isogenic for the replaced autosomes. The
degree of background replacement was quantified by subsequent SNP genotyping,
finding concordance between the marker background and the isogenized lines in
99.6% of all assays (1191 tests out of 1196 examined; see Table A.1 for full autosomal
genotyping results).
Genotyping of SNPs Across Lines: Candidate immune-related genes were
selected for genotyping based on their previously indicated connections to immune
responses in genetic studies and/or large-scale expression assays (Table 2.1). These
genes include well-characterized members of the Toll and imd pathways, as well as
genes involved in other aspects of the response to infection, including hematopoesis
and iron metabolism. There is a significant over-representation of the genes in the
JAK/STAT pathway among the X-linked immunity genes (χ2, P = 7.7 x 10-5), and
several of these genes were included in our study. Notably, none of the 20 genes
encoding antimicrobial peptides genome-wide exist on the X chromosome in D.
melanogaster, so our investigation lacks any genotyped members of this class of
immune genes.
To identify SNPs for genotyping, the entire gene region for each gene,
including roughly 1 kb upstream and downstream, was resequenced in eight of the X-
extraction lines (see Table A.2 for list of primers used). Table 2.1 reports summary
statistics for these sequence alignments, calculated using DnaSP (ROZAS and ROZAS
1995), except for Tajima’s D, which was calculated with VariScan so as not to
exclude all sites with missing data (VILELLA et al. 2005). Once polymorphism data
were collected for all genes, SNPs were chosen for genotyping from among those
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Table 2.1 Genes Selected for Genotyping
Functional 
Group
Gene Name Cytological 
Position
Sequence 
Length
n S π θW D SNPs
Recognition PGRP-LE 13F1 1027 8 4 0.0014 0.0015 -0.2218 1
PGRP-SA 10C6 1414 8 0 0 0 NC 0
Signal domeless 18D13-E1 1484 8 7 0.0028 0.0025 0.3364 6
Transduction Dredd 1B12-13 2452 8 13 0.0018 0.0021 -1.3748 4
hemipterous 11D10 5444 8 65 0.0067 0.0073 -1.1266 14
hopscotch 10B5-6 5388 8 41 0.0040 0.0040 -0.5257 7
pole hole 3A1 3834 8 47 0.0059 0.0058 -0.8160 9
Tak1 19D2 6318 8 115 0.0086 0.0083 -0.0373 5
Traf2 7D16 3327 8 70 0.0092 0.0091 0.3354 3
Traf3 14C4 2704 8 31 0.0058 0.0063 -1.3593 2
Other Dsor1 8D2-3 1171 6 6 0.0043 0.0043 NC 2
lozenge 8D5-6 3452 8 44 0.0066 0.0069 0.9657 4
multi sex combs 8D2 2738 8 21 0.0043 0.0040 -1.3101 2
Ntf2 19E7 2969 8 52 0.0078 0.0082 -0.7046 2
outstretched 17A5 2953 8 13 0.0026 0.0028 0.2036 1
Pvf1 17E1-6 5372 8 110 0.0118 0.0117 NC 10
Rps6 7C2 2278 8 54 0.0103 0.0106 0.3699 3
Ser7 9A2 2339 8 15 0.0023 0.0027 -0.0835 3
Transferrin 1 17A9 3135 8 28 0.0034 0.0037 -1.4206 6
unpaired 2 17A3 2524 8 21 0.0043 0.0039 -0.4479 3
unpaired 3 17A4 5261 8 190 0.0164 0.0186 -0.8004 4
n = number of lines sequenced, S = segregating sites, D = Tajima's D (NC = not calculated), SNPs = number genotyped
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present at relatively intermediate frequencies in the samples and spaced approximately
500-1,000 bp apart within the genes. SNPs in high linkage disequilibrium (LD) with
one another were generally avoided. Wherever possible, nonsynonymous SNPs were
included; however, the selection of SNPs genotyped included those from exonic,
intronic, 5’ and 3’ untranslated and intergenic regions. In total, 91 SNPs were chosen
from among these 20 genes for genotyping across all 168 lines. PGRP-SA was not
included in the SNP genotyping due to a complete absence of detectable variation
found in the resequenced sample.
To identify the genotype for each line at each selected SNP, the SNPlex system
(Applied Biosystems, Foster City, CA) was used. Oligos were designed and
synthesized to query the genotype of all 91 SNPs (see Figure A.1 for oligo and SNP
information). The associated GeneMapper software was used to make the initial
SNPlex allele calls, and these were followed by manual inspection. 88 of the 91 SNP
assays in the SNPlex system yielded useful genotypic information across the 168 lines
(see Table A.3 for genotype calls at each site for all lines).
Bacterial Cultures and Infections: Bacterial stocks were chosen based on
previous use for immune challenges in D. melanogaster. The strain of Gram-positive
bacterium Enterococcus faecalis was derived from that used by LAZZARO et al. (2006)
(identified via 16S rDNA sequence and results of API 20Strep substrate utilization
testing). We also selected Gram-negative Serratia marcescens, derived from ATCC
strain 13880, which also had been used in previous studies (LAZZARO et al. 2006;
LAZZARO et al. 2004). Bacterial cultures for infections were grown from freezer
stocks, and cultures were grown overnight at 37° to a final concentration of OD600 ≈
1.0 for each day of infections.
Bacterial Load Quantification: Bacterial clearing ability of the lines was
measured through quantification of bacterial load after infection with bacteria,
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following LAZZARO et al. (2004). D. melanogaster were individually infected by
pricking their thoraces with 0.1-mm tungsten needles (Fine Science Tools, Foster City,
CA) dipped in bacterial culture. For each bacterium, a block design of infections was
used: each round of infections was repeated three times over six days in a two-week
span, with half the lines infected on a given day. For each round of infections, 12
males and 12 females from each line, aged approximately 3-10 days, were infected
(for technical feasibility, several people served as infectors on each day, but lines were
randomized among infectors from day to day). Approximately 26-30 hours after
infection, three groups of three flies per line were homogenized in 500 µl of LB broth,
and were then plated onto LB agar plates using a spiral plater (Spiral Biotech,
Bethesda, MD). Homogenates with E. faecalis bacteria were diluted 1:1000 pre-
plating to achieve a countable level of colonies. Plates were kept at either room
temperature or at 37° to allow bacterial colonies to grow until they could be counted
by a colony counter. These counts allowed inference of the concentration of bacteria
in each homogenate sample. Plates were visually inspected to confirm that colonies
counted were consistent with size and morphology expected. Thus, for each line, both
sexes were infected with each of two bacteria, and each round of infections included
three replicates for each sex and bacterial infection of every line, over three rounds of
infections. This yielded nine independent biological replicates of each infection with a
total of over 21,000 flies infected and 5,046 plates counted.
TaqMan RT-PCR: In addition to bacterial load, expression phenotypes were
measured after infection for a subset of 16 lines, chosen from the phenotypic tails of
sex difference in load after infection with E. faecalis. For each of these lines, 30 males
and 30 females were infected with E. faecalis injections. Eight hours after infection,
three replicates of each line and sex, most with 8-10 flies each, were snap-frozen in
liquid nitrogen, along with three replicates of uninfected flies. RNA was extracted
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using a Trizol:chloroform protocol. cDNA was then synthesized from the isolated
nucleic acid and diluted to fulfill TaqMan protocol requirements (Applied Biosystems,
Foster City, CA). Transcripts were quantified using TaqMan RT-PCR, including
antimicrobial peptide genes (DiptericinA, Defensin, and Metchnikowin), along with X-
linked immune-related genes (Peptidoglycan Recognition Protein-SA and
Transferrin1) and ribosomal protein RpL32 as an autosomal reference gene (see Table
A.4 for probe and primer sequence information). We measured the CT value for each
sample (number of PCR cycles at which the level of fluorescence for the sample
crosses a constant critical threshold value) and used the reciprocal, 1/CT, as a proxy
for expression for further calculations.
Statistics and Association Testing: Bacterial load was determined for each
sample in terms of colony-forming units per fly (cfu/fly). Estimates of bacterial
density from Drosophila homogenates (pools of three flies each) range from 1.0 x 100
to 4.0 x 106 cfu (corresponding to 0.3 x 100 to 1.3 x 106 cfu/fly). All empty plates were
recorded as true zero counts (on a log scale) rather than as missing data; all plates with
density calculated above 3.0 x 106 were too dense to be accurately counted, so these
were all assigned to have densities of 4.0 x 106, which probably underestimates the
number of colonies in most cases. Residuals from the analysis of variance on the raw
cfu counts were distributed non-normally, and log transformation yielded an adequate
fit of residuals to the normal distribution. Statistical analyses were carried out using
the R software (R Development Core Team, 2007) and SAS/STAT software with the
SAS system (SAS Institute, Inc., Cary, NC). To test for significant effect of Line, as
well as a Line × Sex interaction on variation in bacterial load (for each bacterial
infection), we used the mixed models:
yijklmn = µ + Linei + Sexj + (Line × Sex)k + Dayl + Infectorm + Platern +  εijklmno (1a)
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yijklm = µ + Linei + Sexj + Dayl + Infectork + Platerm +  εijklmn (1b)
yijkl = µ + Sexi + Dayj + Infectork + Platerl +  εijklm (1c)
where y is equal to ln(cfu/fly) (bacterial count), Line  (i = 1...168), Sex (j = 1,2), and
the Line × Sex interaction are fixed effects, and Day (k = 1...6), Infector (l = 1...6) and
Plater (m = 1...2) are treated as random effects using the R package lme4. ε is the error
term. The full model (1a) was compared to the partially reduced model (1b) using
ANOVAs to test for the effect of a Line × Sex interaction term. Similarly, the partially
reduced model (1b) was compared to the reduced model (1c) to determine the effect of
Line differences. To test the significance of each effect, load phenotypes were
permuted 1,000 times in R (for each bacterium), while keeping line, sex, and random
effects constant. The coefficients of the model tests from these permutated data
provided a null distribution as a basis of comparison for the actual Line and Line ×
Sex effects estimated from the data, and P-values were calculated for each. The
proportions of variance explained by models incorporating just Line effects or Line ×
Sex interaction effects (r2) were also calculated for each bacterial infection using R.
Mixed models were also employed to test for associations between line
genotypes and the above phenotypes. Here, differences in each load phenotype (e.g.
total E. faecalis load) between two alleles for each SNP were tested for significance
using mixed models:
yijklmno = µ + Allelei + Sexj + (Allele × Sex)k + Linel
+ Daym + Infectorn + Platero + εijklmnop (2)
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where y represents the phenotype of interest, Allele (i = 1,2) corresponds to the
genotype at the SNP in question, as a fixed effect, and Sex (j = 1,2) is also included as
a fixed effect. The Allele × Sex interaction term was included as a fixed effect to
quantify the effects of sex on SNP associations with bacterial load.  Line (l = 1...168),
Day (m = 1...6), Infector (n = 1...6), and Plater (o = 1,2) are all included as random
effects. Nearly identical models were used to test allelic effects on bacterial load in
either males or females individually, with the exception that these did not include Sex
as a fixed effect:
yijklm = µ + Allelei + Linej + Dayk + Infectorl + Platerm + εijklmn  (3)
Because of the potential for linkage disequilibrium among SNPs, tests of association
were not all independent, so significance was assessed using permutation tests. Each
SNP was tested individually, and genotypes were permuted 1,000 times in R, relative
to load phenotypes and the line, sex, day, infector, and plater values. The resulting
coefficients for Allele or Allele × Sex effects provided a null distribution against
which to compare the coefficients from tests with actual values, providing P-values for
each. False discovery rate (FDR) was estimated by calculating q-values for each test
using the qvalue R package (STOREY 2002). To determine the proportion of variance
explained by each SNP, r2 values for models including each SNP alone as a fixed
effect were calculated using R.
Associations between SNP genotypes and expression phenotypes were also
examined using the mixed model:
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 yijklmnopq = µ + Allelei + Sexj + Treatmentk + (Allele × Treatment)l  
        + (Allele × Treatment × Sex)m + RpL32n + Lineo + Platep
        + Replicateq + εijklmnopqr (4)
where y represents the expression level of the gene of interest (1/CT). Here, the fixed
effects include Allele (i = 1...168), corresponding to the genotype at a given SNP,
Treatment (j = 1,2), representing “infected” or “uninfected” state of the flies, Allele ×
Treatment, the interaction of SNP genotype and infection state to test for the effect of
change in expression level after infection, Allele × Treatment × Sex, the influence of
sex on this induction effect, and RpL32, the expression of RpL32, as a covariate to
normalize the expression phenotype measured. Line (o = 1...16), Plate (p = 1,2), and
Replicate (q = 1...3) were all included in the model as random effects. For each
phenotype, every SNP was tested individually. As above, phenotype-genotype
combinations were permuted 1,000 times in R, and the coefficients for SNP ×
Treatment and SNP × Treatment × Sex effects provided null distributions against
which to compare the actual coefficients and assign P-values. FDR values were again
estimated using qvalue. r2 values for models including each SNP alone as a fixed
effect were calculated using R.
Haplotypes of SNPs were assessed for the presence of blocks of high LD
across the X chromosome using the program Haploview (BARRETT et al. 2005). Since
these lines are homozygous for any variation, these comparisons essentially involve
counts of gametes. Missing SNP data (Table A.3) were imputed using the program
fastPHASE version 1.1 (SCHEET and STEPHENS 2006). The 10 haplotype blocks (sets
of 2-3 SNPs within 9 different genes) indicated to have significant levels of LD by the
Haploview program were tested for associations with both load and expression
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phenotypes. These association tests were performed in the same manner as listed
above for single SNPs, using the mixed models:
yijklmno = µ + Haplotypei + Sexj + (Haplotype × Sex)k + Linel
+ Daym + Infectorn + Platero + εijklmnop (5a)
yijklm = µ + Haplotypei + Linej + Dayk + Infectorl + Platerm+ εijklmn (5b)
where Equation 5a tests for genotypic effect of Haplotype (i = 1...10) on bacterial load
and Haplotype × Sex effects on bacterial load in all flies; Equation 5b was used to test
for effects of Haplotype on bacterial load in males or females individually. As above,
P-values were assigned based on null distributions of coefficients of haplotype effects
from permuted data sets.
In addition to associations between single SNP genotypes and phenotypes,
effects of epistatic interactions were also examined. Here, the effects of interactions
between every possible combination of SNP pairs (both within and between genes)
were tested. Rigorous inference of pairwise epistasis normally requires consideration
of all nine two-locus genotypes, and the usual caveats of fitting linear models with
sparse marginal counts apply (COCKERHAM 1954). Here we have homozygous lines,
so there are only four genotypes to contrast, and only one degree of freedom for tests
of the single epistatic component and fixed marginal frequencies, so the model is
closer to that of (CHEVERUD and ROUTMAN 1995). With the low-frequency alleles of
some SNPs, not every SNP pair allowed for valid tests of associations with all four
genotype combinations, so these pairs were not included. For each valid test, two-way
ANOVAs were performed to test associations with each phenotype using models both
with and without SNP interaction terms; a significant difference between the fit of the
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two models to the data indicated an effect of the SNP interaction. The full and reduced
models compared here are as follows:
full: yijk = µ + SNP1i + SNP2j + (SNP1 × SNP2)k + εijkl (6a)
reduced: yij = µ + SNP1i + SNP2j + εijk (6b)
where y is the load or expression phenotype, SNP1 (i = 1...88) and SNP2 (j = 1...88)
are the two SNPs of interest, and SNP1 × SNP2 is the interaction term of the allelic
effects of these two SNPs. Due to the computational time needed to test all SNP
combinations, these simpler linear models were applied, using estimated line means
for the load and expression phenotypes. To accommodate the same random effects as
above, the phenotypic values used were the least squares means for each line obtained
using mixed models in SAS, based on Equation 1b for load phenotypes and Equation
4 for expression phenotypes. These SNP interaction effects were tested for
associations with load in males, females, and both sexes combined, along with the sex
difference in load (female load - male load) for each bacterium. In addition,
associations were tested with induction of expression (infected - uninfected expression
levels) in males, females and both combined. As above, with these ANOVA tests, we
calculated P-values by permuting the genotype-phenotype combinations 1,000 times
and comparing actual F statistics to the null distributions of F statistics from tests with
the permuted data. Again, r2 values were calculated to quantify the proportion of
variance explained by the interaction term; this was determined from the difference in
r2 values of the full and reduced models.
Beyond tests of association between the genotypes and phenotypes of these
lines, we also tested the ability of expression phenotypes to predict load after
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infection. More specifically, we tested the effects of uninfected expression levels and
induction of expression on E. faecalis levels after infection. These tests used the
following models:
yijklmn = µ + Expi + Sexj + (Exp × Sex)k + RpL32l + Platem + Repn+ εijklmno (7a)
yijklmnop = µ + Expi + Infectionj + (Exp × Infection)k + Sexl
     + (Exp × Infection × Sex)m + RpL32n + Plateo + Repp+ εijklmnopq (7b)
Here, y is the load phenotype, ln(cfu per fly), and the model includes Exp (the
expression level of the gene assayed, 1/CT) as a fixed effect, along with RpL32
(expression level of RpL32) as a covariate to normalize the expression level of the
gene of interest. Sex (j = 1,2), along with sex interaction terms are also included as
fixed effects in both (except when each sex is considered individually). Plate (m = 1,2)
and Rep (n = 1...3, replicate) were also included as random effects in these models. In
Formula 7a, Infection status is not included; here only uninfected or infected samples
are considered at one time. In Formula 7b, however, the Expression × Infection term
accounts for induction effects (if uninfected and infected flies have significantly
different expression levels). Again, significance values for these tests were calculated
based on null distributions of coefficients from tests using data permuted 1,000 times.
Results
Variation Observed in X-Linked Immune Genes: To quantify effects of
naturally occurring X-linked variation in immune genes on immune phenotypes, X
chromosomes from a natural population of D. melanogaster were extracted into co-
isogenic autosomal backgrounds. To find polymorphic sites in the immune genes in
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these lines, 21 candidate genes were resequenced in eight sample lines. In the
approximately 67.5 kb of sequence obtained in these lines (including intronic, exonic,
3’ and 5’ untranslated and intergenic regions), 947 SNPs were uncovered, one SNP
about every 71 bases on average.  Out of the SNPs found in this sample, 172 are in
coding regions, and 23 of these (13%) are nonsynonymous. An analysis of the
sequence polymorphisms seen here shows non-skewed values of Tajima’s D, but
somewhat lower levels of variation (Table 2.1) than have been seen in other
population genetic analyses of Drosophila immune genes. Compared to studies
including autosomal immune and non-immune genes from non-African populations of
D. melanogaster (ANDOLFATTO 2001; RAMOS-ONSINS and AGUADE 1998), these X-
linked immune genes have much lower values of θW than the autosomal immune
genes (t-test, P = 0.0002), while still showing significantly higher levels of variation
than X-linked non-immune genes (t-test, P = 0.0127). Most of the autosomal immune
genes assayed for polymorphism, though, have been AMPs, and since none of these
exist on the X chromosome for comparison, this disparity in levels of variation
between X-linked and autosomal immune genes could be due at least in part to
differences among functional groups.
Genetic Variation in Bacterial Load: We calculated bacterial load means for
each D. melanogaster X-extraction line 26-30 hours after infection with E. faecalis
and with S. marcescens. The line means in load span a range of 9.82 to 16.73 natural
log colony-forming units per fly (ln(cfu/fly) for E. faecalis and 7.23 to 10.29
ln(cfu/fly) for S. marcescens, representing 1,007-fold and 21-fold ranges which span
1.6 to 1.1 average within-line phenotypic standard deviations, respectively (Figure
2.1)). Analyses of variance showed that this variation was significant among lines for
both bacteria (P < 0.001 for each). Furthermore, the line means of load for the two
bacterial species are not correlated (correlation coefficient = 0.035, N.S., Figure 2.1C).
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Figure 2.1 Line means of bacterial load after infection with A) Enterococcus faecalis
or B) Serratia marcescens and C) scatterplot of means of load for the two bacteria.
Lines are plotted in rank order for each bacterium in A and B. Bacterial load is
measured as the natural log of the count of colony-forming units per fly ln(cfu/fly),
shown with the standard errors of the mean.
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A lack of correlation of load across bacterial types has been noted in earlier studies
(LAZZARO et al. 2006; LAZZARO et al. 2004), and the interpretation has been that
bacterial-host interactions are bacterial species-specific, which can lead to different
immune response dynamics, depending on the virulence mechanisms employed by the
bacteria and the host response to this infection.
In addition to differences among lines in bacterial load after infection, we also
find variation among lines in differences in load between males and females. Figure
2.2 shows the sex differences in mean load of both bacteria (in terms of ln(cfu/fly)
across all the lines). These differences (female mean cfu/fly – male mean cfu/fly)
range from 1.9 x 107 to –3.6 x 106 cfu/fly (from 1080-fold higher in females to 31-fold
higher in males) for E. faecalis, with a median difference (across the line means) of
6.4 x 106 cfu/fly. No effort was made to control for body size between sexes, but these
sex differences on load are much larger than what might be expected from body size
differences alone. For S. marcescens, the differences range from 9.3 x 104 to –2.8 x
104 cfu/fly (from 11-fold higher in females to 12-fold higher in males), with a median
difference of 5.3 x 103 cfu/fly. Significantly more than half the lines bear mean
differences greater than zero for both E. faecalis (χ2, d.f.= 1, P = 2.3 x 10-18) and S.
marcescens loads (χ2, d.f. = 1, P = 0.0055). With most lines here displaying higher
bacterial load in females than in males after infection, this could imply that males in
these lines have more effective immune responses than females. MCKEAN and
NUNNEY (2005) find the opposite effect (higher load in males after infection) with
plentiful food and mates, yet this study also highlights the condition-dependent nature
of these results. Furthermore, these experiments have included load assays after
different types of bacterial infections, which might not be expected to yield the same
levels of bacterial load or sex differences in load.
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Figure 2.2 Sex differences in mean bacterial load after infection with (A) E. faecalis or
(B) S. marcescens, displayed as (female ln(cfu/fly) – male ln(cfu/fly)) ± (standard
error of the difference) and (C) histogram of P-values of t-tests of sex difference in all
lines after E. faecalis infection (black bars) or S. marcescens infection (gray bars).
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Many of these lines show significant differences between male and female
load, particularly when infected by E. faecalis. When each line is tested for sex effect
on load, the distribution of P-values is highly skewed from an expectation of equal
load in both sexes, with an excess of t-tests with P < 0.05 (χ2, d.f. = 1, P = 8.8 x 10-16)
in flies infected with E. faecalis; however, in those infected with S. marcescens, P-
values from t-tests of sex effects show no significant departure from the expected
distribution (χ2, d.f. = 1, P = 0.36) (Figure 2.2C). Even though these lines show a wide
range of differences between sexes, bacterial load after infection in males and that in
females are significantly correlated for both E. faecalis and S. marcescens
(Spearman’s τ, P = 0.0025, P = 3.21 x 10-11). Thus, for most of the lines, higher (or
lower) bacterial load remains relatively consistent in both sexes. As expected from the
greater sex differences in lines infected with E. faecalis, though, load values in males
and females infected with this bacterium are less strongly correlated than are those in
flies infected with S. marcescens.
Genotypic variation among the extraction lines was tested for association with
variation observed in immune phenotypes. X-linked genes from immune-related
pathways (Figure 2.3) were chosen as candidates and genotyped to determine standing
levels of variation. 88 SNPs in 20 candidate immune genes (Table 2.1) were
individually tested for allelic effects on bacterial load phenotypes after infection with
both E. faecalis and S. marcescens. Table 2.2 lists the q-values, based on P-values
calculated from permuted null distributions, for those SNPs that showed at least one
phenotypic association with FDR < 10% (q < 0.1). While these tests reveal possible
associations with multiple SNPs within different immune genes, any given SNP
typically explains less than 8% of the variance in bacterial load phenotypes (Table
2.2).
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Figure 2.3 Genes in Drosophila immune-related pathways. Those colored black are X-
linked genes included in this study, those outlined in black are X-linked, but were not
genotyped here. Pathway genes and interactions included based on information in
previous studies (ARBOUZOVA and ZEIDLER 2006; FERRANDON et al. 2007; FOLEY and
O'FARRELL 2004; LECLERC and REICHHART 2004; STRONACH and PERRIMON 2002;
WASSARMAN et al. 1995).
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Table 2.2 SNPs Associating with Load Phenotypes
Functional Class Gene Location Change
Ef   
female
Ef       
male
Ef          
ALL
Sm 
female
Sm    
male
Sm        
ALL
Ef       
SNP*Sex
Sm     
SNP*Sex
Signal hopscotch exon V->L 0.688 0.739 0.981 <0.001*** 0.360 0.032* 0.172 0.946
Transduction 0.7 0.3
hopscotch exon <0.001*** 0.025* 0.981 <0.001*** 0.076* <0.001*** <0.001*** 0.022*
0.4 0.5 0.8 0.2 0.4 6.2 0.9
hopscotch exon <0.001*** 0.120 <0.001*** <0.001*** 0.735 0.372 0.274 0.043*
0.4 0.2 0.1 0.7
hemipterous exon Y->C 0.476 <0.001*** <0.001*** 0.445 0.801 0.372 0.323 0.498
1.0 0.6
hemipterous exon A->S 0.476 0.215 0.981 0.847 0.520 0.758 0.029* 0.997
5.9
hemipterous exon 0.258 0.973 0.981 0.732 0.123 0.168 0.029* 0.997
6.2
Tak1 intron 0.258 0.973 0.404 0.775 <0.001*** <0.001*** 0.304 0.417
0.8 0.5
TRAF3 exon 0.999 <0.001*** <0.001*** 0.283 0.393 0.042* 0.000*** 0.997
1.0 0.0 0.1 6.2
Secreted outstretched exon A->S 0.404 0.973 0.521 0.117 <0.001*** <0.001*** 0.850 <0.001***
0.8 0.4 1.1
upd2 exon 0.999 0.356 0.536 0.067* 0.633 0.140 0.925 0.731
0.4
upd3 intergenic 0.306 <0.001*** <0.001*** <0.001*** 0.336 <0.001*** 0.123 <0.001***
0.4 0.2 0.4 0.2 0.9
Iron Metabolism Tsf1 exon 0.999 <0.001*** 0.012* 0.912 0.814 0.906 0.151 0.997
0.9 0.4
Hematopoesis lozenge exon 0.306 <0.001*** 0.688 0.092* <0.001*** <0.001*** <0.001*** 0.997
1.0 0.6 1.2 0.8 7.7
Pvf1 5' UTR 0.999 0.973 0.981 0.851 0.135 0.443 0.987 0.037*
0.6
Pvf1 exon 0.043* 0.120 <0.001*** 0.832 0.633 0.890 0.987 0.731
1.5 0.9
Pvf1 exon 0.000*** 0.221 <0.001*** 0.065* 0.829 0.271 0.487 0.034*
0.5 0.3 0.3 0.7
Pvf1 intron 0.453 0.226 0.134 0.445 0.109 0.028* 0.808 0.997
0.0
Rps6 exon 0.999 0.951 0.981 0.820 0.000*** 0.017* 0.987 0.037*
0.6 0.2 1.0
Serine Protease Ser7 intergenic 0.999 <0.001*** 0.022* 0.117 <0.001*** 0.833 0.029* <0.001***
0.2 0.1 0.4 6.2 0.9
Q-values shown for SNPs that associate with at least one load phenotype (based on having FDR q < 0.1). Percent of total phenotypic variance explained 
shown for each SNP with q < 0.1 (below q-value). Change = amino acid change associated with SNP, where applicable. 69 of 88 SNPs show no 
association with load phenotypes with q < 0.1. *q < 0.1, ***q < 0.001.
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Figure 2.4 Example effects of SNP on both E. faecalis (A & C) and S. marcescens (B
& D) load after infection in females (solid lines) and males (dashed lines). SNPs
shown include hop exon7-01 (synonymous, residue 870) in A & B and hop exon7-02
(synonymous, residue 968) in C & D.
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Out of the 19 SNPs in 12 genes that associate with one or more of the load
phenotypes at this level, eight associate (at least marginally) with phenotypes for both
bacteria; however, five of these show opposite effects across bacteria in one or both
sexes. Examples of this include two SNPs in the gene hopscotch (hop). As depicted in
Figure 2.4, one SNP in exon 7 of the gene (panels A & B) has significant allelic
effects on load in both males and females, with both bacteria. The effects of the two
infections in males, though, appear in opposite directions - a substitution from the “A”
allele to the “G” allele of this SNP associates with a lower E. faecalis load, yet a
higher S. marcescens load after infection. Similarly, for the second SNP in hop exon 7
(306 bp downstream from the first, panels C & D), allelic effects are once again
significantly associated with load in females infected by either bacterium, yet the load
variation in females occurs in opposite directions for the two bacteria.
Besides the distinct phenotypes and associations appearing in response to each
of the two bacterial infections, some SNPs also associate with load variation in a sex-
specific or even sexually antagonistic manner. Out of the 19 SNPs associating with
load, 12 show evidence of sex interactions influencing the associations with the load
of one or both bacterial infection. More specifically, several of these actually appear to
have opposite effects in males and females; most of these SNPs do not show
significant associations in both sexes individually, though, lessening our ability to find
clear instances of sexually antagonistic associations. Any potentially sexually
antagonistic effects, though, only appear with one of the two bacteria in each case. An
example of this is seen with the SNP in hop Exon 7 in Figure 2.4A.
In addition to single-SNP tests of association, we consider the possibility that
multiple SNPs that fall into particular haplotype configurations might correlate with
differences in immune function. We identified haplotypes as collections of SNPs in
LD and subsequently tested these for associations with immune phenotypes.
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Haplotype blocks with significant levels of LD (as defined by the program Haploview,
see Materials and Methods) were identified in 10 sets of 2-3 SNPs across nine genes.
Most of these blocks involved fairly closely located SNPs. Less than 17% of all SNP
pairs within 1 kb of each other were found to be in high LD, consistent with previous
findings that LD decays quickly along the Drosophila genome (CARBONE et al. 2006;
LONG et al. 1998). These blocks of high LD were tested for associations with load
phenotypes. Variation in six of these haplotype blocks significantly associated (P <
0.05) with differences in one or more bacterial load phenotype (Table 2.3). Twelve
individual haplotype-phenotype associations appear with P < 0.05, 10 of which have a
FDR < 10% (q < 0.1). Many of these associations only appear with E. faecalis load
phenotypes; three haplotypes appear to associate with S. marcescens load - but only in
sex × haplotype interactions. Additionally, for all the haplotype blocks that show
significant associations, none of the SNPs included in each haplotype associate
individually with the same load phenotype (with FDR < 10%). Furthermore, many of
the SNPs included in these haplotypes are noncoding or synonymous; the only
nonsynonymous SNPs among these clusters are the two in the Pvf1 haplotype. These
two SNPs, both located in Exon 1, appear to be outside of the identified PDGF domain
and the putative signal peptide of the gene, so no obvious disruption of function is
inferred from their amino acid changes. Overall, it appears that the SNPs within the
significantly associating haplotypes are most likely in linkage disequilibrium with any
variation that could directly lead to phenotypic differences in these lines.
For each possible pair of SNPs among the 88, we tested for pairwise epistasis
based on the significance of the interaction term in two-way ANOVAs. Figure 2.5
depicts those pairs of genes within the Toll, imd, JAK/STAT and JNK pathways that
contain SNPs with interactions associating with load phenotypes with q-values less
than 0.1 for tests of models using SNP pair interactions to explain variation in
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Table 2.3 Multiple SNP Clusters Associating with Load Phenotypes
Gene(SNPs) Location
Ef 
female Ef   male Ef ALL
Sm 
female Sm male Sm ALL
Ef     
Sex*Hap
Sm   
Sex*Hap
Dredd (2,3,4) Exon2, Intron1, 5'intergenic 0.139 0.226 0.489 0.195 0.931 0.443 0.191 0.021*
phl (6,7) Exon4 0.187 0.250 0.017* 0.650 0.096 0.473 0.722 0.328
mxc (1,2) 5'intergenic & Exon2 0.013* 0.037* 0.101 0.325 0.150 0.123 0.028* 0.285
hep (9,10,11) Exon5, Exon4, Exon3 0.043* 0.084 0.121 0.311 0.336 0.209 <0.001** 0.026*
Pvf1 (3,4) Exon1 <0.001** 0.001** 0.019* 0.095 0.274 0.104 0.348 0.625
Tak1 (1,2) Intron4 & Exon3 0.956 0.945 0.974 0.575 0.486 0.484 0.241 0.033*
* P  < 0.05,  ** P  < 0.01
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Figure 2.5 Epistatic interactions associating with bacterial load after infection with (A)
E. faecalis and (B) S. marcescens. Lines between a pair of genes correspond to at least
one interaction between SNPs in those genes having a significant effect on the load
phenotype of the corresponding pattern (ANOVA, q < 0.1). Interactions shown
associating with male or female load were only those that did not also associate with
load in both sexes combined. (Ef = E. faecalis; Sm = S. marcescens)
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bacterial load after infection. Most genes – 11 out of 12 tested in these pathways –
contain SNPs involved in interactions associating with one or more of the load
phenotypes at the q < 0.1 level. Additional interactions were found to be significant at
this threshold involving genes outside these pathways (thus not depicted on these
diagrams), including lozenge, Pvf1, Ser7, and Tsf1. One of the genes, upd2, also had
an interaction between a pair of SNPs within the same gene that associate with a load
phenotype (q < 0.1). The interaction terms of the models explain different amounts of
phenotypic variance, even among interactions showing significant effects (at the q <
0.1 level). Some interactions account for less than 0.1% of the variance, while others
explain up to 20.6% (Pvf1 × Traf2 interaction term with female load after S.
marcescens infection). This amount of variance is substantially higher than that
explained by each SNP individually; the sum of the percent variance explained by the
two included SNPs is less than 0.1% in this instance.
Genetic Variation in Immune Gene Induction: To evaluate the effects of X-
linked genetic variation on immune gene induction, a subset of 16 lines was selected
from the collection of X-extraction lines, and males and females of these lines were
assayed for expression of immune-related genes before and after infection with E.
faecalis. We used the differences in these levels to quantify the induction of gene
expression in response to infection. The genes examined include those encoding the
antimicrobial peptides Defensin (Def), DiptericinA (DptA) and Metchnikowin (Mtk),
as well as Peptidoglycan Recognition Protein-SA (PGRP-SA) and Transferrin1 (Tsf1),
involved in iron transport. The subset of lines was selected from the tails of the
distribution of mean sex differences of E. faecalis loads, allowing for tests of
associations of immune gene induction with sex differences in load.
The 88 immune-related SNPs were tested for association with induction
phenotypes for each of these genes, in males, females, and both sexes combined, as
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well as in phenotypic associations with sex by SNP interactions. Table 2.4 lists the
SNPs that showed association (with FDR < 10%) with one or more of the induction
phenotypes. Only 10 of the 88 SNPs appear with significant associations, yet these
represent variation in seven separate genes (six of which also have SNPs or haplotypes
associating with load phenotypes). While some SNPs show associations with more
than one phenotype, most show isolated effects - five out of the nine associate with
only one of the induction phenotypes. Most of these associations appear with
induction phenotypes in only one sex, yet only one SNP associates significantly with
sex difference in induction. While most of these associations explain less than 8% of
the variance observed (some less than 1%), the Ser7 exonic SNP appears to explain
more than 14% of the observed variance in Mtk induction in females (Table 2.4).
Correlations Between Induction and Load Phenotypes: In addition to
testing associations between genetic variation and immune gene phenotypes, we also
tested whether any of the variation observed in induction of immune genes correlated
with variation in bacterial load after infection with E. faecalis. Here, we tested the
ability of models incorporating expression levels (before and after infection, as well as
levels of induction) to explain levels of bacterial load in these lines of flies. One
putative association was found, where the induction of Tsf1 correlates negatively with
bacterial load after E. faecalis infection (P = 0.008, based on permuted null
distribution) in males. Figure 2.6 displays bacterial load line means plotted against
induction line means of Tsf1 (normalized by RpL32 expression) in both males and
females after infection with E. faecalis. Increased induction levels of Tsf1 associate
with lower levels of bacterial load after infection in males, while female values show
no significant correlation between these traits.
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Table 2.4 SNPs Associating with Immune Gene Induction Phenotypes
Functional Class Gene Location Change Def DptA Mtk PGRP-SA Tsf1 Def DptA Mtk PGRP-SA Tsf1 
Signal pole hole exon 0.997 0.820 0.506 0.230 0.170 0.551 0.518 0.954 0.976 <0.001***
Transduction 3.0
pole hole exon 0.997 0.820 0.887 0.230 0.170 0.368 0.197 0.954 0.144 0.056*
1.8
TRAF2 intergenic 0.023* 0.870 0.813 0.161 0.247 0.551 0.922 NA 0.976 0.806
6.7
TRAF3 exon NA <0.001*** NA 0.228 NA 0.382 <0.001*** 0.954 NA NA
7.1 4.8
Secreted upd2 exon <0.001*** 0.820 1.000 0.248 0.170 0.551 0.943 0.681 0.976 0.042*
0.3 7.9
Iron Metabolism Tsf1 exon <0.001*** NA 0.017* 0.228 NA NA NA NA NA NA
4.5 1.6
Hematopoesis Pvf1 exon A->T NA 0.381 NA NA NA 0.551 0.518 NA NA NA
Pvf1 exon 0.997 0.820 0.992 0.161 0.075* 0.551 0.546 NA 0.976 0.806
1.7
Serine Protease Ser7 intergenic <0.001*** NA <0.001*** 0.228 NA NA NA NA NA NA
4.6 1.2
Ser7 exon 0.261 0.820 0.046* 0.272 0.075* 0.551 0.197 NA 0.976 0.806
14.3 4.5
Functional Class Gene Location Change Def DptA Mtk PGRP-SA Tsf1 Def DptA Mtk PGRP-SA Tsf1 
Signal pole hole exon 0.582 0.682 0.425 0.481 0.277 0.923 0.620 NA 0.759 0.539
Transduction
pole hole exon 0.599 0.645 0.620 0.412 0.387 0.906 0.318 0.760 0.694 0.592
TRAF2 intergenic 0.594 0.874 0.425 0.549 0.912 0.788 0.832 NA 0.657 0.763
TRAF3 exon 0.448 <0.001*** 0.620 0.515 NA NA NA NA NA NA
5.9
Secreted upd2 exon 0.149 0.874 0.620 0.549 0.387 0.788 0.832 0.760 0.657 0.488
Iron Metabolism Tsf1 exon 0.119 0.899 <0.001*** 0.515 0.273 NA NA NA NA NA
1.7
Hematopoesis Pvf1 exon A->T 0.849 0.450 NA 0.515 0.657 NA 0.620 NA <0.001*** NA
0.3
Pvf1 exon 0.691 0.450 0.620 0.515 0.912 0.906 0.832 NA 0.657 0.539
Serine Protease Ser7 intergenic <0.001*** 0.902 <0.001*** 0.515 <0.001*** NA NA NA NA NA
0.2 0.5 0.0
Ser7 exon 0.590 0.450 0.104 0.549 0.908 NA 0.741 NA 0.750 0.539
Q-values shown for SNPs that associate with at least one induction phenotype at an FDR ≤ 10% (q ≤ 0.1); 79 of the 88 SNPs tested showed no association with any induction 
phenotype. Percent of phenotypic variance explained by association shown for each test with q < 0.1 (below q-value). Change = amino acid change associated with SNP, 
where applicable. *q < 0.1, *** q < 0.001
Female Induction Male Induction
Combined Induction Effect of Sex by SNP Interaction on Induction
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Figure 2.6 Line means for bacterial load vs. Tsf1 induction levels (infected minus
uninfected expression, normalized by RpL32 expression) after infection with E.
faecalis in males (closed points, solid regression line) and females (open points,
dashed regression line).
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Discussion
To examine the effects of genomic location on genotypic variation and
phenotype, we measured associations between polymorphisms in X-linked immune
genes and response to bacterial infection in lines of D. melanogaster. These lines,
bearing naturally varying X chromosomes in a co-isogenic autosomal background,
were genotyped for SNPs in 20 immune genes. These X-linked immune genes include
members of numerous immune-related pathways. The Toll and imd pathways, key to
the humoral antimicrobial response in Drosophila, have representatives on the X
chromosome, and the JAK/STAT pathway, also involved in response to bacterial
infection, has a significant excess of its genes on the X (χ2, d.f.=1, P = 7.7 x 10-5).
Interestingly, while the X-linked genes from these pathways include those with roles
in recognition and signaling, there are no antimicrobial peptide genes yet identified on
the X chromosome. The absence of antimicrobial peptide genes on the X chromosome
is highly significant (Fisher’s Exact Test, P = 0.0036), and the cause for this remains a
puzzle.
Other than the genic content of the X compared to the autosomes, this
chromosome also provides a unique environment that may allow different levels and
types of genetic variation to exist compared to that on the autosomes. Furthermore,
since genes on the X chromosome spend 1/3 of their time in hemizygous males, they
are exposed to different selective pressures; hemizygosity may expose recessive
alleles, purging deleterious genotypes and fixing beneficial ones. This is expected to
result in lower levels of variation on the X chromosome relative to autosomes with the
exception of alleles showing antagonistic phenotypes either between sexes or in
different environments or genetic backgrounds (CHARLESWORTH et al. 1987).
For immune-related genes on the X chromosome, we expect that variation may
be maintained in the population more readily if different alleles provide beneficial
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effects in diverse environments, such as with different bacterial infections, or in
distinct genetic backgrounds, including in males vs. females. The results found in this
study agree with this expectation. Genetic variation is observed in X-linked immune
genes, frequently associating with phenotypic variation in immune response. Many of
these associations, though, appear with one bacterial infection and not the other, or act
in a sex-specific or sexually antagonistic manner. Alleles such as these, associating
with phenotypic variation in a condition-specific manner, presumably would not be
selected for or against as rapidly as those with universally beneficial or deleterious
effects, even on the X chromosome. A few SNPs tested here do show more general
associations with the immune phenotypes examined; presumably alleles that appear
relatively detrimental in tests observed here could have been maintained in the
population because of beneficial effects in other circumstances (or for other
phenotypes).
Previous investigations (LAZZARO et al. 2006; LAZZARO et al. 2004) have
involved similar tests of association between genotypic variation in immune genes on
the second and third chromosomes of D. melanogaster and differences in immune
response phenotypes. It is difficult to make direct comparisons between these studies,
involving fly lines from separate populations, different bacterial infections, and
distinct experimental setups, including different levels of replication. We do find,
though, that similar to those studies, variation in numerous genes throughout immune
pathways associate significantly with phenotypic variation. Interestingly, genetic
variation on the second chromosome can explain 47.2% of the total variance in
bacterial load (after infection with S. marcescens, (LAZZARO et al. 2004)), and
variation on the third chromosome can explain 22.1% of the total observed variance in
bacterial load (after infection with P. rettgeri, (SACKTON et al., submitted)), yet X-
linked genetic variation in these lines explains only 15.5% of the total variance in
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bacterial load (after infection with S. marcescens). This suggests a lower level of
naturally occurring variation in X-linked immune genes and/or less influence of that
variation on immune phenotypes than is observed with autosomal genes. Additionally,
this could be due to the fact that the X chromosome, as a shorter portion of the
genome compared to the autosomes, may simply contain fewer loci affecting the
observed immune phenotypes. Individual polymorphisms within immune genes on the
second chromosome, though, appear to explain a larger proportion of the phenotypic
variance than was observed with the SNPs here; numerous autosomal variations
explained more than 5% of the phenotypic variance, whereas the most significant
explained up to 22.7% (LAZZARO et al. 2006, LAZZARO et al. 2004). Thus, variation in
X-linked immune genes could have a lesser influence on phenotypic variance than
polymorphism in autosomal genes, relative to environmental and experimental factors
influencing differences in bacterial load.
The associations found between autosomal genes and immune phenotypes
were strongly biased with respect to the functional class of immunity genes. There was
a preponderance of associations between bacterial load and SNPs in recognition
molecules, and a deficit of associations with SNPs in antimicrobial peptides (LAZZARO
et al. 2004). The X chromosome had a markedly different distribution of functional
classes of immune genes, including an absence of any antimicrobial peptides, and this
may contribute to the observation that there was no departure from random
representation of recognition and signaling functional classes among X-linked genes
that associated with bacterial defense (χ2, d.f. = 1, P = 0.327). Furthermore, since
variation in autosomal antimicrobial peptide genes appears to lack the phenotypic
associations that variation in other autosomal immune genes contain, it seems unlikely
that genic makeup alone would lead to different patterns of association between the X-
linked and the autosomal immune genes.
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While polymorphisms in X-linked genes appear to act mostly in sex-specific or
sexually antagonistic associations with phenotypic variation, associations involving
autosomal variation were much more likely to be sex-independent. An investigation of
associations with variation in immune genes on the second chromosomes uncovered
no significant sex or sex × line effects on load (LAZZARO et al. 2004). Similarly, SNPs
on the third chromosome associating with immune phenotypes show only marginal
effects of sex × SNP interaction (SACKTON et al., submitted). The inflated magnitude
of sexual dimorphism of X-linked immunity genes over autosomal genes is consistent
with several mechanisms that might produce different regulatory responses of X-
linked genes, including unique patterns of sex-biased expression (PARISI et al. 2003)
or imprecision of dosage compensation.
In addition to dimorphic effects on correlations between genotype and load, we
also observe sex-specific associations between induction levels and load in these lines.
This suggests that activation of parts of the immune response may be regulated in sex-
specific manners. This may reflect differences between the sexes in immune response
needs and/or priorities. Since Drosophila males and females may have different fitness
impacts of immune system activation (MCKEAN and NUNNEY 2001; MCKEAN and
NUNNEY 2005), it is reasonable to expect some genotypes to have different phenotypic
effects between the sexes.
As well as the sexual dimorphism that appears in the associations between X-
linked genetic variation and immune response phenotypes, distinct responses to
different species of bacterial infections were also observed here. Four out of the 19
SNPs (21.1%) that associate with bacterial load phenotypes in these lines (in both
sexes combined, with P < 0.05), though, show associations with variation in response
to both E. faecalis and S. marcescens, while only one out of 36 (2.8%) of all of the
autosomal SNPs associating with load differences after infections with one of these
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two bacteria are commonly found between the two. This excess of overlapping
associations among X-linked polymorphisms over those on the autosomes is
marginally significant (Fisher’s Exact Test, P = 0.048), indicating a higher level of
generality in the X-linked associations with response to different bacterial infections.
Most of the variation tested in these lines (both X-linked and autosomal), though,
appears to have the same effect across infections; flies bearing an allele that associates
with lower load after infection with one bacterium tend to have lower load after the
infection with the other bacterium as well. Thus, while the variation among X-linked
and autosomal immune genes may vary in generality of response to different bacteria,
there is not much evidence for antagonistic variation between bacterial infections.
The widespread presence of sex differences in associations in this study underscores
the complexity of the association between immune response and polymorphisms in X-
linked immune genes. These effects impacting genotype-phenotype correlations
appear to be more striking with X-linked variation than with that on the autosomes;
this is not unexpected, though, given the genomic environments of genes on these
respective chromosomes. If the X-linked variation existing in natural populations
includes alleles detrimental in one sex but not the other, these alleles are less likely to
be selected against and may remain in the population in spite of negative phenotypic
effects. Thus, even though we may expect genotypic variation associating with
phenotypic effects to be relatively uncommon on the X chromosome, phenotypic
differences observed here do correlate with polymorphisms in these lines. The
complex patterns of association seen, however, show that these segregating
polymorphisms bear characteristics consistent with predicted effects of natural
selection on X-linked variation.
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CHAPTER 3
FUNCTIONAL REGULATORY DIVERGENCE OF THE INNATE IMMUNE
SYSTEM IN INTERSPECIFIC DROSOPHILA HYBRIDS
Abstract
In order to investigate divergence of immune regulation among Drosophila
species, we have engaged in a detailed study of innate immune function in F1 hybrids
of D. melanogaster and D. simulans. If pathways have diverged between the species
such that incompatibilities have arisen between interacting components of the immune
network, we expect the hybrids to display dysregulation of immune genes. We have
quantified gene induction in hybrid and parental flies in response to bacterial infection.
These results show that while the hybrid flies do not suffer widespread immune
breakdown, they show significantly different regulation of many immune genes
relative to the parents. We examine this divergence in terms of additivity and
expression differences among genes, observing distinct patterns of dysregulation
among functional groups within the pathways of the innate immune system. The
functional groups most sensitive to misexpression in the hybrids are the downstream
components of the network, indicative of some propagation of dysregulation
throughout the immune pathways. Interestingly, this dysregulation does not appear to
associate with phenotypic differences in bacterial load post-infection in hybrids,
possibly highlighting some robustness of function of innate immune response to
perturbations like hybridization.
Introduction
Innate immunity has garnered interest in numerous areas of biological research
due to its ubiquity throughout the animal kingdom; in addition to serving as the only
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response to infection in invertebrates, the innate immune system provides an initial,
generalized attack against invading microbes and activates the adaptive immune
response in humans and other vertebrates (MEDZHITOV and JANEWAY 1997). The deep
evolutionary conservation of these pathways across taxa underscores the importance
of maintaining their components and functions for proper immune response.
Nevertheless, divergence in the innate immune response is evident – even between
closely related species – in the form of nucleotide or amino acid sequence differences
among orthologs, as well as at the level of which genes and gene families comprise the
immune pathways (DATE et al. 1998; SACKTON et al. 2007). This may reflect distinct
pathogen environments, driving diverse selection pressures and different roles of
immune response in the context of life history traits among species (SCHMID-HEMPEL
2003). If components of the innate immune system have diverged between two closely
related Drosophila species, we expect to see disruption of immune response regulation
in hybrids between those species. In this study, we quantify levels of dysregulation in
the hybrid immune response to pinpoint regulatory divergence between the parental
species.
Drosophila has become an effective model system for the investigation of the
evolution of innate immunity due to the well-studied genetics of insect response to
infection and the comparative resources available. While immune genes as a group
may undergo greater levels of positive selection than non-immune genes in flies
(SCHLENKE and BEGUN 2003), it has also become evident that when divided among
more specific functions, different subgroups of immune genes show distinct patterns
of evolution. For example, antimicrobial peptides (AMPs), despite facing direct
contact with invading microbial cells, have shown little amino acid divergence among
Drosophila species (CLARK and WANG 1997; DATE et al. 1998; LAZZARO and CLARK
2003; RAMOS-ONSINS and AGUADE 1998). On the other hand, some immune-related
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recognition proteins (scavenger receptors) show evidence of rapid evolution
(LAZZARO 2005). More recently, large-scale examination of patterns of selection
acting upon each of the immune genes in the genomes of multiple Drosophila species
has become possible. (SACKTON et al. 2007) used the newly sequenced genomes of six
species in the melanogaster subgroup to make sweeping comparisons of immune
genes. They found further evidence of distinct patterns of selection among different
functional classes of immune genes. In addition to the wealth of sequence data
available for the genomes of these Drosophila species, the use of genome-wide
expression arrays has allowed for investigation into the details of the regulation of
immune response in flies. Numerous studies using these arrays before and after
microbial infection (APIDIANAKIS et al. 2005; DE GREGORIO et al. 2001; IRVING et al.
2001) have clarified the dynamics of immune response, solidifying existing models of
innate immunity as well as identifying new genes and pathways that are regulated in
response to infection.
Throughout an organism, there are numerous systems whose regulatory
components may coevolve (DOVER 1992; SHAW et al. 2002). While maintaining
proper regulation within a species, if the interactions have diverged separately in two
lineages, these may yield incompatibilities in the context of interspecific hybrids
(LANDRY et al. 2007; TRUE and HAAG 2001). Divergence between closely related
species has been inferred from irregular development or enzyme expression patterns in
interspecific hybrids (DICKINSON et al. 1984; PARKER et al. 1985; WHITT et al. 1973;
WHITT et al. 1977), and more recently, regulatory divergence between species has
been estimated through the quantification of genome-wide expression levels in F1
hybrids using microarrays (AUGER et al. 2005; MICHALAK and NOOR 2003;
MOEHRING et al. 2007; RANZ et al. 2004). These studies have revealed numerous
instances of non-additivity of expression in hybrid individuals relative to parental
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phenotypes, indicative of specifically evolved regulatory mechanisms. Furthermore, in
complex regulatory networks, one would expect hybrids to be particularly prone to
dysregulation; if one or more portions of a pathway have diverged between parental
species such that they result in incompatibilities in the hybrids, these may propagate
throughout the network, manifesting in large-scale disruptions of regulatory
phenotypes.
Since the innate immune pathways in Drosophila contain many interacting
components and regulatory elements, it is likely that these may have diverged between
species and that interspecific hybrids may bear phenotypes reflecting this divergence.
To investigate divergence of the regulatory elements of the innate immune system
between Drosophila species, we have quantified dysregulation of the immune response
in interspecific hybrids by assaying transcription abundance in D. melanogaster, D.
simulans, and their F1 hybrids before and after infection. If genes throughout the
innate immune pathways have diverged between these two species, we expect the
hybrids to display non-additive levels of expression. Additionally, if different portions
of these networks bear different levels of interspecific divergence, the patterns of
dysregulation throughout the hybrid immune response should reflect those differences.
Materials and Methods
Fly Lines and Crosses: Inbred stocks of Drosophila melanogaster zygotic
hybrid rescue (zhr) strain (provided by A. Orr) and a Tsimbazaza strain of D. simulans
(provided by H. Hollocher) were used to construct hybrid crosses. Lines of each were
maintained in lab cultures, and from these we collected D. melanogaster virgin
females and D. simulans males. Interspecific crosses were set up with approximately
10 D. melanogaster females and 10 D. simulans males per vial. Intraspecific crosses
were also set up simultaneously, with about 10 females and 10 males apiece, to
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produce D. melanogaster and D. simulans offspring under similar conditions and at
similar ages as the F1 hybrid flies. F1 hybrid female flies (male hybrids from this
cross are not viable), along with D. melanogaster and D. simulans female flies, were
collected after eclosion.
Bacterial Cultures and Infections: To assay response to bacterial infection in
the flies, we infected them with Gram-negative Serratia marcescens. This bacterium,
chosen based on its previous use for immune studies in D. melanogaster (LAZZARO et
al. 2004), was derived from ATCC strain 13880. Bacterial cultures for infections were
grown overnight from freezer stocks, to a concentration of OD600 ≈ 1.0. Female
offspring from D. melanogaster, D. simulans and the D. mel × D. sim hybrid cross
were infected at approximately three to seven days after eclosion. Flies were infected
by pricking their thoraces with 0.1-mm tungsten needles (Fine Science Tools, Foster
City, CA) dipped in bacterial culture.
Transcript Quantification Using BeadChip Arrays: To estimate expression
differences before and after bacterial infection in hybrid flies and those from parental
strains, we used custom BeadChip Arrays (Illumina Inc., San Diego, CA) to quantify
transcript abundance in the samples. These were designed to include probes for 171
immune-related genes, along with 542 genes representing controls or pathways
investigated in other experiments (SACKTON et al., submitted). See Table B.1 for a full
list of genes included on the BeadChips, including classification of immune-related
genes by functional group. Flies from each strain were snap-frozen in liquid nitrogen
at six and at 12 hours after infection, in three replicate pools of approximately 12-15
flies each. Uninfected flies were also frozen immediately after infection to measure
baseline expression levels. For each sample, we isolated mRNA using a
Trizol:chloroform extraction, and then we synthesized cDNA and hybridized it to the
BeadChips using the BeadChip protocol. BeadChips were scanned, and the resulting
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signal values were normalized across arrays and across chips using qspline in the
beadarray R package.
Bacterial Load Quantification: Following previous studies (LAZZARO et al.
2004), bacterial clearing ability was estimated by quantifying bacterial load in infected
flies. Approximately 12 or 25 hours after infection, D. melanogaster, D. simulans, and
F1 hybrid flies were homogenized, three at a time, in 500 µl of LB broth. These
samples (n = 4-9 for each line and time point) were then plated onto agar plates using
a spiral plater (Spiral Biotech, Bethesda, MD). Plates were kept overnight to allow
colonies to grow enough to be counted by a colony counter to infer bacterial
concentration inside each homogenate sample. Plates were visually inspected to ensure
that colonies counted showed size and morphology expected.
Statistical Analysis: To test for expression differences before and after
bacterial infection, we used mixed linear models incorporating infection status as a
fixed effect, along with other random effects:
yijk = µ + Infectioni + Probej + Replicatek + εijkl (1)
Here, y is equal to transcript level, and Infection (i = 1,2) represents the infection
status of the flies (either uninfected or infected), included as a fixed effect. Probe (j =
1,2), representing the two separate probes for each gene on the array, and Replicate (k
= 1...3) were each included as random effects. Transcript abundance is estimated by
log2(Signal), where Signal is the normalized measurement from the arrays, log-
transformed to achieve a more normal distribution. These tests were performed
separately for each individual gene, at both six and 12 hours after infection, and for D.
melanogaster, D. simulans and F1 hybrid flies. In order to assess significance of the
results of these tests, we compared the coefficients of the infection effect to a null
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distribution comprised of coefficients calculated from tests of the same model with
expression data permuted 1,000 times relative to the genotype and infection status for
each gene.
To evaluate differences in expression levels among these groups of flies, we
used similar mixed models to test for significant effect of group or “species” on
expression. The models were set up as follows:
yijk = µ + Speciesi + Probej + Replicatek + εijkl (2)
In this case, y is again equal to transcript level, and Species (i = 1...3) is a fixed effect
including the three groups of flies, D. melanogaster, D. simulans and F1 hybrids.
Probe and Replicate are both included as random effects as in Equation 1. Here, we
tested differences among flies for each gene on the chip, examining each treatment
type and time point separately. As above, significance for each test was determined by
comparison to a null distribution of coefficients calculated using data permuted 1,000
times.
In addition to expression differences among flies, we also quantified induction
differences, where induction represents the change in expression before and after
infection. To achieve this, we employed similar mixed models, including an
interaction term to test the epistatic effect of treatment status (infected vs. uninfected)
on species differences in expression:
yijklm = µ + Speciesi + Treatmentj + (Species×Treatment)k
+ Probel + Replicatem + εijklmn (3)
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using the same setup as Equation 2, with the addition of Treatment (j = 1,2),
representing the infection status of the flies, along with an interaction term between
this and Species groups as fixed effects. These interactions were examined separately
for six hours after infection and 12 hours after infection, for each gene individually.
Once again, we permuted the expression values 1,000 times and collected coefficients
for the interaction term against which we could compare the actual results to
determine the significance for each test.
For each gene showing differences in expression or induction among the
groups of flies, we tested for the presence of non-additive expression (or induction) in
the F1 hybrids relative to parental levels. The null hypothesis was that F1 expression
levels were equal to midparent expression values, indicative of entirely additive
effects. To test the validity of this hypothesis for each gene, we performed tests using
models set up like Equation 2, where the only “species” groups included were parental
(D. melanogaster and D. simulans samples combined) and F1 hybrid flies. Significant
differences (P < 0.05) between parental mean and hybrid expression values allowed us
to reject the hypothesis of complete additivity. For these genes, we tested whether
hybrid expression showed evidence of dominance or transgressive variation. In this
case, the null hypothesis was that F1 expression levels equaled one of the parental
expression levels, indicative of dominant effects of that parental allele. We tested for
differences among groups of flies as above, but only including expression values for
hybrids and one parental species at a time for this set of genes. Significant differences
between hybrids and parental values provided evidence for transgressive effects, while
no difference here left us unable to reject the hypothesis of dominance of expression in
the hybrids.
To compare induction patterns of genes belonging to the Toll and imd
pathways in the context of their functional groupings within the pathways, we
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quantitatively organized genes by degree of similarity in patterns of expression
changes after infection using a simple hierarchical agglomerative clustering algorithm
(Cluster 3.0, DE HOON et al. 2004). Genes were grouped with hierarchical, centroid
linkage clustering using Euclidean distances to determine similarity. In addition, we
included an expected gene order based on relative location in the humoral pathways.
This informed the clustering such that once nodes of the gene tree were defined, the
orientation of each node ordered the genes according to pathway location, wherever
possible. When the trees for each group of genes were defined, we used Java
TreeView 1.1.3 (SALDANHA 2004) to visualize the gene clusters and associated
dendrograms. To quantify clustering of gene expression patterns relative to layout of
the genes in the Toll and imd pathways, we calculated the correlation coefficients of
gene orders from cluster analysis with those in the immune network. To determine
significance of each correlation value, we permuted the clustered gene orders 1,000
times and calculated correlations for each to achieve a null distribution, and then we
calculated P-values for the actual correlation coefficients based on these distributions.
Results
Expression Changes After Infection: To examine differences in immune
response between hybrid and parental flies, we quantified transcript abundance for
genes related to innate immunity and other pathways (including those involved in
metabolism and reproduction) using custom Illumina BeadChip arrays. Induction (or
repression) levels of genes represented on the arrays were estimated by comparing
transcript levels before and after infection. Genes showing significant differences
(with a nominal P < 0.05) in transcript abundance between uninfected and infected
flies (at six or 12 hours after infection) were considered to be induced or repressed.
Out of all immune-related genes on the array, 14.8% of the tests for all three groups of
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flies (76 out of 513) at 6 hours and 8.8% of tests (45 out of 513) at 12 hours had P <
0.05, both of which include significantly more than the 5% that would be expected by
chance (χ2, d.f. = 1, P6hr = 1.99 x 10-24, P12hr = 8.86 x 10-5); however, given the fact that
many of these genes were selected for their previously observed induction in flies after
infection, this is not surprising. Non-immune genes on the array also show some
expression changes, yet these are not as substantial, with 8.2% of tests (89 out of
1089) at 6 hours and only 1.6% of tests (17 out of 1089) at 12 hours bearing
significantly different expression levels before and after infection with P < 0.05.
Distributions of P-values for tests of expression differences before and after infection
are shown in Figure 3.1A for immunity genes and for the genes whose products
function in either metabolism or reproduction. Genes in these groups bear significantly
different distributions of P-values, with substantially more immune genes having
induction tests with P < 0.05 than either of the other classes of genes (χ2, d.f. = 2, P =
4.55 x 10-8). Furthermore, even within the immune group, genes corresponding to
different functions also show distinct levels of expression changes after infection (χ2,
d.f. = 2, P = 3.50 x 10-18, Figure 3.1B).
Since numerous investigations have quantified expression differences in
Drosophila after bacterial infection using whole genome arrays, we compared our
results to data from three of these (APIDIANAKIS et al. 2005; DE GREGORIO et al. 2001;
IRVING et al. 2001) to evaluate the uniqueness of the genes induced here. Out of the
set of genes showing expression changes in our study, only 37.6% (64 out of 170) of
the genes with differences at six hours and 54% (34 out of 63) with differences at 12
hours were also found to be induced or repressed after infection in one or more of the
other screens (based on the definitions of significant expression differences given in
each paper). Similarly, out of the 227 genes on the BeadChips that had been shown to
be induced in one of these previous studies, 39.6% (90 genes) had significant
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Figure 3.1 Distributions of P-values for tests of expression differences before and after
infection in groups of genes. Plot A shows immunity (orange), metabolism (brown)
and reproduction (purple) genes. Plot B displays functional groups within immunity
genes: recognition (green), signaling (blue) and effector (red) genes. Distributions of
groups in both A and B vary significantly in the proportion of genes with P < 0.05 (χ2,
d.f. = 2, P = 4.55 x 10-8 & P = 3.50 x 10-18, respectively).
A
B
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differences in expression after infection in this experiment. Causes of these differences
may include genetic variation among the lines used and a difference in expression
technologies. Most previous investigators have relied on Affymetrix expression
microarrays, and there will inevitably be false negatives when contrasting this
genome-wide approach with our more focused and sensitive test of immune related
genes. There were also differences among previous studies, due to many experimental
variables besides the expression platform, including different methods of infection,
different timing, and genetic differences among the Drosophila stocks. Furthermore,
these studies assayed response to infection with a variety of bacteria; infections with
different species of varying levels of pathogenicity in the flies will inevitably have
different influences on patterns of expression genome-wide.
Patterns of Non-Additivity in F1 Hybrid Expression: In addition to
comparing the number of genes changing expression after infection in the three groups
of flies, we also examined levels of expression of genes in F1 hybrids relative to those
in D. melanogaster and D. simulans. To quantify regulatory differences between
hybrids and parental species in the expression of immune-related genes, we classified
all genes with expression or induction differences among fly groups as showing
additive, dominant, or transgressive patterns (Table B.1). We find a substantial
number of immune genes showing non-additive expression levels in hybrids – in
uninfected flies as well as after infection. Interestingly, not only do levels of non-
additivity in immune genes vary across time points, but immune genes in distinct
functional roles (recognition, signaling, or effector) also show diverse patterns of
additive, dominant, and transgressive expression, as shown in Figure 3.2. Here we
observe that expression levels of most of these immune genes – both before and after
infection – are non-additive in F1 hybrids, relative to parental levels. On the other
hand, induction/repression levels (expression differences before and after infection)
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Recognition Signaling Effector
n=3 n=16 n=15
B
Recognition Signaling Effector
n=6 n=16 n=18
C
Recognition Signaling Effector
n=3 n=15 n=11
D
Recognition Signaling Effector
n=1 n=4 n=10
E
Recognition Signaling Effector
n=2 n=5 n=11
Figure 3.2 Proportion of immune genes differently expressed among D. melanogaster,
D. simulans and F1 hybrid flies in recognition, signaling and effector classes showing
patterns of additive (white), dominant (gray) or transgressive (black) expression
patterns in the F1 hybrids. A) Expression in uninfected flies. B) Expression in flies 6
hours after infection with S. marcescens. C) Expression in flies 12 hours after
infection with S. marcescens. D) Induction/repression in flies 6 hours after infection
with S. marcescens. E) Induction/repression in flies 12 hours after infection with S.
marcescens. Y-axes for plots represent proportion of all genes differently expressed
among groups of flies belonging to each pattern of expression; numbers at the top of
each column indicate total number of genes in that column.
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appear to be much more conserved in these flies; fewer genes show differences in
levels of expression change among groups of flies, and most genes that are differently
induced/repressed show additive effects in hybrids. In fact, only genes with effector
functions show evidence for transgressive effects of induction or repression; other
genes that differ among species groups only display additive or dominant effects.
Expression Levels Among Different Functional Classes of Immune Genes
in F1 Hybrids: To further examine the differences between hybrid and parental mean
expression levels indicated by the non-additive effects apparent in groups of the
immune genes, we plotted expression levels for all immune genes in hybrids against
parental mean expression of these genes, shown in Figure 3.3. Through these
comparisons, it is evident that a substantial number of immune genes appear as
outliers, indicative of non-additive expression in the hybrids. These outliers
(arbitrarily defined as points that lie outside of the 95% confidence interval of the
regression line) appear among genes expressed in uninfected flies, as well as in flies
six or 12 hours after infection (Figure 3.3A). Strikingly, the patterns of outliers in
expression levels vary widely among functional classes of immune genes. More
specifically, genes coding for effectors are highly over-represented among the higher
group of outliers (χ2, d.f. = 1, P = 7.19 x 10-13), where hybrid expression is higher than
parental mean expression, while genes coding for signaling proteins are highly over-
represented among lower outliers (χ2, d.f. = 1, P = 4.03 x 10-11), with lower hybrid
than parental mean expression.
In addition to comparisons between hybrid and parental expression levels, we
also examined levels of change in expression after infection in these flies (Figure
3.3B). Once again, it is apparent here that many genes in hybrids are induced (or
repressed) at levels consistent with additivity, yet there are still numerous immune
genes that appear as outliers in this comparison. In this case, there are not significant
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Figure 3.3 F1 vs. parental mean expression (A) and induction/repression (B) levels in
immune genes. Recognition genes are shown in green, signaling genes in blue, and
effectors in red. Gray lines represent 95% confidence intervals of the regression line
for the data.
B
A
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differences between outliers showing higher or lower induction levels, but effector
genes are once again prominent; the genes from this functional class are significantly
over-represented among all the outliers (χ2, d.f. = 1, P = 1.01 x 10-9).
Coordinated Regulatory Differences in Hybrid Expression Change after
Infection: To evaluate differences in induction or repression of immune genes in
hybrids compared to flies from the parental species in the context of defined humoral
pathways, we examined the patterns of genes clustered together based on similar
patterns of induction/repression across samples (Figure 3.4). When the order of the
clustered genes was compared to the order of gene products within the humoral
immune pathways, we found these to be significantly correlated for genes in both the
Toll and imd pathways (correlation coefficients = 0.643, 0.689; P = 0.008, 0.017,
respectively). Through this, we see that induction patterns across all species groups
appear to be more similar among genes closely grouped within the immune pathways.
To examine F1-specific patterns of coordinated gene regulation, we noted
which uniquely induced or repressed genes in hybrids belonged to the Toll and imd
pathways (Figure 3.5).  Only a handful of genes throughout these pathways showed
expression changes only in the hybrids, yet some patterns in the regulation of these
genes are apparent, at least at six hours after infection. At this time point, the only
genes that we observe to be uniquely regulated in the hybrids all belong to the imd
pathway and show positive expression changes after infection, consistent with a
systemic over-induction of genes in the imd pathway in response to Gram-negative
infection in hybrids.
Bacterial Clearing Ability in Hybrids and Parental Species: As a proxy for
systemic response to bacterial infection, we quantified bacterial load in terms of
colony-forming units (cfu) per fly, at 12 and 25 hours after infection with S.
marcescens in D. melanogaster, D. simulans and F1 hybrid flies. As shown in
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Figure 3.4 Genes throughout Toll and imd pathways (excluding effectors), clustered
based on patterns of changes in expression levels after infection among samples. Scale
bar indicates magnitude of expression change (log2(Signal) in infected flies –
log2(Signal) in uninfected flies).
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Figure 3.5 Genes uniquely induced in F1 hybrids throughout humoral immune
pathways. Genes in black are induced only in hybrids six (A) or 12 hours (B) after
infection with S. marcescens. Pathway genes and interactions included based on
information in previous studies (ARBOUZOVA and ZEIDLER 2006; FERRANDON et al.
2007; FOLEY and O'FARRELL 2004; LECLERC and REICHHART 2004; STRONACH and
PERRIMON 2002; WASSARMAN et al. 1995).
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Figure 3.6, hybrid flies show similar bacterial levels after infection compared to the
parental species, with no significant differences in load among groups of flies at 12
hours (ANOVA, P = 0.9815) or at 25 hours after infection (ANOVA, P = 0.7719).
Additionally, mortality was observed in the flies with and without bacterial infection;
the hybrids showed no significant difference in survival compared with the parental
flies, up to 4 days after infection (t-test, P = 0.251).
Discussion
Here we report our findings of regulatory divergence in innate immunity
between D. melanogaster and D. simulans, inferred from dysregulation of the immune
response in the interspecific hybrids of these flies. Despite a general trend of additivity
of expression of most immune genes in the hybrids, significant evidence for non-
additive regulation was also detected across diverse parts of the innate immune
pathway, indicative of divergent control of expression in response to bacterial
infection in the two species.  Interestingly, though the hybrids contain many genes that
differ from parental levels of expression, the systemic immune phenotypes do not
appear to be compromised in the hybrid flies; bacterial levels and survival rates after
infection are consistent between hybrid and parental flies, indicating a robustness of
the immune response to regulatory perturbations.
It is not surprising that the F1 hybrids examined here display distinctive
expression profiles compared to parental species. If regulatory controls of transcription
throughout the genome have diverged separately in two species, new combinations of
cis- and trans-regulatory factors that arise in the hybrids may lead to unique
expression patterns in the hybrids. Previous studies quantifying genome-wide
transcript levels in closely related Drosophila species and their hybrids have also
found substantial evidence for non-additive expression levels in interspecific hybrids
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Figure 3.6 Bacterial load after infection in D. melanogaster (dark gray), D. simulans
(white) and F1 hybrid (light gray) flies. Load represented as ln(cfu per fly) at 12 and
25 hours after infection with S. marcescens.
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(RANZ et al. 2004). Using data from previous assays of genome-wide regulatory
differences in interspecific Drosophila hybrids, ARTIERI et al. (2007) found significant
correlations between sequence divergence between the parental species and hybrid
dysregulation. We found no association between levels of amino acid divergence
between D. melanogaster and D. simulans and levels of dysregulation in the hybrids
as assessed by BeadChip analysis. We did, however, find a correlation between the
difference in parental expression levels and degree of hybrid dysregulation for the
genes examined (ANOVA, P = 0.0218). This may indicate that for the groups of genes
examined here, the functional context and regulatory control of a gene may better
predict hybrid dysregulation of the immune response than will interspecific divergence
at the sequence level.
Beyond examining correlations of individual gene properties, such as sequence
divergence, with that gene’s expression in hybrid flies, we find that genes belonging to
different functional groups within the innate immune response show distinct patterns
of dysregulation in hybrids. These functional groups, bearing genes whose products
are involved in recognition, signaling, and effector roles in the response to infection,
have been previously shown to have distinct patterns of sequence diversity – in terms
of both naturally occurring variation within populations as well as divergence among
species (LAZZARO et al. 2006; LAZZARO et al. 2004). The hybrid dysregulation that we
see here indicates that interspecific divergence in immune pathway genes manifests
differently not only in sequence differences, but also in distinct regulatory patterns
among groups of immune genes. In this case, the effector genes appear to be the most
dysregulated in hybrids after infection; these tend to be over-expressed in the hybrids
at all timepoints, and they are the group of genes most likely to show aberrant levels of
induction or repression in the hybrids after infection. The patterns of disrupted
expression in these downstream components of the immune response could indicate
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that regulatory differences in upstream components propagate throughout the network,
leading to the highest levels of dysregulation in these effectors.
In addition to being the group with an abundance of genes displaying unique
patterns of expression in the hybrids, the effectors also show greater levels of hybrid
overexpression than other functional groups. This directionality of the disruption may
indicate that the regulatory breakdown in these hybrids is not random. We might
expect some level of overexpression of immune genes in the hybrid flies relative to
parents, since hybrids between D. melanogaster and D. simulans have been shown to
have enlarged fat bodies (DICKINSON et al. 1984); however, this would not necessarily
lead to distinct differences in hybrid dysregulation among the genes corresponding to
separate functional groups within the immune pathways. The widespread
overexpression of the downstream genes in the hybrid immune response may reflect
some sort of basal regulatory mechanism of the pathways; perhaps the immune system
in these flies is primed to have high AMP expression in response to infection.
While an active response to infection may be beneficial in the face of regular
exposure to microbes, it could be costly if it takes too much energy away from other
vital tasks. To counter this, the Drosophila immune response typically includes
negative feedback mechanisms. Since the hybrid flies in this study display a more
active response to infection than the parental flies, this may represent a disruption of
the negative feedback in the immune pathways, potentially due to divergent regulation
of these mechanisms between the two parental species. If such disruption is present,
we would expect there to be decreased expression levels of genes with roles in
repression of the immune response in hybrids. We do, in fact, find evidence for this –
we observe that Dnr1, previously shown to repress activation of the imd pathway
(FOLEY and O'FARRELL 2004), is downregulated in hybrids more than in parents at
both six and 12 hours after infection, though most of these differences are not
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significant. It should also be noted that not all genes classified as members of the
group of effectors are antimicrobial peptides. Some of these genes encode proteins
involved in stress response that can be transcribed in response to infection, yet may be
induced as a result of other stresses – either at a systemic or cellular level. While
overexpression of these genes may reflect an overactive immune system, they could
also reflect instances of dysregulation in the hybrids independent of the response to
infection.
While differences in the regulation of immune gene expression are evident
between the parental species and with the F1 hybrids, it is also apparent that induction
and repression patterns are at least somewhat consistent among genes that are closely
positioned functionally in the humoral immune pathways. This is not entirely
expected, since the Toll and imd pathways are not transcriptional networks; upstream
genes in the pathways do not directly control the transcription of their downstream
neighbors. On the other hand, it is not surprising that there would be some level of
coordination of expression of genes clustered within the pathways, since the gene
products of these genes interact. This does show that not only the expression changes
after infection, but also their relative magnitudes across genotypes, are somewhat
consistent with their positions in the humoral pathways, implying coordinated
regulation of expression as well as evolution of that regulation.
The observation that members of the Toll pathway are dysregulated in hybrids
also raises questions about the effects of imprecise regulation of pleiotropic genes.
With its role in the control of embryonic development as well as immune response in
Drosophila, an intact Toll pathway is critical for proper function of multiple
phenotypes at various life stages in the fly. Patterns of dysregulation of Toll genes
could be associated with developmental differences in hybrids; distinct morphological
and developmental features have in fact been observed in hybrids of these Drosophila
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species (DAVID et al. 2002; MARKOW and RICKER 1991; STURTEVANT 1920).
Dysregulation of the Toll pathway in these interspecific hybrids has clearly extended
beyond control of embryonic development, though; differences in induction and
repression of Toll genes in hybrids as a result of bacterial infection in adult flies are
indicative of regulatory divergence specific to the immune response.
As pairs of species diverge, the hybrids that they may form can bear
dysfunctional phenotypes, ranging from inviability and sterility to more subtle
differences in morphology or regulation. Through the juxtaposition of two diverged
genomes, it is likely that numerous systems throughout a hybrid individual may be
disrupted and that even seemingly subtle regulatory differences could have fitness
consequences (ORTIZ-BARRIENTOS et al. 2007). In this investigation of immune
dysregulation of interspecific Drosophila hybrids, we have found that regulatory
divergence of the innate immune system between D. melanogaster and D. simulans
manifests distinctly in different portions of the immune response in F1 hybrids, with
the most notable disparities appearing in the downstream pathway components.
Furthermore, despite clear differences in patterns of expression and induction after
infection in the F1 hybrids, these flies appear as immunocompetent as flies from the
parental species, revealing a robustness of the immune function to even widespread
regulatory perturbations, and potentially highlighting an evolved ability of the immune
networks to tolerate expression differences – at least in flies maintained in laboratory
conditions.
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CHAPTER 4
GENOME-WIDE REGULATORY DIVERGENCE AFTER BACTERIAL
INFECTION IN INTERSPECIFIC DROSOPHILA HYBRIDS
Abstract
In order to assess the divergence of the innate immune response and genome-
wide consequences of bacterial infection between Drosophila species, we have
quantified transcript abundance before and after infection in D. melanogaster, D.
simulans and their F1 hybrids using Illumina short-read sequencing. If pathways in
this system have diverged such that incompatibilities have arisen between interacting
components of the immune network, we expect the hybrids to display dysregulation of
immune genes. Furthermore, since immune system activation may impact the entire
organism, we have examined the relationship between regulatory divergence and the
influences of a systemic response to infection by assaying genome-wide transcript
levels in these flies. With this, we find evidence for regulatory differences in the
hybrids relative to the parental species after infection. Consistent with our previous
study (Chapter 3), we observe distinct regulatory patterns among separate functional
groups of genes within the immune response, and we also see hybrid dysregulation in
non-immune pathways in response to infection, indicative of the broad effects of
divergence in the innate immune response.
Introduction
As closely related species evolve, they tend to display increasingly divergent
genotypes and phenotypes. If these species are relatively recently diverged, however,
some differences may be subtle, and changes in some genes may be balanced by
compensatory changes in other genes, yielding phenotypes that are not obviously
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different between the species. Some divergence at this level can be uncovered by
examining F1 hybrids between the diverged pair of species. Since interspecific hybrids
bear two distinct genomes juxtaposed in a single individual, they have the potential to
display dysregulation of the parental phenotypes if diverged regulatory mechanisms
do not act appropriately when combined (LANDRY et al. 2007; TRUE and HAAG 2001).
Previous studies have uncovered evidence of divergence of key functions within
hybrid individuals, leading to differences in enzyme levels or developmental patterns
in these organisms, when compared to the parental species (DICKINSON et al. 1984;
PARKER et al. 1985; WHITT et al. 1977).
More recently, studies of hybrid dysregulation have expanded to the genomic
scale as a variety of resources have become available for studying genome-wide
expression levels in numerous species. While some of these studies have assayed
regulatory divergence in taxa such as whitefish, maize, and other plants (AUGER et al.
2005; HEGARTY et al. 2005; RENAULT et al. 2009; SWANSON-WAGNER et al. 2006), a
concerted effort has been focused on expression patterns in interspecific Drosophila
hybrids (MICHALAK and NOOR 2003; MOEHRING et al. 2007; RANZ et al. 2004;
REILAND and NOOR 2002). One common finding among many of these studies is that
hybrids tend to display non-additive expression for many genes throughout the
genome. This may indicate that as species diverge, regulation of expression evolves
throughout the genome, and that these regulatory controls interact such that the hybrid
expression is driven outside of the parental range.
Beyond constitutive transcript abundance and developmental or reproductive
defects, it is expected that dysregulation in hybrids would be likely to occur in
regulatory networks throughout the genome, and that responses to outside stimuli by
such networks may be compromised in hybrids, or at least improperly activated. One
such network is that of the innate immune response in Drosophila. A complex set of
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pathways, involving recognition of invading microbes, signaling transduction, and the
transcription of effectors such as antimicrobial peptides (AMPs), the innate immune
network would seem susceptible to regulatory divergence between species leading to
improper immune response in interspecific hybrids. Previously, we found evidence for
such dysregulation when we quantified expression levels before and after infection in
a set of immune and non-immune genes (Chapter 3). Through this, we found non-
additive expression patterns, as well as overactivation of portions of the immune
response in hybrids, with variation in this dysregulation among genes belonging to
separate functional groups within the immune response. This is consistent with
previous findings that genes from these groups show distinct levels of polymorphism
and divergence among Drosophila species (SACKTON et al. 2007).
Here, we have further investigated the level of regulatory divergence in
immune response in Drosophila by assaying genome-wide transcript abundance in F1
hybrids using Illumina short-read sequencing of cDNA before and after infection. This
sequencing method (RNA-seq) has been gaining popularity as a flexible approach to
quantify genome-wide expression levels, and has been used successfully in a number
of model systems so far (CLOONAN et al. 2008; MORTAZAVI et al. 2008;
NAGALAKSHMI et al. 2008). Not only does this allow us to query transcript levels for
genes across the genome to evaluate widespread impacts of bacterial infection in the
hybrids, but we can also distinguish parental alleles within the F1 hybrids to quantify
allele-specific dysregulation in these flies. With this, we have found evidence for
hybrid dysregulation in the response to infection that varies among different functional
components of the immune response, consistent with our previous findings of distinct
patterns of evolution among these groups. Furthermore, we have found dysregulation
of other pathways throughout the genome, potentially indicative of a cost of immune
activation that may also be affected by divergent regulatory patterns in the hybrids.
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Materials and Methods
Fly Lines and Crosses: We used inbred laboratory stocks of the D.
melanogaster zygotic hybrid rescue (zhr) strain (provided by A. Orr) and a
Tsimbazaza strain of D. simulans (provided by H. Hollocher) for the hybrid crosses.
We collected virgin D. melanogaster females and D. simulans males and mated the
flies in vials with approximately 10 females and 10 males apiece. Crosses including
only D. melanogaster or only D. simulans males and females were also set up, to yield
flies from the parental species reared under similar conditions. We collected F1 hybrid
female flies (since male hybrids from this cross are not viable), as well as females
from each of the intraspecific crosses, for infection.
Bacterial Cultures and Infections: To provoke a response involving multiple
aspects of the innate immune pathways, we infected flies with both Gram-positive and
Gram-negative bacteria simultaneously. To achieve this, we used a combination of
Enterococcus faecalis & Serratia marcescens. Cultures of Gram-positive E. faecalis
(derived from the strain used by LAZZARO et al. (2006)), identified using 16S rDNA
sequence and the results of API 20Strep substrate utilization) and Gram-negative S.
marcescens, derived from ATCC strain 13880 (also previously used by LAZZARO et
al. (2004)) were combined at a 1:1 ratio after being separately grown overnight from
freezer stocks and diluted to a concentration with OD600 ~ 1.0. We infected flies by
dipping 0.1-mm tungsten needles (Fine Science Tools, Foster City, CA) into the
bacterial mix and using these to pierce the flies’ thoraces. We froze both infected and
uninfected flies 12 hours later, using liquid nitrogen.
Transcript Quantification via Short-Read Sequencing: We isolated mRNA
from whole flies (approximately 50 females per sample) using a Trizol:chloroform
extraction and  then synthesized cDNA using oligo-dT priming. cDNA transcripts
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were sequenced using the Illumina Solexa GA2 platform at the Cornell Bioresource
Center. One lane was used to sequence each of the six samples (D. melanogaster, D.
simulans and F1 hybrid flies in either uninfected or infected states), providing
approximately 300-400 megabases of sequence for each, with 36 bases per sequenced
read.
Alignment of Reads to Reference Genomes: We processed sequenced reads
and aligned them to reference sequences using Maq (Mapping and Assembly with
Qualities) software (LI et al. 2008). To identify reads corresponding to transcripts
throughout the genomes of both species, we used sequences representing the D.
melanogaster or D. simulans genome, from genome-wide alignments for D.
melanogaster and D. simulans (alignments produced using MAVID (BRAY and
PACHTER 2004), obtained from Assembly/Alignment/Annotation of 12 related
Drosophila species website, http://rana.lbl.gov/drosophila/). These references included
76.7% and 93.9% of the D. melanogaster and D. simulans complete genome sequence
available, respectively.
Using Maq protocols, we converted Illumina output sequences and reference
sequences to the appropriate formats for alignment. Reads from each sample were
aligned to the appropriate reference genome(s), with the Maq settings tolerating the
alignment of reads bearing up to three mismatches with the reference. Sequences from
D. melanogaster and D. simulans samples were aligned to their respective genomes,
and the sequences from F1 hybrid samples were aligned to both references. This
yielded matches for 23.4 to 34.8% of the reads for each sample. Only hits with quality
scores of 10 or greater were analyzed, eliminating any non-unique alignments
genome-wide.
Quantification and Normalization of Read Density: To examine transcript
levels for each gene in the genome, we quantified read density for each sample at
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bases annotated in the D. melanogaster genome. For each base annotated as uniquely
belonging to the transcript of one gene, we classified the base as either being identical
between D. melanogaster and D. simulans, divergent between the species, or as a gap
in the alignment. At each identical base within a transcript, we counted the number of
hits that aligned for a given sample. For total transcript abundance in the hybrids, we
only used the alignment to the D. melanogaster reference genome. Since only non-
divergent sites were used to determine transcript levels, both parental alleles should be
detected here. Furthermore, we expect that a high proportion of alleles from the D.
simulans parent will still align to a D. melanogaster reference sequence; when reads
sequenced from the D. simulans sample were aligned to the D. melanogaster reference
as a test, 85% as many reads matched as when the same reads were aligned to the D.
simulans genome.
To normalize the read counts across samples, we divided counts in each
sample by the total number of mapped reads in that sample (with each sample
multiplied by the maximum number of aligned reads among samples to keep the
numbers at the same magnitude). To control for different reference lengths among
genes, we divided the normalized count totals for each transcript by the number of
identical sites in that transcript, yielding a read density (number of hits per kb) for
each gene in the genome. This normalization is similar to that used by MORTAZAVI et
al. (2008) for quantifying transcript levels through RNA-seq.
Allele-specific Read Density in Hybrids: Since interspecific hybrids bear
alleles from two parental genomes, we also wanted to assay transcript abundance from
each parental allele in the F1 hybrid flies.  For this, we aligned sequences from F1
hybrid samples to both D. melanogaster and D. simulans reference genomes and
counted the number of hits belonging to each parental allele at each divergent site
within annotated transcripts. Out of all divergent sites within annotated transcripts,
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only those with at least 5 hits in one or more samples were included. These counts
were also normalized across samples, and the total number of counts at all divergent
sites within a gene was normalized by the length of the transcript.
Statistical Analysis: To test for effects of infection and genotype × infection
interactions on phenotypes, we performed ANOVAs on the data, for groups of genes
categorized by functional pathways. Pathways were determined based on annotations
from the Kyoto Encyclopedia of Genes and Genomes (KEGG, KANEHISA and GOTO
2000). For this, we tested the following model for groups of transcribed genes
belonging to each pathway:
yijk = µ + Infectioni + Genotypej + (Infection × Genotype)k +  εijkl      (1)
where y represents the phenotype of interest for each gene in the group (expression
levels or proportion of parental alleles), and Infection (i = 1,2), Genotype (j = 1,2), and
their interaction term are fixed effects. Since pathway members were not entirely
independent (some transcribed genes belonged to more than one annotated pathway),
we determined the significance of each effect by permuting the data 1,000 times and
comparing the actual statistic for each to the null distribution of statistics from the
permuted data.
Results
Transcripts Identified by Short-Read Sequencing: After aligning sequenced
reads from each sample to the reference genomes, transcripts from many of the
annotated genes in the Drosophila melanogaster genome were detected. Out of 13,400
annotated genes that included sites aligned between D. melanogaster and D. simulans,
10,977 (81.9%) of these had sites to which sequenced reads aligned uniquely. Of
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these, we have defined 4,574 as being transcribed in one or more samples, using a read
density cutoff of at least 36 hits, or one fully sequenced read, per kb. Many of these
appear to be commonly transcribed in D. melanogaster, and D. simulans, but not
necessarily in F1 hybrid flies, with 1,253 (27.4%) of the transcribed genes appearing
in the two parental species, and only 693 (15.2%) transcribed in all three groups.
Figure 4.1 illustrates the overlap of the transcribed genes among these genotypes.
Transcript Abundance in Parental and Hybrid Flies: Transcript abundance
in hybrids is positively correlated with the parental mean transcript levels genome-
wide (Pearson’s correlation, P < 2.2 x 10-16), indicative of largely additive effects
acting upon expression levels in the hybrid flies. Figure 4.2A shows a plot of these
transcript levels, represented as log2(hits per kb). We also see, though, that expression
levels in hybrids are much more variable than the parental mean levels, with
significant differences in variance between the groups both before and after infection
(F-test, P < 1.0 x 10-30, P = 3.22 x 10-49, respectively). Furthermore, differences in
expression between hybrids and parents vary widely among genes; some genes show
up to 655-fold higher transcript abundance in the parents, while others have up to 864-
fold higher levels of transcript in the hybrid flies. Figure 4.2B illustrates the
distribution of these differences among transcribed genes, before and after infection.
To evaluate the effects of bacterial infection on genome-wide expression levels
in hybrids, we also examined the changes in transcript levels before and after infection
in hybrids and parental species. As with the actual transcript levels, the levels of
induction or repression show varying levels of similarity between hybrids and parents.
Figure 4.3 shows changes in transcript levels in hybrids relative to those in parents,
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Figure 4.1 Counts of genes transcribed in one or more of the groups of flies (with at
least 36 hits per kb), in either uninfected or infected samples.
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Figure 4.2 (A) Genome-wide transcript levels in hybrids and parents, as log2(Hits/kb),
for genes before and after bacterial infection. Dotted line corresponds to y = x. (B)
Distribution of differences in parental and hybrid expression levels (parental mean –
hybrid log2(Hits/kb)) for transcribed genes throughout the genome, in uninfected flies
(dashed line) and infected flies (solid line).
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Figure 4.3 Changes in transcript level after infection in hybrids and parental species
(A) and disparities between induction levels in the two groups (B) among genes with
at least 100 hits per kb in one or more samples. Dashed line in (A) corresponds to y =
x.
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among the most highly transcribed genes (those with at least 100 hits per kb in one or
more samples). Interestingly, we observe more genes with greater induction in parents,
yet genes showing the greatest difference between genotypes are induced more highly
in hybrids.
Functional Differences in Hybrid Dysregulation: While it is apparent that
F1 hybrids can show distinct regulation of expression in response to infection
compared with the parental species, it has also become clear that these patterns of
hybrid dysregulation are not consistent among groups of genes with different
functional roles. To directly assay the response to infection in these interspecific
hybrids, we examined the transcription of immune-related genes before and after
infection. Overall, genes belonging to the innate immune pathways show a significant
increase in expression level after infection (ANOVA, P < 2.20 x 10-16); different
functional groups within the immune response show distinct patterns, though. Figure
4.4A illustrates mean expression levels for groups of genes coding for recognition,
signaling and effector proteins in hybrids and parents before and after infection
(transcribed genes included in each functional group listed in Table C.1). While genes
in each of these groups show significant increases in expression after infection, genes
in the effector class show a distinct pattern of expression, with generally higher
transcript levels, relative to other immune genes. Effectors also show fairly high levels
of variance in expression level in each sample, likely due to a subset of genes being
highly expressed following infection, while others are not activated – genes in the
effector class are not all antimicrobial peptides, so it is unlikely that all genes in this
functional group would be identically regulated after infection. Additionally, genes in
the signaling group show a significant effect of the interaction between genotype and
infection; these genes are more highly induced in hybrids than in the parents.
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Figure 4.4 Expression levels before and after bacterial infection among genes in
different functional groups within the immune pathways (A) or involved in other
pathways throughout the genome (B). Hybrid uninfected and infected expression
levels (white and light gray bars) and parental mean uninfected and infected
expression levels (dark gray and black bars) are shown, as the average of log2(hits per
kb) for each group. Non-immune pathways are included for which there is a
significant effect of a genotype x infection interaction (P < 0.05) on expression.
Asterisks in each plot indicate genotype x infection interactions with * P < 0.05 and
** P < 0.01.
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Beyond the defined members of the innate immune response, we expect other
genes throughout the genome to undergo expression changes after infection, either as a
direct reaction to bacterial infection or as a consequence of the impact of immune
response on the rest of the organism. Furthermore, if non-immune genes play a critical
role after infection, and if this function is disrupted in interspecific hybrids, we expect
hybrids to induce or repress these genes at a different magnitude than the parental
species. To investigate coordinated non-immune responses to infection, we tested
expression difference in hybrids and parents before and after infection in other
pathways throughout the genome, as identified through KEGG. Table 4.1 lists
pathways with a significant effect of either infection or a genotype by infection
interaction on expression levels (based on ANOVA tests, with P < 0.05). For the three
pathways here affected by a genotype-by-infection interaction, we have plotted
expression means in Figure 4.4B. Notably, the non-immune pathways with the most
significant interactions show decreased expression in hybrids, while the parents show
induction in the included genes after infection. Furthermore, most of the non-immune
pathways with apparent changes in expression after bacterial infection appear related
to metabolism and other housekeeping processes. This could be indicative of indirect
effects or costs on the system as a result of immune response, some of which may be
sensitive to the genotype of two diverged parental alleles in these flies.
Allele-specific Differences in Transcript Abundance in Hybrids: In
addition to overall transcript levels in hybrids relative to flies of the parental species,
we also examined the relative abundances of the two parental alleles in the hybrids
before and after infection. If expression regulation of a given gene has evolved
between D. melanogaster and D. simulans, we expect that at least some of that
expression difference may be reflected in allele-specific transcript abundance in the F1
hybrids. Among related groups of transcribed genes, if the D. melanogaster allele
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Table 4.1 Pathways Showing Significant Effects of Infection on Expression
Pathway Name Infection Genotype x 
Infection
Ribosome 0.075 0.003
Histidine metabolism 0.107 0.037
Inositol metabolism 0.028 0.048
Bisphenol A degradation 0.038 0.051
Bile acid biosynthesis 0.037 0.059
Biosynthesis of unsaturated fatty acids 0.048 0.106
DNA replication 0.042 0.656
ANOVA P -values < 0.05 indicated in bold
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comprises approximately 50% of the transcript for all genes (yielding an average
proportion for the group of about 0.5, with a low level of variance), we assume that the
transcripts for genes in that group in hybrids are fairly equally represented, and that
expression is mostly additive. Conversely, if genes in a group are consistently
regulated with a bias toward the expression of one parental allele over the other, we
expect to observe the average proportion of the D. melanogaster allele for the group to
be either above or below 0.5, but the variance should still be low. Furthermore, if the
allelic proportions within a group have a wide variance, the genes in that group appear
to be less coordinated with regard to allele-specific transcription.
To look at allelic transcription levels within the immune response and their
changes after infection, we examined average proportions of the parental alleles for
genes belonging to recognition, signaling, and effector functional groups (Figure
4.5A). As with overall expression levels, we see that the patterns of allelic expression
for these samples vary among the functional groups. While all samples show
proportions of the D. melanogaster allele close to 0.5, the signaling genes show the
lowest level of variability in these proportions. Signaling genes also appear to have
lower variance in expression levels compared to genes in the effector group, yet this
difference does not appear as striking. The signaling genes also show an effect of
genotype on allelic proportions; the proportion of D. melanogaster allele in hybrids is
significantly greater than the proportion of D. melanogaster transcript within the
parental totals (ANOVA, P = 0.00124).
Genome-wide, we examined average proportions of the parental alleles in
genes belonging to pathways as defined in KEGG. Table 4.2 lists those with
significant effects of infection or a genotype by infection interaction on these
proportions. Averages across samples are shown for those pathways where the
genotype by infection effect has P < 0.05 (ANOVA), in Figure 4.5B. These pathways
94
Figure 4.5 Average proportions of D. melanogaster allele in expressed genes in (A)
functional groups within the innate immune pathways and in (B) genes involved in
non-immune pathways. Allelic proportions are shown for hybrid expression before
and after infection (white and light gray bars), and proportions of D. melanogaster
transcript out of total parental transcript before and after infection are shown (dark
gray and black bars). (C) Average proportions of D. melanogaster allele in infected
hybrids for all pathways tested. Dashed lines illustrate proportions equal to 0.5 on each
plot. Asterisks indicate pathways with a significant genotype effect (in plot A) or a
significant genotype x infection interaction effect (in plot B) on allelic proportions:  *
P < 0.05; ** P < 0.01. (Abbreviations for pathways: Aminosugars = Aminosugars
metabolism; Glycophos. = Glycophospholipid metabolism; Purine = Purine
metabolism; Glycan deg. = Glycan structures – degradation; SNARE = SNARE
interactions in vesicular transport.)
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Table 4.2 Pathways Showing Significant Effects of Infection on Allelic Proportions
Pathway Name Infection Genotype x 
Infection
Aminosugars metabolism 0.294 0.024
Glycerophospholipid metabolism 0.878 0.03
Purine metabolism 0.444 0.032
Glycan structures - degradation 0.771 0.041
SNARE interactions in vesicular transport 0.716 0.048
Bile acid biosynthesis 0.004 0.506
Calcium signaling pathway 0.018 0.633
3-Chloroacrylic acid degradation 0.021 0.294
Apoptosis 0.021 0.503
TGF-beta signaling pathway 0.035 0.793
Lysine degradation 0.048 0.202
ANOVA P -values < 0.05 indicated in bold
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show a variety of patterns for the proportions of the parental alleles, potentially
indicative of heterogeneous levels of divergence in the regulation of expression of
these genes after infection. Similarly, across all pathways tested, the proportions of the
D. melanogaster allele among hybrid transcripts vary substantially; Figure 4.5C shows
a plot of the proportion of melanogaster allelic expression among means for
transcripts in each pathway in hybrids after infection.
For a more specific evaluation of variability in allelic transcript abundance
throughout the immune response, we examined allelic proportions in individual genes
throughout the Toll and imd pathways (Figure 4.6). From this, we see some variations
in allelic proportions throughout the network, particularly in the downstream
components. On a gene-by-gene basis, however, the variability was sufficiently
chaotic that we have little power to detect pathway-wide patterns.
Discussion
Using the power of an RNA-seq approach to quantify expression differences
among samples, we were able to assay changes in transcript level in response to
infection in Drosophila species and their F1 hybrids, as well as changes in relative
transcript abundance of the two parental alleles in the hybrids. From this, we found
further evidence for divergent regulation of the immune response between D.
melanogaster and D. simulans as revealed through dysregulation of transcription after
infection in their F1 hybrid, particularly in examinations of separate functional groups
throughout the innate immune pathways. Additionally, we found effects of
dysregulation of the response to infection, evinced by the irregular control of non-
immune pathways genome-wide in hybrids.
With this experimental design, we have used internal comparisons between
uninfected and infected samples to compare levels of transcript abundance across
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Figure 4.6 Differences in proportions of the two parental alleles in hybrids within the
transcripts of genes in the Toll (A) and imd (B) pathways before and after infection (to
the left and right of each arrow, respectively). For each gene, proportion of the D.
melanogaster allele is shown in red and the D. simulans allele is shown in blue; size of
the circle corresponds to total level of transcript for that gene. Dark colors indicate a
significant difference between the abundance of the two alleles (binomial test, P <
0.05). Open circles indicate absence of transcription. Pathway genes and interactions
included based on information in previous studies (ARBOUZOVA and ZEIDLER 2006;
FERRANDON et al. 2007; FOLEY and O'FARRELL 2004; LECLERC and REICHHART 2004;
STRONACH and PERRIMON 2002; WASSARMAN et al. 1995).
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genes genome-wide. Along with normalizations for transcript length, this allows us to
be fairly confident that any different patterns that we detect among genes should have
a biological basis.  Furthermore, this platform has allowed us more flexibility than
microarrays could; we can compare transcript levels from diverged species and their
hybrids without concern of probe divergence issues, and we are able to detect
differences between the species at divergent sites throughout the transcripts, providing
for quantification of allele-specific expression in the F1 hybrids.
As we observed in a previous study (Chapter 3), the three functionally distinct
groups of immune-related genes (recognition, signaling and effector) display
dissimilar patterns of hybrid dysregulation, indicative of different patterns of evolution
operating on the members of these groups. More specifically, both of these
experiments provide evidence that genes encoding effector proteins can be
substantially dysregulated in hybrids, relative to parental expression levels, in
response to bacterial infection as well as in uninfected flies. This consistent pattern
indicates divergence in the regulation of the innate immune pathways manifesting in
overactivation of the transcription of the downstream genes. Most strikingly, it appears
that genes in the effector group are generally overexpressed in the face of hybrid
breakdown of some regulatory mechanisms. This seems to indicate that the default
state of the immune system is constitutive activation, while negative regulation to
achieve appropriate levels of expression is not conserved enough between species to
be maintained in the context of interspecific hybrids. This is further supported by the
observation that immune-related effectors are over-expressed even in the absence of
bacterial challenge.
While the members of the well-defined innate immune pathways may show the
strongest responses to infection, a systemic bacterial invasion will likely lead to
regulatory differences in multiple gene regulatory pathways throughout an organism.
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By examining genes in non-immune pathways, we can explore greater impacts of the
immune activation in the F1 hybrids. Using KEGG pathway annotations, we were able
to group transcribed genes throughout the genome by their functional pathway
classification and test those pathways for significant responses to infection in
transcript differences. While any number of genes throughout the genome may show
expression differences before and after infection, by testing pathways as groups, we
may detect coordinated regulation of a pathway that is disrupted in the hybrids. With
this, we do find numerous non-immune pathways that show significantly different
responses to infection in hybrids and in the parental species, and interestingly, many of
these are involved in metabolism-related functions. This could be indicative of a larger
effect of dysregulation of the immune response in hybrids: since hybrids appear to
over-express and/or over-induce numerous genes throughout the immune pathways
while maintaining a normally functioning ability to clear bacteria after infection
(Chapter 3), it stands to reason that they may suffer a cost and that other systems may
be under-regulated, which is consistent with patterns of some non-immune
dysregulation apparent here.
Beyond overall transcription levels in genes throughout the genome, we have
also examined allele-specific transcript abundances in the hybrid flies. If proportions
of the parental alleles stay the same after infection, both alleles may appear to be
regulated at the same level.  When we observe average allelic proportions for the
immune genes, based on groups of separate immune-related functions, we again see
distinct patterns among the groups. Both the recognition and effector groups, though,
show relatively higher levels of variance than the signaling group of genes; this may
indicate less coordinated control of expression of genes with recognition and effector
function in hybrids. On average, though, most of the immune genes appear to have
approximately equal proportions of the two allelic transcripts. Strikingly, many of the
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non-immune pathways appear to have greater departure from equal proportions of the
two parental transcripts in the hybrids, both before and after infection. Some of this
may reflect divergent controls of these pathways in the parental species, yet a number
of these pathways have significantly different levels of the alleles in the hybrids
relative to the transcript levels in the parents, indicative of regulatory interaction in the
hybrids.
By sequencing transcripts from hybrid and parental flies before and after
bacterial infection, we are able to infer differences among these genotypes in the
regulation of gene expression after immune challenge. It should be noted, though, that
change in transcript abundance is only one aspect of the regulation of the immune
response; this assay does not take into account control mechanisms such as rate of
translation, post-translational modification, or protein stability. Nevertheless, changes
in transcript levels have been observed previously for genes throughout the genome in
response to infection (APIDIANAKIS et al. 2005; DE GREGORIO et al. 2001; IRVING et
al. 2001), and these can be disrupted in immune pathway mutants (DE GREGORIO et al.
2002). Thus, while transcription may not be the only portion of the immune response
that can vary among genotypes, it is apparent that it can serve as a proxy for gene
regulation among flies and that differences in transcript level are indicative of distinct
responses to infection.
In this study, we have uncovered further evidence for dysregulation of the
hybrid response to infection, indicative of widespread regulatory divergence of genes
throughout the genome between D. melanogaster and D. simulans. Overall, this
emphasizes that in hybrid individuals, numerous parts of the parental genomes may
interact to yield distinct patterns of expression, as a result of parental regulatory
divergence. Furthermore, a perturbation such as immune response activation has the
potential to affect regulation – and dysregulation – of genes throughout the genome.
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CHAPTER 5
DISRUPTION OF THE INNATE IMMUNE RESPONSE IN MUTATION-
PERTURBED INTERSPECIFIC DROSOPHILA HYBRIDS
Abstract
The pathways involved in the innate immune response in Drosophila make up
a complex regulatory network, including numerous proteins that are involved in
multiple interactions in response to infection. Genes encoding members of these
pathways have been shown to bear different levels of variation and distinct patterns of
divergence between species, indicative of unique selective pressures acting on genes
performing separate functions within the immune response. Previously, we found
evidence for dissimilar regulatory evolution among different functional groups of
immune genes by quantifying expression differences in D. melanogaster, D. simulans,
and their F1 hybrids before and after infection, introducing divergent regulatory
mechanisms throughout the immune pathways (Chapter 3; Chapter 4). To further
inspect the sensitivity of the system to divergent genetic interactions in the innate
immune pathways, we examine immune responses of hybrids bearing mutant alleles
for one copy of certain pathway components to determine the effects of interactions
between the remaining allele and diverged interacting proteins on immune function.
With these, we were able to pinpoint the Dredd protein as one that has evolved such
that the disturbance of its conspecific interactions can lead to decreased function of the
immune response.
Introduction
Drosophila has become one of the pre-eminent models for studying the innate
immune system, not only because of the vast array of techniques and resources
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available for these flies, but also due to the high degree of homology present between
their humoral immune pathways and those in other species. Numerous genetic studies
in Drosophila have clarified the members of and interactions within the innate immune
pathways. Furthermore, comparative analyses among Drosophila species have
facilitated evolutionary queries into the system. Many of these studies have focused on
sequence diversity of immunity genes within and between species (CLARK and WANG
1997; DATE et al. 1998; LAZZARO and CLARK 2003; RAMOS-ONSINS and AGUADE
1998; SACKTON et al. 2007; SCHLENKE and BEGUN 2003), while others have examined
variation occurring in natural populations of D. melanogaster (LAZZARO et al. 2006;
LAZZARO et al. 2004; SACKTON et al. submitted). One of the key trends from these
studies is the disparity in levels of variation and natural selection apparent among
genes involved in different functions within the immune pathways.
More recently, we have examined the impacts of interspecific hybridization on
immune function, in order to uncover diverged portions of the immune networks
between D. melanogaster and D. simulans (Chapter 3; Chapter 4). With these studies,
we found differences in hybrid dysregulation of the expression of immune genes
among different functional groups, consistent with previous findings of distinct
patterns of evolution for these groups. Furthermore, we found a preponderance of
over-expressed genes among the downstream effectors of the pathways, providing
evidence for a propagation of dysregulation throughout these pathways in F1 hybrids.
These investigations, similar to those that have previously assayed expression or
phenotype differences in F1 hybrid individuals (DICKINSON et al. 1984; MOEHRING et
al. 2007; PARKER et al. 1985; RANZ et al. 2004; WHITT et al. 1977), revealed systemic
disruptions in hybrid phenotypes, relative to those of the parental species, due to the
juxtaposition of two diverged genomes within an individual.
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While these studies are useful for examining the functional divergence of one
or more networked pathways, they can only uncover dysfunctional phenotypes when
the interactions between one or more diverged gene pairs have a dominant effect.
More specifically, if two genes whose products interact have evolved separately
through distinct lineages, they could potentially yield less fit phenotypes when the
diverged gene products interact in the interspecific hybrids – in some cases leading to
hybrid sterility or inviability and ultimately, speciation (BATESON 1909; DOBZHANSKY
1934; MULLER 1942). Such phenotypes will only manifest in the hybrid organisms,
though, if they are dominant to the conspecific interactions – since F1 hybrids have
both parental alleles for each component of an interaction, normal complexes may still
form in these individuals.
To further probe the divergence in the components of the immune system
between species of Drosophila, we have introduced mutant D. melanogaster alleles
into F1 hybrid backgrounds. For this, we mated D. melanogaster females bearing
mutations in one of several genes throughout the Toll and imd pathways to D.
simulans males. These crosses allowed us to assay immune response phenotypes in
flies bearing genotypes perturbed beyond interspecific hybridization. By including a
mutant D. melanogaster allele, we expect that any evolved interactions involving that
gene’s product will be placed under greater strain; if interspecific interactions are less
fit, the effect of a mutant allele should be greater in a hybrid background than in a D.
melanogaster genetic background. Since some genes in the immune networks,
particularly Relish, Dredd, ird5, key, and Dnr1 in the imd pathway, have been shown
previously to display evidence of positive selection among species in the melanogaster
subgroup (SACKTON et al. 2007), we expect that some of these may have evolved
between D. melanogaster and D. simulans to such a degree that their interactions
within the immune response may be disrupted. Using this approach, we have
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identified genes in the humoral pathways displaying evidence of divergence between
the two species, leading to disruption of normal immune function in these mutant
hybrids.
Materials and Methods
Fly Lines and Crosses: To evaluate the impact of targeted disruptions of the
innate immune response in the context of a hybrid genetic background, we mated D.
melanogaster females bearing mutations in genes throughout the immune pathways to
D. simulans males (strain MD199).  We used mutant stocks containing P element
insertions disrupting genes in the Toll and imd pathways (Exelixis Collection, Harvard
Medical School and Bloomington Drosophila Stock Center at Indiana University;
(THIBAULT et al. 2004)). The stocks we used here included mutants for insertions in
13 genes, listed in Table 5.1 (see Table C.1 for a detailed stock information).
These mutant stocks were created in one of two laboratory strains of D.
melanogaster – either w1118 or y1w67c23. To control for background effects of these
genotypes, these two “wild type” strains were also included in the crossing schemes,
to yield wild type D. melanogaster alleles for the genes of interest, in the appropriate
genetic backgrounds. Thus, we mated virgin females from each D. melanogaster line
to males of the “wild type” D. melanogaster lines, as well as to D. simulans males,
with approximately 10 males and 10 females for each cross vial (Figure 5.1). We also
included crosses of D. simulans females and males, to represent the second parental
genotype. Out of the 13 mutant stocks of D. melanogaster, 10 were able to hybridize
with D. simulans, so these were the only ones used to assay immune response
phenotypes, as listed in Table 5.1.
Bacterial Cultures and Infections: To assay immune response phenotypes
among the different genotypes, we infected the flies with either Gram-negative
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Table 5.1 Genes disrupted in Exelixis P element insertion lines
Pathway Gene Location of Insert
% AA 
Identity   
mel vs. sim
Successful 
hybridization?
spz coding 91 no
Myd88 5ʼ UTR 77 YES
tub 5ʼ UTR 64 no
pll 3ʼ UTR 94 YES
cact 5ʼ UTR 77 YES
Dif 5ʼ UTR 98 no
PGRP-LC 3ʼ intergenic 84 YES
imd 5ʼ intergenic 97 YES
BG4 coding 76 YES
Dredd 5ʼ UTR 85 YES
ird5 coding 87 YES
key coding 81 YES
Rel 5ʼ UTR 85 YES
Toll
imd
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Figure 5.1 Cross scheme used for mutant hybrids and control crosses. “P” indicates
melanogaster allele with P element insertion.
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Serratia marcescens or Gram-positive Enterococcus faecalis. These bacteria were
chosen because of their use in previous studies of immune response in Drosophila
(LAZZARO et al. 2004). The S. marcescens stock was derived from ATCC strain
13880, and the E. faecalis was derived from that used by (LAZZARO et al. 2006)
(identified via 16S rDNA sequence and results of API 20Strep substrate utilization
testing). Cultures were grown overnight from freezer stocks to OD600 ~ 1.0. To infect
the flies, we pricked their thoraces with 0.1-mm tungsten needles (Fine Science Tools,
Foster City, CA) that had been dipped in the bacterial cultures.
Bacterial Load Quantification: To quantify microbial clearing ability, we
measured bacterial load in the flies at 12 and 25 hours after infection with S.
marcescens or E. faecalis. For this, we combined females in groups of three in 500µl
of LB broth and homogenized the flies. Up to 10 replicates of each genotype were
infected each day, on four separate days; in total, between 13 and 34 replicates were
infected for each. We then plated the homogenates onto LB plates using a spiral plater
(Spiral Biotech, Bethesda, MD) and allowed colonies on the plates to grow overnight.
We counted these using a colony counter, giving us an estimate of bacterial load, or
colony-forming units per ml (cfu/ml). We also inspected plates visually to ensure that
the colonies counted were consistent with the size and morphology expected.
Quantification of Transcript Abundance using Pyrosequencing: To
evaluate differences in transcript abundance of the antimicrobial peptide Diptericin
(Dpt) as a result of differential regulation of the immune response among these
genotypes, we used Pyrosequencing (Qiagen, Valencia, CA). This allowed us to assay
relative transcript levels between two parental alleles (in the interspecific hybrids), as
well as quantify relative levels of total transcript between samples from uninfected and
infected flies. For this, we froze flies in liquid nitrogen 12 hours after infection with S.
marcescens or E. faecalis, or without infection, in three replicate pools of
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approximately 13-17 flies each. For each sample, we isolated mRNA using a
Trizol:chloroform extraction, and then we synthesized cDNA using oligo-dT primers.
For the Pyrosequencing, we amplified cDNA from each sample using primers
for Dpt (see Table C.2 for primer and probe sequences). We treated the resulting
products according to Pyrosequencing protocols in order to sequence the region of
interest, including one or more sites with divergent bases between the two parental
species. Overall transcript level for each genotype was determined by averaging the
heights of the peaks across the non-divergent bases as well as across biological
replicates. In order to estimate differences in transcript abundance between the two
alleles in the interspecific hybrids, we normalized the peak heights of both alleles by
the parental levels (to correct for background effects of one or both alleles).
Results
Effect of Genotype on Bacterial Clearing Ability: To evaluate the
phenotypic effects of divergent genes interacting within the innate immune pathways,
we quantified differences in immunocompetence of immune pathway mutants in D.
melanogaster and interspecific hybrid backgrounds. Figure 5.2 shows the bacterial
load differences between the mutant and wild type alleles in each background for each
of the mutants after infection with S. marcescens. Two of the mutants, Dredd and
Myd88, show nearly significant effects of an allele x background interaction on load
(ANOVA, P = 0.079, 0.064, respectively). More specifically, one copy of the mutant
Dredd allele associates with an increased bacterial load after Gram-negative infection
– only in the context of a hybrid genetic background. Conversely, the presence of a
copy of the Myd88 mutant allele appears to lead to an increase in bacterial load only in
the D. melanogaster background, possibly indicating a specificity of the effect
between the genes belonging to Toll and imd pathways in response to this infection.
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Figure 5.2 Differences in bacterial load after infection with S. marcescens between
flies bearing mutant and wild type alleles.  Differences between these genotypes is
shown for flies with D. melanogaster (black bars) and F1 hybrid (gray bars) genetic
backgrounds. Asterisks indicate an allele by background interaction effect with P <
0.1.
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To examine the effect of infection type (Gram-positive vs. Gram-negative) on
the sensitivity to perturbation of members of Toll and imd pathways, we quantified
bacterial load after infection with E. faecalis in crosses involving Dredd and Myd88
mutant alleles. The bacterial clearing phenotypes of these flies are compared to those
after infection with S. marcescens in Figure 5.3. With these infections, however,
neither mutant allele appears to have an effect on the load phenotype that is dependent
upon the genetic background.
Effect of Genotype on Transcription Levels: As a proxy for the induction of
an immune response, we quantified transcript levels of Diptericin (Dpt), an
antimicrobial peptide (AMP) induced upon activation of the imd pathway, shown in
Figure 5.4.  We find that Dpt expression depends upon fly genotype, particularly after
S. marcescens infection. The presence of a mutant Dredd allele decreases the level of
induction of Dpt after infection with S. marcescens. Most notably, though, when the
Dredd mutant allele occurs in an F1 hybrid background, rather than in a D.
melanogaster background, the level of Dpt transcript actually shows a significant
decrease in response to Gram-negative infection (t-test, P = 2.56 x 10-5), again
indicating a detrimental interaction between disruption of the D. melanogaster allele
and a hybrid genetic background, in terms of maintaining a proper immune response.
This effect of this interaction on Dpt transcription appears specific for the
response to infection with S. marcescens – suppression of transcription after E.
faecalis infections does not appear to occur in the presence of mutant alleles.
Additionally, the effect of a mutant allele in a hybrid background on Dpt induction
appears specific to disruptions of Dredd and not Myd88. These results are not
surprising, though, given the fact that Gram-negative bacteria should elicit response
via the imd pathway (including Dredd) more than the Toll pathway (including
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Figure 5.3 Bacterial load after infection in flies bearing wild type alleles (black bars)
and mutant alleles (hatched bars) for Dredd (A & C) and Myd88 (B & D) mutants.
Bacterial load shown for flies after infection with either Gram-negative S. marcescens
(A & B) or Gram-positive E. faecalis (C & D).
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Figure 5.4 Transcript levels of Dpt in uninfected flies (white bars), and in flies
infected with S. marcescens (black bars) or E. faecalis (gray bars). Genotype in
parenthesis indicates genetic background for each mutant.
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Myd88), and Gram-positive infection would not be expected to yield these same
effects on Dpt expression through the imd pathway.
Dredd Genotype Has No Effect on Relative Transcript Levels of Parental
Alleles: In addition to examining total levels of Dpt transcript in these flies, we also
quantified relative abundance of the two parental alleles in the F1 hybrids. We found
that hybrids have approximately equal abundances of the transcripts from each
parental allele, and that the relative transcript levels do not differ significantly between
either infection states or genotypes (ANOVA, P = 0.585, 0.7748, respectively). Figure
5.5 shows the average proportions of the D. melanogaster transcript for hybrids with
or without S. marcescens infection and with wild type or mutant D. melanogaster
alleles of Dredd.
Discussion
Previous studies have shown that interspecific hybrids can manifest disrupted
phenotypes on a variety of scales – from systemic failures leading to inviability to
more minor gene dysregulations, yielding expression patterns for genes throughout the
genome that can deviate from those in the parental species. By examining
dysfunctional phenotypes in F1 hybrids, divergence between the two parental species
in the regulation of those phenotypes can be inferred. Such studies have revealed
delayed development and dysregulated expression of enzymes during development
(PARKER et al. 1985), expression levels outside those of parents for many transcripts
genome-wide (RANZ et al. 2004), and dysregulation of the immune system in response
to infection (Chapter 3; Chapter 4), in interspecific F1 hybrids relative to their parental
species. While a number of these queries have focused on targeted portions of the
hybrid physiology, these patterns of dysregulation could be influenced by divergence
in numerous genes throughout the system of interest.
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Figure 5.5 Proportion of Dpt transcript from the D. melanogaster parental allele in F1
hybrids before and after infection. Flies with wild type (black bars) and Dredd mutant
(hatched bars) alleles are shown.
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Here we use a more targeted approach and have found evidence for
interspecific divergence of one or more of the interactions in the immune pathways
that involve the Dredd protein.  This divergence does not disrupt immune response
phenotypes in the F1 hybrids bearing wild type alleles, but when a mutant allele
occurs in a hybrid background, the flies display signs of decreased
immunocompetence. This is the expected result if interactions involving Dredd have
evolved in D. melanogaster and D. simulans such that disrupting one parental allele
limits the hybrid’s ability to form functional interactions. In this case, the interspecific
interactions are presumably less successful in the activation of the immune response,
and thus the mutant allele has a greater effect in a hybrid than in a D. melanogaster
genetic background. These results are consistent with the previous finding that Dredd,
along with other members of the Relish cleavage complex, appear to evolving under
positive selection (SACKTON et al. 2007).
Dredd was originally identified as a member of the caspase gene family, with a
role during apoptosis in D. melanogaster (CHEN et al. 1998), and it was later found to
be a crucial member of the imd pathway, necessary for response to Gram-negative
bacterial infection in Drosophila (LEULIER et al. 2000). In such a role, there are
numerous potential interactions involving Dredd that could be disrupted, leading to a
dysfunctional immune response. Dredd exists downstream of BG4 in the pathway, and
there is evidence that the two proteins bind via their death-inducing domains (HU and
YANG 2000). Furthermore, Dredd was shown to be necessary for cleavage of Relish,
an NF-κB protein, leading to the activation of AMP transcription (STOVEN et al.
2000), and Dredd and Relish have been shown to physically interact with one another
(STOVEN et al. 2003). Additionally, negative regulators of the imd pathway, Dnr1 and
Caspar, have been shown to repress the response to Gram-negative infection at the
level of Dredd-mediated cleavage of Relish, with evidence that Dnr1 may bind
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directly to Dredd (GUNTERMANN et al. 2009; KIM et al. 2006). One or more of these
interactions could be disrupted in interspecific protein combinations and could
therefore yield the phenotypes observed here.
The complexity of the pathways involved in the Drosophila innate immune
response have the potential to include redundant mechanisms and therefore provide
some degree of robustness to perturbations. On the other hand, in genetic networks,
there may be one or more elements whose stability is critical for proper function of the
network as a whole. By examining immune response in interspecific hybrids bearing
mutant alleles for genes in the innate immune pathways, we have identified at least
one instance of the latter, where interspecific combinations of alleles have disrupted
the proper function of Dredd, leading to a compromised immune response. This
highlights not only the critical nature of Dredd function within the pathways, but also
the specificity of its interactions, which have diverged between Drosophila species.
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APPENDIX A
SUPPLEMENTARY INFORMATION FOR CHAPTER 2
Table A.1 Autosomal Genotyping Results for Restriction Fragment Length
Polymorphisms in Genes Across Chromosomes 2 and 3
            Gene         
Line Dro,AttAB imd Tehao     cact       PGRP-LC DrsL        BG4      AttD        
proportion 
consistent 0.9875 0.98125 1 1 1 1 1 1
FM7a uncut cut cut cut uncut cut
X2 cut uncut cut cut cut uncut cut
X3 cut uncut cut cut cut uncut cut cut
X4 cut uncut cut cut cut uncut cut cut
X6 cut uncut cut cut cut uncut cut cut
X7 uncut uncut cut cut cut uncut cut cut
X9 cut uncut cut cut cut uncut cut cut
X10 cut uncut cut cut cut uncut cut cut
X11 cut uncut cut cut cut uncut cut cut
X12 cut uncut cut cut cut uncut cut cut
X13 cut uncut cut cut cut uncut cut cut
X14 cut uncut cut cut cut uncut cut cut
X15 cut uncut cut cut cut uncut cut cut
X16 cut uncut cut cut cut uncut cut cut
X17 cut uncut cut cut cut uncut cut cut
X22 cut uncut cut cut cut uncut cut cut
X23 cut uncut cut cut cut uncut cut cut
X24 cut uncut cut cut cut uncut cut cut
X25 cut uncut cut cut cut uncut cut cut
X26 cut uncut cut cut cut uncut cut cut
X27 cut uncut cut cut cut uncut cut cut
X28 cut uncut cut cut cut uncut cut cut
X29 cut uncut cut cut cut uncut cut cut
X31 cut uncut cut cut cut uncut cut cut
X33 cut uncut cut cut cut uncut cut cut
X34 cut uncut cut cut cut uncut cut cut
X35 cut uncut cut cut cut uncut cut cut
X36 cut uncut cut cut cut uncut cut cut
X37 cut uncut cut cut cut uncut cut cut
X38 cut uncut cut cut cut uncut cut cut
X39 cut uncut cut cut cut uncut cut cut
X40 cut uncut cut cut cut uncut cut cut
X41 cut uncut cut cut cut uncut cut
X42 cut uncut cut cut cut uncut cut cut
X43 cut uncut cut cut cut uncut cut
X44 cut uncut cut cut cut uncut cut cut
X46 cut uncut cut cut cut uncut cut cut
X47 cut uncut cut cut cut uncut cut cut
X48 cut uncut cut cut cut uncut cut cut
X49 cut uncut cut cut cut uncut cut
X50 cut uncut cut cut cut uncut cut
X51 cut uncut cut cut cut uncut cut
X52 cut uncut cut cut cut uncut cut cut
X53 cut uncut cut cut cut uncut cut cut
X54 cut uncut cut cut cut uncut cut cut
X55 cut uncut cut cut cut uncut cut cut
X56 cut uncut cut cut cut uncut cut cut
X57 cut uncut cut cut cut uncut cut cut
X58 cut uncut cut cut cut uncut cut cut
X59 cut uncut cut cut cut uncut cut cut
X60 cut uncut cut cut cut uncut cut cut
X61 cut cut cut cut cut uncut cut cut
X62 cut uncut cut cut cut uncut cut cut
X63 cut uncut cut cut cut uncut cut cut
X64 cut uncut cut cut cut uncut cut cut
X65 cut uncut cut cut cut uncut cut cut
X68 cut uncut cut cut cut uncut cut cut
X69 cut cut cut cut cut uncut cut cut
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Table A.1 (continued)
X70 cut uncut cut cut cut uncut cut cut
X71 cut uncut cut cut cut uncut cut cut
X73 cut cut cut cut cut uncut cut cut
X74 cut uncut cut cut cut uncut cut cut
X75 cut uncut cut cut cut uncut cut cut
X76 cut uncut cut cut cut uncut cut cut
X79 cut uncut cut cut cut uncut cut cut
X80 cut uncut cut cut cut uncut cut cut
X81 cut uncut cut cut cut uncut cut
X83 cut uncut cut cut cut uncut cut
X84 cut uncut cut cut cut uncut cut cut
X86 cut uncut cut cut cut uncut cut
X87 cut uncut cut cut cut uncut cut cut
X88 cut uncut cut cut cut uncut cut
X89 cut
X90 cut uncut cut cut cut uncut cut
X91 cut uncut cut cut cut uncut cut cut
X92 cut uncut cut cut cut uncut cut cut
X93 cut uncut cut cut cut uncut cut cut
X94 cut uncut cut cut cut uncut cut cut
X95 cut uncut cut cut cut uncut cut cut
X96 cut uncut cut cut cut uncut cut cut
X97 cut uncut cut cut cut uncut cut
X98 cut uncut cut cut cut uncut cut cut
X99 cut uncut cut cut cut uncut cut cut
X101 cut uncut cut cut cut uncut cut
X102 cut uncut cut cut cut uncut cut
X103 cut uncut cut cut cut uncut cut cut
X104 other uncut cut cut cut uncut cut cut
X105 cut uncut cut cut cut uncut cut cut
X106 cut uncut cut cut cut uncut cut cut
X107 cut uncut cut cut cut uncut cut
X108 cut uncut cut cut cut uncut cut cut
X109 cut uncut cut cut cut uncut cut cut
X110 cut uncut cut cut cut uncut cut cut
X111 cut uncut cut cut cut uncut cut cut
X112 cut uncut cut cut cut uncut cut
X113 cut uncut cut cut cut uncut cut
X114 cut uncut cut cut cut uncut cut
X115 cut uncut cut cut cut uncut cut
X116 cut uncut cut cut cut uncut cut
X117 cut uncut cut cut cut uncut cut
X119 cut uncut cut cut cut uncut cut
X122 cut uncut cut cut cut uncut cut
X123 cut uncut cut cut cut uncut cut
X125 cut uncut cut cut cut uncut cut
X126 cut uncut cut cut cut uncut cut
X127 cut uncut cut cut cut uncut cut
X128 cut uncut cut cut cut uncut cut
X130 cut uncut cut cut cut uncut cut
X131 cut uncut cut cut cut uncut cut
X134 cut uncut cut cut cut uncut cut
X136 cut uncut cut cut cut uncut cut
X137 cut uncut cut cut cut uncut cut
X138 cut uncut cut cut cut uncut cut
X139 cut uncut cut cut cut uncut cut
X140 cut uncut cut cut cut uncut cut
X142 cut uncut cut cut cut uncut cut
X143 cut uncut cut cut cut uncut cut
X144 cut uncut cut cut cut uncut cut
X145 cut uncut cut cut cut uncut cut
X146 cut uncut cut cut cut uncut cut
X148 cut uncut cut cut cut uncut cut
X149 cut uncut cut cut cut uncut cut
X151 cut uncut cut cut cut uncut cut
X152 cut uncut cut cut cut uncut cut
X153 cut uncut cut cut cut uncut cut
X154 cut uncut cut cut cut uncut cut
X155 cut uncut cut cut cut uncut cut
X158 cut uncut cut cut cut uncut cut
X160 cut uncut cut cut cut uncut cut
X164 cut uncut cut cut cut uncut cut
X166 cut uncut cut cut cut uncut cut
X167 cut uncut cut cut cut uncut cut
X168 cut uncut cut cut cut uncut cut
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Table A.1 (continued)
X169 cut uncut cut cut cut uncut cut
X172 cut uncut cut cut cut uncut cut
X173 cut uncut cut cut cut uncut cut
X174 cut uncut cut cut cut uncut cut
X201 cut uncut cut cut cut uncut cut
X202 cut uncut cut cut cut uncut cut
X203 cut uncut cut cut cut uncut cut
X204 cut uncut cut cut cut uncut cut
X205 cut uncut cut cut cut uncut cut
X206 cut uncut cut cut cut uncut cut
X207 cut uncut cut cut cut uncut cut
X208 cut uncut cut cut cut uncut cut
X209 cut uncut cut cut cut uncut cut
X210 cut uncut cut cut cut uncut cut
X211 cut uncut cut cut cut uncut cut
X212 cut uncut cut cut cut uncut cut
X213 cut uncut cut cut cut uncut cut
X214 cut uncut cut cut cut uncut cut
X215 cut uncut cut cut cut uncut cut
X216 cut uncut cut cut cut uncut cut
X217 cut uncut cut cut cut uncut cut
X218 cut uncut cut cut cut uncut cut
X219 cut uncut cut cut uncut cut
X220 cut uncut cut cut cut cut
X221 cut uncut cut cut cut uncut cut
X222 cut uncut cut cut cut uncut cut
X223 cut uncut cut cut cut uncut cut
X224 cut uncut cut cut cut uncut cut
X225 cut uncut cut cut cut uncut cut
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Table A.2 Resequencing Primers
Gene Location Primer Sequence Direction
dome 322868 GCGCGCATATACGTCCATA reverse
323949 CCATTCCACAATCTCGGTTC forward
324467 GTCCAGACTCGTCCGTCAG forward
328272 GACGCCTGTTGTCTGCTGTA reverse
328437 ACTGGCGTGCATGTGTGTA reverse
329307 TGAAGCGCTTGTAGTTGTCG reverse
329494 CTGCCTGGACTACGACTTCC forward
330487 GTCGACAGGTAGCCCCAGT forward
330520 GTTTGGCACCTATCGCATTT forward
Dredd 103613 TGACGAAGTGGTTGTGAGGT reverse
103626 ACCCCAATAAGAAACCTTACAAT reverse
104818 TCTCTTGCTTGACTGCCATC reverse
105060 CAGGAGATCCACTTCGCTTC forward
105694 ATAGCCGTGGCCTGAAGAG reverse
106354 TCGAATTTTTCGCCAGTTTT forward
106399 AAAAGAAGGAAACACCCCAAT forward
Dsor1 198092 AATGAGTGGGGTGGGAGAGT forward
199438 TCAAATCCCATCCATTGCTT forward
199836 GTGCGGGAAATTACATTCGT reverse
201052 AAAGATAATCCTCCAATGCAAA reverse
hep 152490 CACAGCCAAGCATAACAGGA reverse
152909 TTTGAATTGTCGCTTGTTGC reverse
154130 AATCTGCTGGAGCTGAGTGG forward
154513 GTGGCAAACTGTCGCTTC forward
154506 AACATAGGTGGCAAACTGTCG reverse
154642 CTGCACCATCACCATGAAAC reverse
155193 CCGCTCCAAAGTGACCAG reverse
155406 AGCACGAATCCGTTTCACAG forward
156340 TGGCTGATTGCATGAAAAAC reverse
156532 ACTGGAAGTGCGATCGGTTC forward
156340 TGGCTGATTGCATGAAAAAC reverse
156865 TGAGTGAGTTTTGCGTGTGA reverse
156998 GGAAAGCCATCATGAGCAAA forward
159226 GGGCTCTGTACAAGCGACA reverse
159965 ATGTTCGAGGGCTTCACATC reverse
160154 GCTCAAGCTGTCCAAGAAGC forward
161016 CAATGTCCGATGAACGAATG reverse
161527 TTGCTCGCTCATTATGTACCA reverse
161631 TAGTTTCCGCGAATTTCAGG forward
161638 TGGTTAATAGTTTCCGCGAAT forward
162286 CGATTTTTCTCAGCCCACTT reverse
163439 TCAGCGACAAAACAAACAGG forward
163959 GTTTCTGAGGTGCCGATGTT forward
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Table A.2 (continued)
hop 274275 CCATCCCTTTCGTTTTCGTA reverse
275322 GGCGACTGGTGTCCATCT reverse
275449 TACGACCTGATGCAGCTGTG forward
275469 CCAGTTGTCCCGATTTCATT forward
275804 ACGCTTGCTTTTCGCATAGT reverse
276983 CGCAACGAGTAAGTTGAGCA forward
277393 ATGACCCAACCGAGAAGATG reverse
277510 GATCCGAATTCGTACGTGCT forward
277896 ATCGAATCTGCGCAAAAGAC reverse
279132 CAGTGCTTGAAATGCTTGCT forward
279489 CCTTCTCCGTCTGAAACTGC reverse
279616 TCTGCAGTGGATCCTTGTTG forward
280013 AGTGCAACGGAATTGGTGTT reverse
281669 GAACTAGAACCTCGCGTTGC forward
lz 235452 AAACGATTGGATTCGACTCAG forward
236290 TTTGCACTTCACTCGGCTAA reverse
237836 TGTCCTTCAAAATCAAAGTGAA forward
240167 CGGGTGCACAAAAAGAAAAT reverse
244400 GTTAATCGAACTGCGCGATG forward
245283 GCGTTTTGGGTTACCGATT forward
245450 TTGGAAAGTGGGGATTAGGG reverse
246318 AGGGGAAGCCATCGATGTAG reverse
253049 GCACCTGCAACACCAGATG forward
254073 CAACTTGCAGATATTTTGGGATT reverse
mxc 194219 CTTTTCGCCTTGCCTTTCTT forward
194244 TTTCGCTTGCAAGACTTTAGG forward
195025 CAAATGCCTCTTCCTTTTGC reverse
194897 GCGACATCAGCGGAGAAA forward
197005 ATCTAGCACAATTCTTTGATCGT reverse
Ntf2 113279 CAAATGGCAATGAATATTTAATTTTAG forward
113327 TGCTTTTCCGAATGTGAAGA forward
114294 TTCTCGAAGTTTCGGGTGAC forward
114483 TGAATTGATTGAAACTAATGAAACA reverse
115273 CCCGTTACTAGTGCAGTTAAAGA forward
115410 TCCTGAGATCTCGACGTTCAT reverse
115577 TCAAAACAAGAGAGAATGCTATGG reverse
115955 CGGCAGTTTCTTTGTGCAG forward
117037 GCACTGCAAAGGAATGAAATC reverse
117613 AAACTTATGTAGGCGATGATCC reverse
os 152853 CCTCAAAATGGGAAGTACGAA reverse
152869 ACGAAGTTCTTTTCCATCATAAA reverse
154156 GCGTCTCGAGATGAACAAGC forward
154028 TGCTTCACAAAGCGCATATC reverse
155238 CGCAGAAGAGAAAGTGGCTA forward
155085 CGCTATCGATAACCGTTAGACC reverse
155849 CCCGCCCTCAATATACACAC forward
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Table A.2 (continued)
PGRP-LE 95395 AAACTGCCAGTAGCTGGAAAA reverse
95994 AGCTGTGTGTACTGCGTGGT reverse
97097 TAAGGTGGACACGACACGAA forward
97607 TTTTCGGATCTGGACAAAGC forward
PGRP-SA 191815 TTTTTCCTCGCCCTCTTTTT forward
193314 CGACACATTTTTGTAAATTATGACAG reverse
phl 273661 GCCTATGCACGCCATCTATT forward
273273 TGGAAAGGATACAAGCCAGAA forward
275609 CTCGAAGCCACCATCTTCAT forward
275729 TGTGACCGATCGAATGTTGT reverse
276530 TCCGTGAAGATAGGCGACTT forward
276690 AAGGCATAAACGTCCGACTG reverse
277575 GAACCTTGTGTGTAAACATAAACCA reverse
277615 TGAATATACGGCTGGGTGGT reverse
Pvf1 74559 CGGATTGGATGTGAGTGTTG forward
75186 GTGTTCTGGTTTTGCTCGAA reverse
76087 CTACTGCTCCCCCGTCTACA forward
76833 ACCACAGGGAGACGGATAGA reverse
79380 CGTACCCTCGGAGTGATGAT forward
79800 CTTCGCGGCTTTGAAGAAT forward
80882 TTTCGCTGCGTGAGAATATG reverse
80713 CGTTTTGTTTGCAGCTTGAT forward
81346 CGGCGAGAAATACTCGTATGTAA forward
81484 AACCGATTCCCCACTTGTTT reverse
81858 CGTTATTATCACGGCGGTTAG forward
82943 TGGTACACGTTGCAGTCCTC reverse
82768 GGATCCACGCTGATCTCCT forward
83430 GGAATTCGCGCAGTATGAAT reverse
83287 CCCAACAAGTTCCTCGCTTA forward
84226 CACCCATCGATGTCTTGGA reverse
84386 CCTTCTCAGTACTCGGGGATT reverse
85062 CGTGGAACTCGACTACAGCA reverse
Rps6 100048 GCTGGCTAGCTCATAACCAAA reverse
100808 GTGTCCCTTCTTCAGGAGCA reverse
102386 GGCTTTTCGATAGGCTTGTG forward
Ser7 236140 TCAATAGCACCAATGCAAAGA forward
236901 GAATTCCACCGAGTTGCAGT reverse
236787 CAGCAATTTGGCAGTGAGTT forward
237893 TTATCACGTCCGGTGAACTG forward
238577 AGGGATTTGGAATGCTTTGA reverse
Tak1 196554 TTAAGGTCGTCGGCAATAAA reverse
196578 GGTCGTCGGCAATAAATAGAA reverse
196911 AAACAAAGTGCTATGGTTAATCG reverse
197877 TTTGCTGCAATGACAATTCC reverse
197098 AGAAGGCTGGGTGGTCATC forward
198605 TGTGTTGGAGTGTGGAGCAT forward
201271 AAAAGATTCCTTGTGCATTCG reverse
201992 CAGCACGAACGGTGAGTTT forward
201849 GCCATTGTGTCTCTGAACGA reverse
202939 TCTGCCCGTCTTTAAAACCT forward
202794 GACAATCTGCGAGCAGTTCA reverse
203374 CCGTATACTTGGAGCCTTCG reverse
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Table A.2 (continued)
203437 TCATCATGGTCGACTTGTCC reverse
203499 ACAAGGGACGCAATCTGAAG forward
204115 TTCTGCGGGGAAAAAGATTA reverse
204256 ATCACAATGCGTTCGTGTGT forward
205112 TGCGACTGACAACTTTTACCA reverse
205249 ATCCACTAGGGTTGGCATCA forward
205727 TTATCGTTATCGGCGAGTCC forward
205767 TCCATTGATGTCGCTGGAAT forward
Traf2 38316 GTTCCAAATTGCGCCATAAT reverse
39038 CAAAAGTCAATGCAGATCACG forward
39572 GATCCACCTTGGTGCAAACT reverse
39688 GATCGGCTGCTCATCAAGA forward
40081 CAATCGTGCCATTGCTGTAG reverse
40916 ACTGCTACTGGCCGCAAT reverse
41011 GCGCACAGTTTGCAGCAT forward
41679 GATTCGATTTCGCTTTGAGG forward
Traf3 81982 ACTTCAATCCCGATCCACAT forward
82520 TTTGGCTGAGTTTAGTGTGCAT forward
83247 TGGATGTCCAGTACTGCTGTG forward
84911 CATACAAGAACACGCCAACG reverse
Tsf1 234903 TCACTGCAATTTTTCCAGCTT forward
235473 GGGAAAGAAGCAGCACATCT forward
236278 AGCCAGTGTGGCAGGACTT reverse
236581 GCCTTCTCCAAGGTGCAGTA forward
236694 GCCATCCTCGCACAGATATT reverse
237205 AGGGCTCAGGATGATGTCC forward
238054 GGAAACTTTGTAGCATTGTATTTGG reverse
238059 GGCTGGGAAACTTTGTAGCA reverse
upd2 88810 TGGTCCTCTATTTGGCTTGG reverse
89315 AACTCGATCTCGCAGAGCATA reverse
90057 GCTTTCCTCCATTGCCCTTA reverse
90303 CCACAACCTGCGACTCTTCT forward
91399 CGGAAGTCGTGAATCGAAAT forward
upd3 122615 GAGAAAGTTCTTCCCCTCGAA forward
123203 CCGATCACCATCCGTAAGTT forward
123349 GACGTCTCCGTTTTGTCGTT reverse
124190 CCAAATATTGGTCTCAATCGAA forward
124343 TACGCTGAAGAAAGCATGGA reverse
124817 TGGAGTGGAGTGTTGTGGAG reverse
126451 TGCGATTATATTTATATGTGTGCGTA forward
126465 TATGTGTGCGTATGGGTTTG forward
127477 CAAGAAACGCCAAAGGGTAA forward
127624 GCCCGTTTGGTTCTGTAGAT reverse
128460 TCCAGCGATCACGTTTTATG forward
128576 CGAATTGAGATTCGGATTGA reverse
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Figure A.1 SNPlex Oligos
>dome5UTR_01
GGATCCAAGATGGCGTTGGCGCCACCCCGGCAGCCGGNAAGCANCATGAGCAGCANGAC
GAGCTGCTCCTGGGCCACCATCTTCCTGGTCNTGGTTCTGCTCCCAATCCTA[A/T]TCCTAAT
CCTAATCCCCTCCTTCCCTTGCTGTTAAGGTTTACTCTGGCTCNCTCTCTCTCTCTCTCTCNC
ACTCTGTTCTCTCTGTCTTTAGCTCTTTTCCTCTCTTTC
>domeExon1_01
GTAGTCCAGGCAGTTGAAGTCGCGCACCAGGAGCGGCCTGGTGCCCACGTAGACCTTTGA
CTTGTTGATCACATACTCGTCGCACATGCAGTGGTAGTCGTTCTCTTGCTC[C/T]ACGGCATT
CGTGTCGCTAAACAGGATGGTGGTGTTGTTCAGGATTCGGATGTGCTTGGAATCGCGGTAG
ACGCGGCCGCCGCCTGTAAAGTACAGCTTCTCCACCGG
>domeExon1_02
GGTTTGCCAATGCCCCAATAATTAGCTGCCAAGCAGCTTACGGCGCATATTCATATTCACA
TATAGGTACTAACCACCATCCCAGTTCCCCTCCTACTCACACTGCTGTTCCGTTGATGCGGT
ACTCGCTGATGGAGTACCGAAAGTCCGG[T/C]CCGTTCAGCTCGTGCTCCTCCAGGNGCTCC
CAGTAGAAGCGCATAGCCTTCTCCGACGAGTAGACATAGAAGCTGCCGTAGGTGACGCGN
GGAGGGCGGCGCGGCGGCGCCGGAGCGGTGGCGAACGCATAAA
>domeExon3_01
GAACGGGCACGTAGCCGCTGAGCGGAATCTGGGACAGCGGCTGGGACATCGGAGCGGTCA
TTGCAGTCGAAGGAACTGAGAACGTGTGATCATTATCCGAGGGACCGT[T/G]GCCGCCCCA
GCTCTTCATCTGTGTNGGCTTGATGTAACCATTGGTGCAACTCTGCTCCCGATCCATTTCGC
TCTCGCGCTGCTGTTGCTGCTGCTCCCGCTCCCTCTCCTGCTCACGATCCCTCTCCCTC
>domeExon3_02
TAAAATGATGCACACCCGTGCATAAATGATGAGCGCTCCGGTATCTTAGAGGACGTGCCG
ATTGTGGGCCATGGCGTTCAGATCCTGCGGCGTTACGTAGCCATTGATTTGCGGCTGGAGG
[C/G]GAGAGTGCTGGTTGCCGCCTCCCGGCGCCCCACCAGCGGCGTGCGTCGGCGATCCCA
CGGTGGCGGCCAGAGGTGGCTTTATCAGCCCAGTGAGCTGCAACTGCTCCATGGTGGTATA
GCCGATGTCAGCCATT
>dome3UTR_01
TTAGCTTTATATTGAAATACAGCGATGTGCGTATTGTGTAAATAGGGTATTAATAGTATAA
GCTCGATCCGCTCGACGCGTGGATGGTTAAGTGGGTAAGTAAGTGTACAGTACGAATATAT
[A/G]TAAAAAAATACTATTGCGTTACAAATACTTTCTGCCTCACACGCATCGCAAAGAATA
CAAAATAAATTACAAACGTAAAACTACATTCGTCCGAGGAGTTTTCACTAATTACTATAAA
CAGCTGCCCGACAGTGGTTTCTAGTTTCCA
>DreddExon3_01
AATGCGCTCTATGATGCCCATGTGATCCACGTNGTCGTACGCNNCCACATTGTATCCCATC
GAGGAAAACACCTCGATTAGTCGTTCTTTATCCACATCCGTGCCATCCCGTCTACGCAGTG
G[G/T]TCGGGCGACAGAAATTTCTGTGGAGAAGGGCAATGTTGTACTTCTTTTTGTTACTCA
ATATTGCAGAGATGAAACCATATTATCCCTGCTAACATTCCGGTGAAACTTCTGCTGGTTG
ATAATCAAGGC
>DreddExon1_01 (DreddExon2_01)
GTTACTCAATATTGCAGAGATGAAACCATATTATCCCTGCTAACATTCCGGTGAAACTTCT
GCTGGTTGATAATCAAGGCGATTCCTGCGTTCTCCCGGGTCAA[C/T]TTAAGAGCATCTATT
TGTGTGGAACAGTACGACTGCTGGTTATCCGATTCAATCTCTTGCTTGACTGCCATCGCAG
CAGTGCCAGCCGCATCTGGCTCCGGAGCGT
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>DreddIntron1_01
CACTTTGCGGGAAGTCTGATCGTGTCATGGCCAAAAGTTTCTGCAGAATGTAGGTGGCATC
CGAGTGGTCGTCGCCATAAAGCAGAAAGCAGAGGCCCACCTA[G/A]AAGAAAACGAAGGT
TCTACTGTTTAATTAACACTTTGGNCTAGCGGATGTGTAAAACATTTGAGTCATATTCGAA
AAGTCCTCCCAGGGAGGTGCCATACCTTTT
>Dredd5inter_01
CCGATCGATATCGATAAATGGATATGTTTTCTGCANNAGCGAAAGATCGGGGTGCTACCTA
TTAATTATACTTAAGAAACAGATGATGTAGTTTTTTGATAT[A/C]GAAGTTTAACAACCGGT
TCAACAATCGGTTAATATTTAAAAATGTCGCAGCCAGCGAGCCTTTAGCTTTAAAAGTAAG
CTTGCGTTCACGGTTTTTGGGGAAATACCAAATATACTAGGTAAAAACATCGATTAACTAA
TAT
>Dsor15inter_01
TTAGTAATATCTAATCCTAATATCCTTTCCATTTAAGTTGTGACCATTGGCCGCTTTAGTCG
TAGGAGTGTATTAACGGTATTTGGTAATCGCGACATCTGGCCA[T/C]ACCGCACCGTCTGCG
AAAAAAACCCAAAAGTCGCCGATTTTGGCTGATTATTGCAAAAATAATATTAACTATCCGT
TTGCTGTTCGTGTGCTCGGTTCGGGTGTG
>Dsor1Exon2_01
GTCCGACGAGGATCTGGAGAAGCTGGGCGAGCTCGGATCGGGCAATGGCGGCGTGGTGAT
GAAGGTCCGGCACACGCACACACACCTGATCATGGCCAGGAAACTGATCCATCTGGAGGT
GAAGCCGGC[G/A]ATCAAGAAACAGATCCTGCGCGAACTGAAAGTCCTGCACGAATGTAA
TTTCCCGCACATTGTCGGTTTCTACGGCGCCTTCTACAGCGACGGCGAGATCAGTATCTGC
ATGGAGTATATGGACGGTGGA
>hepExon1_01
CAGGGGCGNGACGCGGGCAGATGGAACGGAACCGGAAACGACAGGGCCGCGCGCACCGG
AGAGGACGATCTGGTCGTGGGACTCATTCTGCGCCTGGAGCTT[T/C]GCCTCCAAGGATTGC
AGCCGACTGCCGATCGTTTCGAACTCAATGGTGGACATTATATCGAGTCGATTTGGTTCGA
TTTTTTATAGTTAGTTGCTAGTATCGTTGGATTTTGGTATT
>hepIntron1_01
AATTTCTATCAATTTAAGCCTNATAAATAATCGAATAACGACNACTTTTGTCTTTAATAAA
CCAATTTTGTTCNGATAAATTAACATATAGACCGTTATATTTTGTTA[G/A]CTATTTATTCAT
TTAACTTTTGCTCGCTCATTATGTACCACGAACTTGAAANNCTATNCAATAGCTGATTNCA
CTGTTAAAATTTGGGTGTGATTTTAAGTACCCCTGAAA
>hepExon2_01
ACCGGCTTCTTGGACAGCTTGAGCAGCTTGTCAAAGCACATGGACATCAGCTCCATGCAGA
TCCACACATCCGGATCGCGAACGAAGCAGCCAAGGCACTTGAC[A/G]ATGTACTTGCAGTC
GTGCGATTTGAGCACAACATCCAGATCCATCAGGATGCGTTTGTTCTCCTCCGCGTTGCCA
GTGCGTCGCATCTGCTTCACGGCGATGATCG
>hepExon3_01
TAGTCTATTTTTCCCTATCATAGCCCTCNCGCTCTTTATACNCACCGCCATATAAGCTGCAC
AGCCGGCGGATCGAGTGTTNGCCTTGGAGTCCACCAGGCG[T/A]CCGCTGATCCCGAAATC
ACAGAGCTTGATGTTCCCGCGCTCATCGATCAGAATGTTCGAGGGCTTCACATCTCGATGG
ATGACTCCGTGCTTGTCCTTCA
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>hepExon4_01
GACTAAAGTTGTAACCCTCGCCGTATGGCAAACACGGCGGCTCCGAGTCAAGCACCTTGGT
GAGCACCTCGAAGTCCGTGTTGCATCCCTCGTACGGGGATCGCGC[T/G]GTGGCCAGCTCC
ACCAGCGTTATGCCCAGTGACCACACATCTGCGCGAATGTCGTACTTTGGTTTCTTGGGGT
CGATGCGCTCCGGCTNTAAAAT
>hepExon5_01
AGCGGACGGGTCGTGGGAATAATGCTGAAGGATCTGGCACAGATCACCGGATGGGCTCAC
CTCTGGAGCGTTGGATCGCCATTGGNGCGCAGTCGGTTATCCTT[G/A]ATGCTCTGAAACCA
ATTGGGCACATCTACTTTGGCTGATTCATAAATCCGGATGAAGGGCTGGGCCAAAAGCTCC
GGATACTTGGGTCGATCCTGATGGTTCTTT
>hepExon5_02
ACAGGCACAACANATCATCAGCCGGGAATAGCGGACGGGTCGTGGGAATAATGCTGAAG
GATCTGGCACAGATCACCGGATGGGCTCACCTCTGGAGCGTTGGATCGCCATTGG[C/A]GC
GCAGTCGGTTATCCTTNATGCTCTGAAACCAATTGGGCACATCTACTTTGGCTGATTCATA
AATCCGGATGAAGGGCTGGGCCAAAAGCTCCGGATACTTGGGTCGAT
>hepExon7_01
TTGCTTGCGCGGCAACGAGGGGGAGGGTGAGGANAGGCCCAAATTCAAGGTCGTCGTGGT
CGCATTACTACTACTATCACAGCTGTCGNAGGCTTGGGAATTTTCCG[T/C]TGGCAGGCGCC
AAGTGGGCGTGGTCGTTGGCGTTGTCNTGAGCACTGTAGCTGCAATATTTGGCGGTGTTGT
TGCTGTTGCCGCCGCNGCTGCTGCTGCTGTTGCTG
>hepExon7_02
GTGAGTTGCAGGGTCGGCGATTCTGTGGGGAATTGCTTGCGCGGCAACGAGGGGGAGGGT
GAGGANAGGCCCAAATTCAAGGTCGTCGTGGTCGCATTACTACTACTATCACAGCTGTCG[
T/C]AGGCTTGGGAATTTTCCGNTGGCAGGCGCCAAGTGGGCGTGGTCGTTGGCGTTGTCNT
GAGCACTGTAGCTGCAATATTTGGCGGTGTTGTTGCTGTTGCCGCCG
>hepExon8_01
AGAGGTGGAGTGCGTTGATGGCGGCGGCGGCACATAGTTGCTGTGAAACGGATTCGTGCT
GGTCACTCCAACGGGCGGCTGCTGGCGCTGCTGCTGATACCGCTC[A/G]GCCGCCTCCTTCT
CGCGCAGCTGATTCTGCTGGTGGTAGAAGCGCTGCAGCACTGCATATTGAAATTNATATGT
TAGTTNCANACATANCCCAGCAAATGACTAGATCATTATACCT
>hepExon8_02
CCATAATCCGACTGCTGTTCCGGTGATCTAGNCTGGAGCGTGGGACTNGTTCCCGTTGCCT
CGGCGGCGATGGGCAGNGGCTGATACTGCAGCTGCTCGCCAGTGCCGCCCG[C/A]TCCAAA
GTGACCAGCTGCCCCCAATCCCGATGCCGGAGCCGAACCGATTCCCAATCCCGCCATGTTT
CCCGTTCCGGAACCAGACGATGGNGATATGCTGGCGGGATTGATGG
>hepExon8_03
CGCTCCGCTGCTGGAGCTCTGNCCCAAAAGTTGTCGGCGTGCGTACAGCTTGCTCAGCTTA
CTGGCCACCATGTTGCCGTTTCCTCCATAATCCGACTGCTGTTCCGGTGATCTAG[A/G]CTG
GAGCGTGGGACTNGTTCCCGTTGCCTCGGCGGCGATGGGCAGNGGCTGATACTGCAGCTG
CTCGCCAGTGCCGCCCGNTCCAAAGTGACCAGCTGCCCCCAAT
>hepExon8_04
AAGAATGTTATGATTTTATTTCTGAGCTTGTGGACTAGTTAGCAATTCAAGTGATGGCTCA
CCTGCATCGTGTTGCTCCCGACTGCAACCGTCCAGGCT[G/A]CTATTGCTCGCTCCGCTGCT
GGAGCTCTGNCCCAAAAGTTGTCGGCGTGCGTACAGCTTGCTCAGCTTACTGGCCACCATG
TTGCCGTTTCCTCCATAATCCGACTGCTGTTCCGG
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>hepExon9_01
AAGCTACTGGTGCCACCGCCGGGCAGCGGTTCCGTCGTGGGCGAGGTGCTCTGGCTGGTAT
TNNTACTGCTGCTGGCCGCCGACAAGGTGCGATAGTAGTAAGACTTGCCACCGCTGCCGTT
ATT[C/T]ACAACGCTCCTGTACGCCGGCGGCTGCGGATGCACTGGCTCCTGGTCTCGATCCA
TGCTGGACGCCACCGGCGACGTGGCTGTGGAATTCAATTGGGTTTTAACATAGGTGGCAAA
CTGTCGCTTCATGGCACCGGCAAGAGTGTTGA
>hopExon1_01
GCCAAATGGGATACCTGATGCACATAGTGCCACTTCAAACGCTCCACACTCAGCGAATTCG
CTTTTAGACTNCGGAAAACCTCACGTATCTTGGAGCCCACAAAGAAGCTGTGGGCGCGCC
ACA[A/G]GCTCGGTGGCAAATACAGTTTGTAAAGCTTCTCGATGGAGCGCATCGCCTGCTG
ATCCTCCGACTGTTCCTGATCGTCGATTAGCATATCCATCACGGCCAGTCCCGTTGATTTGT
CC
>hopExon1_02
AAAAGACCAAGCAAGTTCGGCTTAAAAGATTAAAATTTAGTTGGAAGCGAACTCTTTGGG
ATNTAAAGNTCACCGATTACAAGTGAACCACTCACCTGATGTAGAT[A/G]CCCAGGTAGGA
GATGAAGGACTTCATCTCCTTCTCCGTCTGAAACTGCATCTCGTAGCCCTTGGGCAGACCA
ACGATTTCCAGCCGCACAGAGG
>hopExon4_01
TGATGTGCGCCACTTCGTGCAGTGAGTTTANTACATGCTCGCCGTTGTTGTAGCTTAGCTTC
CATTGCGAGTCCTTGCGCACGATCCTAAATGTCTCCGTCTTGCA[G/A]CGTTCCTGATCGGT
TTTCTTGGCCATGCTGCAAAGGTGAGCGGGATTTTCGCATGAGATAAAACCGATCACATCT
AATTNGGGCATCATCAATCACACACACA
>hopExon4_02
GCAGTAGCAGCAGCGGCGGCTTGTCATATTTGGAGGCGGGNATGCNATAGCGATCGGGAC
TATCCGCTTGAATGATGTGCGCCACTTCGTGCAGTGAGTTTA[G/C]TACATGCTCGCCGTTG
TTGTAGCTTAGCTTCCATTGCGAGTCCTTGCGCACGATCCTAAATGTCTCCGTCTTGCANCG
TTCCTGATCGGTTTTCTTGGCCATGCTGCAAAGGTGAGCGGGA
>hopExon7_01
AGACAGTGCCATAATGACCGCGCCCGATCATGTTCTCCATGTTGTAGATCACTCGACATTC
GCTGGTCAGCGGTATGACCATCAACATATTCGAACGCGGAAAGGGTAG[A/G]AAGGGTAT
GTCGCTTCTATCGATCACGGTCTCGTCTCCAGTTCCATNTGGAAAAAAAAATAGAAGATGA
AATGTATGCCAATCTCNTAACGCTGCTTTCGNCTGCTCA
>hopExon7_02
AACCACTCACATTTGCAATATCTAAAGCGAAGCTGACGAGCCGTGGATTATTGAGATTGGG
TGCCGTGAAACGCAGGTAAATGTCGAAGGAACCAGATTGCAGATA[T/C]TCCATAATGATG
CAGTGCGACTTCTCAGCCCAATACTTGAACTTGACTATGTTCGGATGACTGAGGGTGCGCA
TGATGCCGATCTCGCGATGAAAATCGGTCGACACCTG
>hopExon8_01
CGGAANTGGCGAANTGCGCCAGGCCGANGTCTGAGATTTTGACGCAGTCACCATCGCCGT
TGTGGTCCACCAAAATGTTGCGGGCGGCCAGGTCGCGGTGGAT[G/T]AGTCCCATGTCGGA
CAAGTATTTCATGCCCTGCGACGAGAANCATTTGGATTAAGTACTGNATCAAAAGGAAAT
ATNNCTTCTAAAGTCGTAAACATGAGTTTTCTATACCAAAG
>lzIntron1_02 (lzIntron2_01)
GGGCTTCCACATCGTGGCAATCACGATCATCGGACGCAGCCTTATCGGATTCCATGGGTAT
GATGATCGTGATGATGATACCGATGGCGATGATGATGGTGAT[G/A]CCAGTGAAGATGGGA
137
CTGGCATCGCCGTCGGAATATGCGTAAATTGATATCAATAATTGTTATTGATATCAACGCA
CGAGNCGTTCCCCTTTTTTATTTTGTTA
>lzExon5_01 (lzExon6_01)
CGGTGCTGCCCGAGATGCATGGCCATGGATTCGCCACCGATCCCTACCAGACGGCCGGCTA
TGGCGGTGGCAATACGGGCGGAGGCAGTGCATCCAAATCGGAACTGGACTA[T/C]GGCGG
CAGCTACAATCAGGCGTGGTCGAATGGCTATCAGAACTATCAGTATGGCAGTTGTTTGGCC
ACCGCCCAGTACGGTCCTCAGG
>lzExon5_02 (lzExon6_02)
TCGGAACTGGACTANGGCGGCAGCTACAATCAGGCGTGGTCGAATGGCTATCAGAACTAT
CAGTATGGCAGTTGTTTGGCCACCGCCCAGTACGGTCCTCAGGC[G/T]GCGCCGCCACCAC
AGCCACCGCCTCCGCCGCCGGTGGTGCTGTGCCCGCAGCTGTACTCCACGGTCAATCAGAA
TCAAATCCACCTGCATCTGCACAGCAGCGAGAAGCTG
>lzExon5_03 (lzExon6_03)
ACTCCACGGTCAATCAGAATCAAATCCACCTGCATCTGCACAGCAGCGAGAAGCTGGAGC
AGTATCTGGGCACGGCCACTAGTGCGGACCATCTCACCATTGGATC[C/T]CTGACGGGCAG
CAGTCGTTCCAGCATTGAAATTGGCCAGGATCAGTACCANCAGCAGGTGCANCACGCACA
GCAGCAGCAACAGC
>mxc5inter_01
TATCGATATAGTCCCGTTGTTTGCGCTTGGCTGCCAAGCCTTATTAGGAGCGNGGGAAATA
ATGGTAATAATTAAAGCAAAGAAATACGTCTCTTTCGCTTAAAA[C/A]AAATTATAGCAGT
TTTTATTGCTTTGANGGTCTTGCTTCAATTCGTTTTTATGTGTACGTTACAGTACTTAGAATC
CGATATTCGTTAAACTATCGATATGGGAATGCTGC
>mxcExon2_01
CATAACNCTGATCATGTTATTCTTTTACAGATGTACCATTGGAAATCTTTCTCACTTTCAAT
AAGATAAAGACGCTCACCCAGGATGTGCAGCAGATAGCCAAGGC[A/T]CTAAGCAACTCCC
AGCTTCTGGAGCTGGATGAGACCGAACTAAAGGTCAAGCGACGTACCAAGCTACCAGATC
AGCGCGATGTCAACGACNAAACCTTGTA
>Ntf25inter_01
GTGAAAATACAAGCGATTCCACATTATGAATAAACGGATCTAAAAATCAACTTTAGATAC
CTTACAATGGATTGTAAGTTGCGTTAGNTTAAGTATGACCTG[C/G]AATTAAACAACAAAT
CAAAGAAAAGTCGTCCCGAGCGAGGAAAAAAAATAATATATGAAACACAAATAATTGTTT
TCCAAATGACCAAGTATTACGCCTGACAG
>Ntf2Intron1_01
AAGTTTCGGGTGACACATTACGCCCANGCNCGCATAAATAAATACNCACATACGAAATAT
ATGGCCAACATACAACTGCGGTNAGCACNATAGGGCCCAATATAC[G/A]ATATAAATTCGT
GAAAAAATTGTATTAATATCTTGAAAAATATGGCATAATTGTGTTTCATTAGTTTCAATCA
NTTCAGTTNTTTTGTCACAT
>osExon1_01
AGCTCTGTGGAGAAGCAGATAAAATGGGGAGCGGATTACATATGGATCGGGTCCAAAGAG
CGCTGCCGTTTGAACTCACCTGCCTGGGACGCTGGCGATTGAAGCGATCACCCGCCGAGGG
ATGATAGTTGCCACCGCAGGGATTGG[C/A]CCACTCCAGGGCGGTGGTGTTCTCGTCGAAG
TTGCGATAGTCGATCCAGTTGCTGTTCCGCTTTCTGTGGCGCTTGCGCGGACTAGCGGCGCT
GGCAGGGATCGTGCCCTGATTGGGATG
138
>PGRPLE3inter_01 (PGRPLEExon3_01)
CAGCAAACTTGAATACTCACAGATAACCACATATTTAACAGGCAGTTGCAAGGGCAGTGG
CTCGTCCATGGGCTTCTGTGCTAGCCACGAAGAGCGCGGAATGATGGCG[G/C]ACAGCTCC
TTGGGTATTTTGAATTCTGTAAGTGAAATCGGTATCCTATGGTTAACGTGTATGCATCCCCT
GGTGAATGATAGCTTACTCTGGCGCCTGA
>phl5UTR_01
CGACGNNNTGTGTCGGGGCTGCCACTTGAATCNAACCCATNTATGTTTCTTCCATCACTAC
CNCCTGNACCTTGTATATGGTTAGTTGATTAATAGCCACGTCA[G/A]AAACTAATTTACCTG
TTGCCGCTCGTACCAGATCCAGATTTGTACTATCCCGAGAAGTTAAAAGCTCTAGGCAAAT
TAACAATTAGCCGCGACACAAACCCCGTTTC
>phl5UTR_02
ATTCGCGGAAAGTAAATAAATTGTTATAGCCAAGGTGAAATAACGAGCGGCCAGCTAGTG
GCGATACTGATACTNTTGCGAACGTTGGGCAGCCACCGAC[G/A]GTGCCGGCTGGTCAGGN
TGTTATCGGGTAATTGGCAGCTCCTTTGGAAAATCCTCAAGTTCAGCTGCTTCTGCACACA
CTGACCTTCATTATACATACATACCGTATATA
>phlExon2_01
TGCATGTGGAGGAGATCTTTGTCAGGCTGCTGGATAAGTTTCCCATTAGGACACACATCAA
GCACCAGATCATACGGAAGACCTTCTTCTCGTTGGTATTCTG[C/T]GAGGGCTGTCGAAGGC
TTCTGTTCACCGGGTTCTACTGTAGCCAGTGTAATTTTCGATTCCATCAGAGGTGTGCCAAT
AGAGTGCCGATGCTGTGCCAGCCCTTTCCCA
>phlExon2_02
CTGTAGCCAGTGTAATTTTCGATTCCATCAGAGGTGTGCCAATAGAGTGCCGATGCTGTGC
CAGCCCTTTCCCATGGATAGCTACTATCAGCTACTGCTGGCCGA[G/A]AATCCGGATAATG
GCGTTGGTTTCCCCGGCAGAGGCACTGCTGTCCGCTTCAATATGAGCAGCCGGAGTCGCAG
TCGTCGTTGCAGCAGCAGTGGCAGCAGCAGCAGCT
>phlExon2_03
CCGGATAATGGCGTTGGTTTCCCCGGCAGAGGCACTGCTGTCCGCTTCAATATGAGCAGCC
GGAGTCGCAGTCGTCGTTGCAGCAGCAGTGGCAGCAGCAGCAGCTC[G/A]AAGCCACCATC
TTCATCCTNCGGCAATCATCGACAGGGTCGTCCGCCGAGGATCAGCCAAGACGATCGTCCA
>phlExon4_01
ACACCGAGTCCCGCCCAGTTGCAGGCGTTTAAGAACGAGGTGGCCATGCTNAANAAGACG
CGCCACTGCAATATCCTCCTCTTCATGGGCTGTGTATCCAAACCATC[T/C]CTAGCGATTGT
GACCCAGTGGTGCGAGGGCAGCAGTCTCTACAAGCACGTCCATGTCAGCGAAACCAAGTT
TAANTTGAACACGCTCATCGATATCGGACGTCAGGTGGCC
>phlExon4_02
TCTCTACAAGCACGTCCATGTCAGCGAAACCAANTTTAANTTGAACACGCTCATCGATATC
GGACGTCAGGTGGCCCAGGGNATGGATTACCTGCATGCCAAGAA[T/C]ATCATTCATAGGT
GGGTTTCCGTATGGTCANCAGTTGTAATCGGTTAANAATNATATTTTCATTTCTCTCTTTTA
GAGACCTCAAGTCAAACAACATCTTTTTGCACGAGGA
>phlExon5_01
GGCCACTGCGAAAACTCGATGGTCGGGTGAAAAGCAAGCCAATCAACCCACGGGCAGTAT
TTTATGGATGGCTCCAGAGGTGATTCGCATGCAGGAGCT[A/G]AACCCCTACTCCTTCCAGT
CGGACGTTTATGCNTTTGGTATCGTGATGTACGAACTGTTGGCGGAGTGCTTGCCCTACGG
TCATATTAGCAACAAGGATCAGATCCTGTTTATGGTGGG
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>phl3UTR_01
ACTACTGAAACTAAACTAAACTAAACTAAACTAGCTGATCGCAATTACATTATACACATTA
TACTTATACTACAAGAGATGGTGTTGTTTCTGGAGTCGAGC[A/G]CGATGAAGAACATTTA
ATTCAGGTATTATTTGTTATNCCATTGTCATTAACTACTTCTTGGTTTATGTTTACACACAA
GGTTCTAGGAATTTTTAAGTATGGAACCACCC
>Pvf15UTR_01
ACAAACTTAAACGCGCTCAAATATATATCACAAATTATTAAATACAAAACCCCCCATTTGT
GCACACATATTTTTTGTTGTTTGTTTTTCGTTTCGTGCTAACCGATTTGTGCCATTGAACTTC
GTGTAAAACATAATATTT[A/T]GAATTTTCAAGCCGTGTTTCCATAAAGTAAGTGGTGCTTC
TCAAAATTTCAACATTTCAACACAAATCAGCAGCGTAAACAAACAAGCNAGCGACCCTCG
AC
>Pvf15UTR_02 (Pvf1Intron1_01)
GTATTGGAATTCTTGTGCGGGGAGCAATTGCCTGGCGGGAGGCACTCCCTTCGCGTAATTA
AGGACCGCCCAAGTGGGGATCGCGNTNCCGAGATGATTCCTTT[T/C]GGTTCCTCGCCTTCT
CCTCCTTGAGATTACTTGATATGATTTGATATCTTCGGGTGACGCACCGGGAAGGAATGCC
TCGAAAGTGTGAGAATAAATACAGCTGA
>Pvf1Exon1_01 (Pvf1Exon2_01)
GAAAACTGTTCTTCCATCGCATCCGCATGGCCATGTCCCGAATCCGAATNCTGAAGCCCAT
GCAGCATCCATTGCTCNTCCTGCCAGTGCTCCTTCTCGTCCTGATCGTCAGCGAG[G/T]CAG
CGGCGGGCTCCTTGGTGTCCCCGAACAACAGGCANCCNTCGCAGAGGTTCTTCTACGCCGC
CGCNACGTCCTCCTCCTCCACGCAGACCAAGGTGCGCCTGCT
>Pvf1Exon1_02 (Pvf1Exon2_02)
GCANCCNTCGCAGAGGTTCTTCTACGCCGCCGCNACGTCCTCCTCCTCCACGCAGACCAAG
GTGCGCCTGCTCCGCCANGCGGACGATCCCAGTGCGGCGCCGGGT[G/A]CACTGGAGGGCA
GCTGCTGCCAAGGAGCAGCTGCGGAAGCCGGAACACCATTGACGGTAAGACAAATGCTAC
AATCACNCCACACATCCATCANTATGGTAA
>Pvf1Intron1_01 (Pvf1Intron2_01)
ATCTGAGACCCCAATCCCAGACCCCAAACCCCACCAAAGATCGGGAGCAGCCGGTGGACA
GTGGCGCCGTTGTCTCAGCATATTCTCACGCAGCGAAATGGGAATAGAAACTACACACCA
A[A/G]AGTACAGTTTTAACTAAATTTTGTAACTAGCAAGNNAATTTTATNTTTNTTTTATTA
AAGNAGNAACTTGTAGATACTTTTGNAANCAATTTACTAAGTA
>Pvf1Intron1_02 (Pvf1Intron2_02)
TGCTCCTCCGCCGCTTGGAACGGCTACCGAAATACGGTCAAAATAACTGGGTGACGCACG
ATGGCGTCGATTTGGTGTTNATTCCATCCATTTNTATGCAGTCGCCGTA[C/A]GTTTTTCAAT
GGAATCTCGACGTCGATACGCATGGTAGTAGTGGTAGTAGTGGTAGTAGTGGCCCATGACT
AAATCCAAATGAATTTGCGGNTGAACTGAATCCATGT
>Pvf1Exon4_01 (Pvf1Exon5_01)
ACCTAATATCCCAATTACNATATTCCCAATCNCCAGCAACNGTGAGGAATGCAACGCCGG
CGAGCTGCTCCCCGCAACCGACGATCGTGGAGCTGAAGCC[A/G]CCGGCGGAGGACGAGG
CNAACTACTACTATATGCCCGNGTGCACGCGGATCAGCCGATGCAATGGATGNTGCGGAT
CCACGCTGATCTCCTGNCAGCCAACGGAGGTA
>Pvf1Exon4_03 (Pvf1Exon5_02)
CTGCGGGTGCGCAAGGTGGACCGGCGCGGNCACNAGCGGACGCAGNCCGTTCANNTATCA
TCNCCGTGGAGCAGCATACGCAGTGCCGCTGCGATTG[T/C]CGCACGAAGGCGGAGGACTG
140
CAACGTGTACCAGTCGTATCGCAAGGATNTNTGCCGCTGCGANTGCCACAACACNNANGC
CCGGGACAAGTGCCTGGAGCAGGCCGAGA
>Pvf1Intron4_01 (Pvf1Intron5_01)
TTTTTGCAGTTAAAGTAGAAAATGAATTAGTGAAAAACATTTAGTAGTTATCAGTTCAGAG
TTCTCAGGTNCCACTGTTTGGTTTTTGGTTTTTGTTTAAACTTATTATTTGTTCAACTGCT[G/
A]GCACACACTCTGTACATATATATAGTTTACGTAATTTANGNCACTTTATAAATGTATGTA
NGNTTTTACTTCNGTTTCTTTTGTGTTTCGTTTTAGATTAAAAA
>Pvf1Exon5_01 (Pvf1Exon6_01)
ATAACCTAAAATTGTTAATTAATTTTCGATTTTGTTCTTTCATTCGCAGCCGGCTGCACCCA
TCGATGTCTTGGATCGCAAACGCTTCATTGTCCAGGCGGTACAGGTGGA[T/C]CCCGATAAC
ACCACCCTGTACAGTGTTTGAGGACAGTTGGTTCGCCNCGGAGNNCGAAGTAGAAACGCC
AGCNTCCTAGCGGGGAATCCCCGAGTACTGAGAAGG
>Rps65inter_01
ACACGAGAATGGAGATAATTGCACTGATTCATCAAACATGCTATATTGTGCGTTCTAAATA
TTTATTTATGCGACTTTTTAAATACATCTTGAAACGAATTATATCG[G/A]TACAATCGATTTC
ANNATAAACTTCAAAAACAATATATATAGATTTTANNGAATTDCTGCATTCAATNTCGNNN
NCNCNNNNNCATCCCTGGTCTCACAAGC
>Rps6Intron1_01
CAATCNCTGGACNTTNTCGCTTGCAATTTGTTTGATCNCCGCGCCAATGCTTGCGCTTTAGC
ATTTTCGCAATATTTCACAAATTGATATAATTTATATCAGTA[T/A]TATCACAAATTTTTAGC
NCACCTTCATATTGTCGGTCTGTTTGCNCGCAACGCAGAAAAAAAAAGAAACGGCGGAGG
TCTGTTGGCTGCGAGCGCAGGGTTGAAAA
>Rps6Exon3_01
TTGGACTCCTTCTTGCGCTGCACCAACAGNTTGGCGTAGTCGGCGGAAGCCTCCTTGGAAG
CGATCTGGCGCTTCTTCTTCAGCGCAATGCGACGGTGCTTGCGCTGCAGCACAACGGG[G/T]
GTGATCAGGCGCTGAATTTTGGGGGCCTTGGAGGTGGCCTTCTTGTTGTCCTTGGCGGGCA
AAGGGCGACGCACAACGAAGCGACGCACATCATCTTCCTT
>Ser75inter_01
CTGGAAGCGCGATTGGAAGGCGGCAACGGGTTTTNCCGCCCAGCCGCAATCAATGAGAAT
CGATCCGATCGTAGCTAATCAACGCAGCGTCGGCGATGGAAAAG[G/C]CAAATCAAAAGC
CAATCTCTGAGATTCAAAAAGCTTCCGAGGGTCGCGGCTTGAGGTTGCCGATCGCCAGTAG
ATCAGTAGTTGATTGCCAGCCACCGGGGACGC
>Ser7Exon3_01
TGAACTGGCTGCAGATGCAGAATCTGGAGCCCGTCTGTTTGCCACCGCAGAGGGGCAGGT
ATGCCAATCAGCTGGCCGGCTCAGCNGCCGATGTTTCCGGCTGGGGC[A/C]AGACCGAGTC
CAGCGGCAGCAGCAAGATCAAGCAAAAGGCNATGCTGCACATCCAGCCGCAGGATCAGTG
CCAGGAGGCNTTTTACAAGGACACCAAGATTACGCTCGCCGATAGTC
>Ser7Exon3_02
CGGCAATCGATATGTCTATCTGGCCGGCGTGGTCTCCATTGGACGGAAACACTGTGGCACA
GCGTTGTTTTCCGGAATTTACACCCGGGTCAGCAGCTACATGGACTGGAT[A/T]GAAAGCA
CCATTCGAGCCAATCGCATTTAAGCGACTCTCGACTTTCGTTTCCGTTTTCGGCTATTTTTG
GGCACCCATAACGCAAAGTCAAGCTCATTGTGACCTT
>Tak15UTR_01
GCGCTATTTTGGTAGAATTACNGGGATTTCGCCTTTTTAGTGGCTACGATTCCGTGGGTTCC
CGATTTCATTGCTGGCTAACTGTGCCTTTGGTTCCCTCTTGGG[G/T]ACAGAGTTTTCGGAAT
141
CTTTGCAAGATCTAGACCTGGATTCATCATAAAGTTTCTNGCCTTTGTATAGATTGCGACTG
ACAACTTTTACCACGTCATTT
>Tak1Intron1_01
TGGGTTTTTTAACNGAGCTGTTACNAAGCATACACTTTTAAAACGAAAAAATAACCGNTTA
TAGATTAAAACATGCTTTNTGAAAGTGCGATAATCGTCT[G/T]ACTAACTAAGAATGAGTA
CTTGCTCTGCCCTAAATGGTATATGATTACTGGTTGTTTATCGTTTCAAGATTGCGTATACG
TATACACCAATAGGAGCTCTAGACTTT
>Tak1Exon2_01
ACGCGCGACAACTGCTTCACCTCCTTCTCGATGTCCTTCTGCTCGGCGCTGGCGAAGAACT
CCTTGACGGCAACCAGCTTGTCGCGCCAAACGGCCTTGCAGACCAC[T/A]CCGTAGGACCC
ATGGCCGACTTTCTGCGGGGNAAAAGATTATTAGATCTGANTCAACAGTTGTACCCTCNTT
GNGCANNACTCCTCAATACNNANTATACGTTATACANCTTG
>Tak1Exon3_01
GCTTCCTGGACAGAACCTCCCATAGAACAATGGCCCAGCTNAAAATGTCACACTTCTCCGT
ATACTTGGAGCCTTCGAAGACCTCGGGCGCCATCCAAGCGGCACT[G/A]CCGCGATTGTTG
GTCATCATGGTCGACTTGTCCGCCACCGTGCCGAAGTCNCATATCTTCAGATTGNNTCCCTT
GTNRRTCAAGAGCAGGTT
>Tak1Exon4_01 (Tak1Intron4_01)
ACAATATCGAATTTAAATTAGGTTTTAAAGACGGGCAGAGTAAAAGAACGCTTTCCTCAAT
AGATGTAAANAATTNACCAATTGACTCTTTTACAATTGTGTATTGACCCAATAAAGC[T/C]G
TCTCACCTGTTGATTAACAAANGTGTATTCCAGGGCCTTGTCCGCCCCCGTATAGTCCTTGA
CGATCTCGTGCATAACGCCCACTATGTACTGCATCGACGGG
>Traf2Exon1_01
GGATGCACCATGCACAACTTGATGCGACCCTTGAAGGGCCAGTCCAAGTGGTAATCGTTCT
CCGACTGCATCAGATGCACATGCAAGCTGAGCACATGCGGTTT[C/T]CGCGGCTGAATGTT
CAGCCGCGCACAGAANTTGTAGCCATGNGGCGAGGTGTAGCACTCGTGCGAGTACACTTG
ATTGTTGGCATTNGNCCGCAGGCG
>Traf2Exon1_02
TATTCTCCAGTCGCGTNTCCTGCTCGCGNNTNNNNTNTTCCAAAACCACAATTNNCTGGNA
CATCGTTTGCACAATCTGCTCATCCACACCATTGGCATATTGCG[G/A]CGGTGGCGGCAGCT
GCTGCTGGCCATGACCNTTNTCCACGGCGGCGCCACTTGTGCTGGGCTTGTGNGGCTGCCA
GGTGGCAATGGCTGTCTGCTGGAATGCCTGCA
>Traf2Exon1_03
AGATGTCGTGCTCGGCGGACAGACGCTTGTTGTCCATGGGGCAGCATTGATTGTTCTTTTG
CATCCAGGCGGTGAGGCAGCTGCGACAAAATCGATGGCCGCACGA[C/T]GTCAACACCGGC
TCATTTAGCCAATCGATGCAAATGGCGCACTCGTATCGCGAGTCCAGCAGCTCCTCCTCCT
GTTCCCCGGATGTATCCGAACCNGGTGCAT
>Traf25inter_01
TANCGTGTTAATTGTGCTAAATTTAGTTNTTATTTTACANNTAANANNAAATCAATGTAAA
ACCATCACTTGTATAGTTTANTTGGTTGTTAGAAGCTGATA[G/A]CGTGTAAACAACATGGC
CTGCGCAGATGCAGGCCAGTGTGAACACNCTCGTTTNGTTTTGGCGGCGGTGGGCGAGCAT
ATAAAACGGCAGTGTTTTTCGGATTGGCGAGC
>Traf3Exon2_01
TCCCATNTGAAGGAGTGTCCACGCAACCAGCACAATCTGAGCAATCAGCAACGCATGAGT
GTCAGCATGGATCGCCTGGATAGGCAGTCGGATCAGCGTCT[C/G]CTGGTCATTGAACAGG
142
ACGTGGGCACCATTCGGTCCGTTCTCAACGAGGAGATACGACAGCGTTTGCATCTCATTAC
CGATGTGGGCAACATACGGAAGCAGAACCA
>Traf3Exon3_01
TGAGAACGAGNGNCTCAACNGGGAGAAGTTCTTTCAGATCGAGGAGTTNCTGCAGCAAGA
TCAATGAGGACATCAAAACAAAGCTGGGCAACAGTGACTATGTGACGTC[A/G]AAGCAGG
CCACATTGGACTANGAGGTGAAGAATGTGAAGAACATTGTGTGCGAAACGGAGGAACGTT
GCGATAAATTGGATCGAGCACTTCACCAGACCATGCAG
>Tsf15inter_01
TAGCATACTAATTGATTTGCGAAAATCGCATTTAATGGCATAGCCATATATCAGTGTCGNA
AACTCGTTTGCCGGAGTATATAGGCCTGGATTGCCGCCCACTCA[C/T]GCCTTTCCTCGGGG
AAAAACCGGTCGCCTGGACTGTCTTTCTTTCTTTATTGTTATGATTGCTATTNTTATTATTAT
TACTATTATTATTGGTATTGGTATTGGTATTA
>Tsf1Exon2_02
TGGAGTGCGTGGCTGGACGGGATCGAGTGGACTGCCTGGAGCTGATCGAGCAGCGCAAGG
CCGATGTGCTGGCCACCGAGCCGGAGGACATGTACATCGCCTA[T/C]CATCGCAAGAACGA
GGANTATCGCGTGATCTNTGAGATCCGAACGCAGCAGGACAAGGATGGTAAGTGGTGCAN
ATGCTCGTGGGAGCAAAA
>Tsf1Exon3_01
CCTGCCACACTGGCTTCGGCCGCAACGTCGGCTACAAGATCCCCATCACCAAGCTGAAGA
ACACGCACGTCCTGAAGGTGTCCGCCGATCCGCAGATCTCCGC[T/C]ACGGAGCGCGAACT
GAAGTCGCTGTCCGAGTTCTTCACGCAGTCGTGNCTGGTGGGCACCTACTCCACGCATCCG
GAAACGGATCGCCTGCTGAAGAAGAAGTAC
>Tsf1Exon3_02
AGTCGCGTCTGGAGCGCTTCTTCGCCAATGGACTGCAGGCGCAGAACAAGGACGCCGCCG
CCCATCTGCTCATCCAGCCGAATGCCGTGTACCACAGCAAGGATGC[T/C]GCCATCGATCCC
AAGGTCTATTTGGAGCGTGCCGGCTACAAGGATGTGATCGAGCGTGATGGCAGTGCCATC
AGGAAGATCCGCTTGTGNGCCCAGAACGACGA
>Tsf1Exon3_03
CCATCGATCCCAAGGTCTATTTGGAGCGTGCCGGCTACAAGGATGTGATCGAGCGTGATGG
CAGTGCCATCAGGAAGATCCGCTTGTGNGCCCAGAACGACGA[C/A]GAGTTCGCCAAATGC
CAGGCGCTGCACCAGGCTGCCTACGCCCGCNACGCTCGTCCGGAACTCGAGTGCGTTCAGT
CCACCGATTGTGTGGTGGCTCTGACCAAGAAG
>Tsf1Exon3_04
CGCAACNGGCTANGCGGATGCCCGTAGCAACCAGCTGCAGCCAATNGTNTACGAGCAGAG
GGCTCAGGATGATGTCCTTGTGGCGGTCGCAGCACCCGGCGTTACACGGGAG[G/T]CTCTC
CAGAAGGCCAGCATGTAAGTGGAATCCCTCGATCATCCGTAGCANATTAGCTACATATACT
ATCAATATTCCGCAGCAANTTCAATGNGANTTGCGAACGATCCCGTGCTGCTGCCGCC
>upd2Exon1_01
GATGATGAGGATGACGATGACGACGAGGAAGATCGGCCGGAGTTGTCCTCGTCGTAGGNG
TAGTCCAGTGCCACCTGGTCGCGCAAGTGTCGCGCCTTGGT[G/A]AATGGCATCACGACGC
TCAGGATCATGATCACTAGCAGCACCTGCCGGNTGTGGCAGCTCCAGCTGCTGTGTGCACT
CCTGCTGCTGCGGCTGCTTTGGCTNTGTTGGCTG
>upd2Intron1_01
GAAATCGATGAGTAATGCATATTGGCTGTGTGACAGAATTTCTCGAACGTTTCGGGTTCAA
CTAACTGCCTAAGTANCTGTCCTGCNAAAGATGCTAACAGGACAC[A/G]CAACGCACAAAA
143
GTATCTATGTATCTTAGTATCTATGAAGNTGCNTTGCGACTATGTAAATATAAACTGTTATC
AAACAATGTAAGAAAAGCTTGGTGTAGGTTGCTTTCCTC
>upd2Exon3_01
TCGCCGCAGGACACGGTGCAGGGTCTTCCACACGTTGTTCAGATACTGGAAGTACAGCTCC
TTGCTGACCTTCAGGTCGCGCTGGTCCGCCTCCATGGATCCGTTGGC[T/G]GGCGTGTGAAA
GTTGAGACGCTCCTCCATCGCCTGCCGGCTAACGCGGCTCAGCTTCGCACCATTGCTGTTC
GGATAGGAGGCGTTTATGGTCAACTCGA
>upd2Exon3_02
TGCCGAGGGCTCAAGACTCATTGGATCCGCCATCGGAGCCGGAACTGCCACCGGATCCGTT
CGAGGAGCCCACGTCGAGCATTTCCGAGCTGCCCGCCCGCAG[C/G]CCGCTCGCACCAGTT
CCGTGAATCGCCGCCAGGTGTCGCCGCTCGGCACTATTGCGTCGCGGTCGCCGCAGGACAC
GGTGCAGGGTCTTCCACACGTTGTTCAGATACTGGAAGTA
>(upd3Exon1_01)upd35inter_01
TCCGCCAATTGGACAGATCAACACGATAAGCCGAAATCAAAAGCAGCAGTTACCCGATCC
GTACCAGTGTGCCTCGTACAATGGTTTAAAAATAGCTCGGCCAAATCAT[G/A]ACACCGAT
CACCATCCGTAAGTTTGGCCGCCANCGGTGNGCGTTGGGCGGCNGACGGCGAGTGGGAGT
GGCAGTGGCAGTGAGCGGTACACGGTACATGGTAC
>(upd3Intron1_01)upd35inter_02
CGGTGGAGCGTAGTCGGCAANCATGAATGAATCGCCGTGTCTGCGAGCGTGAGAGCCCGG
CTCGCGGTTGAACAAATCGTGTCGTCATTGACGGCTGTCG[G/T]CGGCCGACGGAGCGTAT
GAGTAATATTCTTGTGAAATTGAACGGAAATAANTGAAATTCATGCCAACCCCCATAAATT
GCCGACTATTTGCGGGGGNTACTTCGGAACG
>upd3Exon2_04
CAGAGCGGCCAACTTCCGGCTGACNTTCCAGCAGAAANTNAATGCCAGCAGTACGCATCT
GGACTGGGAGAACACCTGCAATCTGAAGCCCACGGGTCTGAACGAAACGCA[C/T]AGCAA
GGCGAAACGCTGCAAGAAACGCCAAAGGGTAAGTTTCAANCGAAANTTGGCTCTTANCTG
ANNNATNNDTNGGCACAACTAATTCACACACTATTATCTATA
>upd3Exon3_01
TGCAGAANCTACAGAACCAAACGGGCCGCGAGCTGCGGGGCATCCAGGCCGAGGACAAG
GCCAGGATCACCACCAATGCGGACAAGCTGGCCACAGTGAGCACCAA[G/A]ACTCTGGAC
ATTGTCGAGAAGAACAAGTGGCGATTCTATAAGGGAAACTACAGATTCCTGCCCCGTNTG
AATCTCACTAGCAAACAGGTGAGTGT
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Table A.3 Genotypes at Each SNP
              SNP           
Line dome3UTR_01dome5UTR_01domeExon1_01domeExon1_02domeExon3_01domeExon3_02Dredd5inter_01DreddExon1_01DreddExon3_01
1 NA A C NA NA NA A C NA
2 NA A NA NA T NA NA NA NA
3 NA A T NA NA NA C C G
4 A A C NA T NA A C G
6 NA A C NA T NA NA NA G
7 A A NA NA T C C C G
8 NA A C NA NA NA C C G
9 NA A C T T NA A C G
10 NA A C NA NA NA C C G
11 NA A C NA NA NA A C G
12 NA A C NA NA NA A T T
13 NA A C NA NA NA A C G
14 A A C C T NA A T T
15 A A C T G C A T G
16 A A C T T C C C G
17 A A C T T C A T G
22 NA A C NA NA NA C C G
23 A T C C T NA C C G
24 A A C T G NA A C G
25 NA A C T T NA A C G
26 A A C T T NA A NA G
27 A A C C G C A C G
28 A T C C T C A T T
29 A T C C T C A C G
31 NA A C C T NA C C G
33 A A C T T NA A T G
34 A A C T T NA A C G
35 A A C NA NA NA A T G
36 NA A T C NA NA A NA G
37 A A C C T C A C G
38 A A C T T C A T T
39 A A C T T C NA NA NA
40 NA T C C T NA A T G
41 NA A C NA NA NA A C G
42 NA T C NA NA NA A T G
43 NA A C C NA NA A NA G
44 NA A C NA NA NA A NA G
45 NA A C C T NA A C G
46 NA A C NA NA NA C C G
47 NA A C NA NA NA A T G
48 NA A C NA NA NA A C G
49 A A C T T NA A T G
50 NA A C NA NA NA A T G
51 NA T C NA NA NA A NA G
52 NA A C NA NA NA C C G
53 NA A C NA NA NA A NA G
54 A A C C T NA A T G
55 NA A T C T NA A T T
56 NA A C NA NA NA A T T
57 A A C T G C C C G
58 A A C T T C A T G
59 A A C C NA C A C G
60 NA A C C T NA A T G
61 A NA NA NA NA C NA NA NA
62 A A C T T C A T G
63 A A C C T NA A T G
64 A A C C T C A T G
65 NA A C C T NA A NA G
68 A T C C T C A C G
69 NA A T C T C A C G
70 A A C T G C C C G
71 A A T C T C A T G
73 A A C T T C A C G
74 A A T C T C A C G
75 A A C C G C A C G
76 NA A C NA NA NA A T G
79 NA A C C T C C C G
80 A A C C T C C C G
81 A A C C T C C C G
84 A A C T T C A C G
86 A A T C T C A T G
87 A A C T T C A C G
88 NA A C NA NA NA A C G
89 A A C T T C C C G
90 A A C T G C C C G
91 NA A C C T C A T T
92 A A C C T C C C G
93 A A NA T T C C C G
94 A A C C G C A C G
95 A A C T G C A T G
96 A A C T NA C A C G
97 A A C T T C A C G
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Table A.3 (continued)
             SNP           
Line dome3UTR_01dome5UTR_01domeExon1_01domeExon1_02domeExon3_01domeExon3_02Dredd5inter_01DreddExon1_01DreddExon3_01
98 NA A C C T NA A C G
99 NA A T C T C C C G
101 A A C T G C A C G
102 A A T C T C A C G
103 NA A C C T NA A T G
104 A A C C T C A C G
105 A A C C T C A C G
106 A A C NA T C A T G
107 A A C T G C C C G
108 NA A C C T NA A C G
109 A A NA NA NA C NA NA G
110 NA A C T T C NA C G
111 NA A C C NA NA A C G
112 NA T C C NA NA A C G
113 A A C C T C A C G
114 NA A C C T C C C G
115 A A C T T C A C G
116 A A C T G C A T G
117 NA A C T T NA C C G
119 A A C T T C A C G
122 A A C T T C C C G
123 NA A T C T C A C G
125 A A C T T C A C G
126 A A C C T C A T G
127 A A C T G C A C G
128 A A C T T C A T G
130 A A C T G C A T G
131 A A C C T C A T G
134 A A C C T C A C G
136 A A NA C T C A C G
137 NA A C C T NA NA T G
138 NA A T C T C A C G
139 A A C C T C A T NA
140 A A C C T C C C G
142 A A C T G C A C G
143 A A C T T C A C G
144 A A C C T C A T G
145 NA A C C T NA A C G
146 A A C T T C C C G
148 A A C C T C A C G
149 A A C C T C C C G
151 A A C T T C C C G
152 A T C C G C A T G
153 NA T C C T NA A C G
154 A A T C T C A C G
155 A A C C T C A T G
158 A A C C T C A C G
160 NA A T C T C C C G
164 NA A C T G C A C G
166 NA A C C T C A T G
167 A A C C NA C C C G
168 A A C C G C C C G
169 A A T C T C A C G
172 A A C T G C NA T G
173 A A C C G C A C G
174 A A C T T C A T T
201 A A C T G C A C G
202 A A C T G C A C G
203 A A C C T C A C G
204 A A C C T C A NA G
205 A A T C T C A T G
206 A T C C T C A C G
207 A A C T G C A C G
208 A A C T T C NA C G
209 A A C T T C A C G
210 A A C T T C C C G
211 NA A C C T NA NA C G
212 A A C T NA C NA C G
213 A A C C G C A T G
214 NA A C C T NA A T G
215 A A C C T C A C G
216 A A C T T C A NA G
217 A A C T T C A C G
218 A A C T T C A T T
219 NA A C T T NA C C G
220 A A C NA NA C C C G
221 NA A T C T C NA NA G
222 A T C C T C C C G
223 A T C C T C A T G
224 A A C C G C A T G
225 A NA C C T C A T G
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Table A.3 (continued)
             SNP           
Line DreddIntron1_01Dsor15inter_01Dsor1Exon2_01hepExon1_01hepExon2_01hepExon3_01hepExon4_01hepExon5_01hepExon5_02
1 A NA NA T NA NA G A NA
2 NA NA G T A NA G NA C
3 G NA NA C NA NA G A NA
4 G NA G NA A NA NA NA C
6 NA T G T A A G A C
7 G NA G T A A G A NA
8 NA NA G T A NA G NA C
9 G C G T A NA G A C
10 NA NA NA T NA NA G A NA
11 G NA NA T NA NA G A NA
12 G NA NA T NA NA G A NA
13 G NA NA T NA NA G A NA
14 G NA G T A A G A C
15 NA NA G T A A G A C
16 G NA G T A A G A C
17 G C G T A T T G C
22 G NA NA T NA NA T G NA
23 G T G T A A G A C
24 A NA A C NA NA T G C
25 NA NA G T A NA G A C
26 G NA A T A A G A C
27 G C G T A A G A NA
28 NA C G T A A G A C
29 NA NA G T A A G A C
31 NA NA G T A A G A C
33 G C G T A A G A C
34 G NA A T A A G A C
35 G NA A T A A G A C
36 NA NA G T A NA G A C
37 A NA G T A A G A C
38 G NA G T A A G A C
39 NA NA G T A A G A C
40 G NA G T A NA G A C
41 A NA NA T NA NA G A NA
42 G NA NA T NA NA T G NA
43 G NA NA T NA NA G A NA
44 NA NA NA T NA NA G A NA
45 A NA A T A NA G A C
46 NA NA NA T NA NA G A NA
47 G T NA T NA NA G A NA
48 NA NA NA T NA NA G A NA
49 G NA G T A NA G A NA
50 NA NA NA T NA NA G A NA
51 NA NA NA T NA NA NA NA NA
52 NA NA NA T NA NA G A NA
53 NA NA G T A NA G A C
54 NA NA G T A NA T G C
55 G C G T A NA G A C
56 NA C NA T NA NA G A NA
57 NA NA NA NA NA NA NA NA NA
58 G C G T A A G A C
59 NA C G T A A G A C
60 NA NA G T A T G A C
61 NA NA G NA G T NA NA C
62 NA NA G T A A G A A
63 NA C G T A A G A A
64 NA NA G T A T T G C
65 NA NA G T A A G A NA
68 NA C G T A A G A C
69 NA NA A T A A G A C
70 NA T G C G T T G C
71 G NA G T A A G A C
73 NA C G T A A G A C
74 NA C G T A A G A C
75 G NA A T A A G A C
76 NA NA NA T NA NA G A NA
79 NA NA G T A A G A C
80 NA T G C G T G A C
81 NA T G T A A G A C
84 A T G T A A G A A
86 NA NA A T A A G A C
87 NA C G T A A G A C
88 G C NA T A NA G A NA
89 NA NA G T A A G A C
90 G T G T A A G A C
91 NA NA G C A T G A C
92 NA NA G T A A G A C
93 G NA G T A A G A C
94 NA C G T A A G A A
95 G NA G T A A G A A
96 NA NA G T A A G A C
97 NA NA G T A A G A C
147
Table A.3 (continued)
             SNP           
Line DreddIntron1_01Dsor15inter_01Dsor1Exon2_01hepExon1_01hepExon2_01hepExon3_01hepExon4_01hepExon5_01hepExon5_02
98 A C G T A A G A C
99 G C G C A T G A C
101 NA C G T A A G A C
102 NA NA G T A A G A C
103 G C G T A A G A C
104 NA NA G T A A G A C
105 NA NA G T A A G A C
106 G NA G T A A G A C
107 NA NA G T A T T G C
108 A NA G T A A G A C
109 G NA G NA A T NA NA C
110 NA NA G T A A G A C
111 G T NA T A NA T G NA
112 G C NA T A NA NA A NA
113 G C G T A A G A C
114 G C G T A A G A C
115 G C G T A A G A C
116 G C A T A A G A C
117 G C A T A A G A C
119 A C G T A A G A A
122 G C A T A A G A C
123 G C G T A A G A C
125 G T G T A T T G C
126 G T G T A A G A C
127 A C G T A A G A C
128 G C A T A A G A C
130 G C G T A A G A A
131 G T G T A A G A C
134 A C G T A A G A A
136 G C NA T A A G A NA
137 G C G T A A NA A C
138 A C G T A A G A C
139 G C G T A A G A C
140 G C G T A A G A C
142 G C NA T A A G A C
143 G T G T A A G A C
144 G C G T A A G A C
145 A C G T A A G A C
146 G C G T A A G A C
148 A C G T A A G A C
149 G T G T A T G A C
151 G C G T A A G A C
152 G NA G T A A G A C
153 G NA G T A A G A C
154 A C G T A T G A C
155 G C G T A A G A C
158 G T G T A A G A C
160 G C G T A A G A C
164 A C A T A A G A C
166 G C G T A A G A C
167 G C A T A A G A NA
168 G C A T A A G A A
169 G C G T A A G A C
172 G C G T A A G A C
173 G C G T A A G A C
174 G C G T A T G A C
201 A C G T A A G A C
202 G T G T A A G A C
203 A T G C A T G G C
204 NA T G T A A G A C
205 G T G T A A G A C
206 G C A T A A G A C
207 G C G T A A G A C
208 G C G T A A G A C
209 A C G T A A G A C
210 G C G T A A G A A
211 G T G T A A G A C
212 G C NA T A A G A C
213 G C G T A A G A C
214 G C G T A A G A C
215 A C G T A A G A C
216 G C G T A A G A A
217 G C G T A A G A C
218 G C G T A T T G C
219 G NA G T A A G A C
220 G C G NA NA NA T G C
221 G C G T A A G A C
222 G C G T A A G A C
223 G NA G T A A G A C
224 G C G C A T T G C
225 G C G T A NA G A C
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Table A.3 (continued)
             SNP           
Line hepExon7_01hepExon7_02hepExon8_01hepExon8_02hepExon8_03hepExon8_04hepExon9_01hepIntron1_01hopExon1_01
1 NA T NA NA NA NA NA NA NA
2 NA NA NA NA NA NA C G NA
3 T T NA NA NA G NA NA NA
4 NA T NA NA NA G C NA NA
6 C T NA NA A G C G NA
7 T T G C A G C G NA
8 NA NA NA NA NA NA C G NA
9 T T NA NA A G C G NA
10 T T NA NA NA G NA NA NA
11 T T NA NA NA G NA NA NA
12 T C NA NA NA G NA NA NA
13 T T NA NA NA G NA NA NA
14 C T NA NA G A C G NA
15 C T NA C A G C G NA
16 T T G C A G C G G
17 T T A C A G C G A
22 T T NA NA NA G NA NA NA
23 T C G C A G C G A
24 C T NA NA G G T A NA
25 T T NA NA A G C G NA
26 T T NA C A G C G A
27 T T G C A G C G NA
28 T T G C A G C G NA
29 T T G C A G C G A
31 T NA G C A G C G NA
33 C T NA C A G C G A
34 C T NA NA A G C G NA
35 T T NA C A G C G NA
36 T T NA NA NA G C G NA
37 T C G C A G C G A
38 T T NA C A G C G A
39 NA T G C A G C G NA
40 T T NA NA A G C G NA
41 T C NA NA NA G NA NA NA
42 T T NA NA NA G NA NA NA
43 T T NA NA NA G NA NA NA
44 T T NA NA NA G NA NA NA
45 NA T NA NA A G C G NA
46 T T NA NA NA G NA NA NA
47 C T NA NA NA G NA NA NA
48 T T NA NA NA G NA NA NA
49 T T NA NA A G C G NA
50 T T NA NA NA G NA NA NA
51 T T NA NA NA G NA NA NA
52 T T NA NA NA G NA NA NA
53 T T NA NA A G C G NA
54 C T NA NA A A C G NA
55 T T NA NA A G C G NA
56 T T NA NA NA G NA NA NA
57 NA T G NA NA G NA NA NA
58 T T G C A G C G A
59 T T G C A G C G A
60 T T G C A G C G A
61 NA NA G NA G NA T A A
62 T T G C A G C G A
63 T T G NA A G C G A
64 T T A C A G C G A
65 T T G C A G C G NA
68 C T G C A G C G A
69 T T G C A G C G A
70 C T G A G G T A G
71 NA T G C A G C G A
73 T C G C A G C G A
74 T T G C A G C G NA
75 T T G C A G C G NA
76 T T NA NA NA G NA NA NA
79 T T G C A G C G A
80 T T G C A G C A G
81 T T G C A G C G G
84 T T G C A G C G G
86 T T G C A G C G A
87 T T G C NA NA C G G
88 T T NA NA NA G NA G NA
89 NA T G NA NA G NA G A
90 C T G C A G C G NA
91 T C G C A G C A A
92 T C G C A G C G A
93 T T G C A G C G A
94 T T G C A G C G A
95 T T G C A G C G A
96 T T G C A G C G A
97 T T G C A G C G A
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Table A.3 (continued)
             SNP           
Line hepExon7_01hepExon7_02hepExon8_01hepExon8_02hepExon8_03hepExon8_04hepExon9_01hepIntron1_01hopExon1_01
98 NA T A C A G C G A
99 T T G C A G C A A
101 T T G C A G C G G
102 T T G C A G C G G
103 T T G C A G C G A
104 T T G C A G C G A
105 T C G C A G C G A
106 T T G C A G C G NA
107 NA T A C A A C G A
108 C T A C A G C G NA
109 NA T G C NA G C G NA
110 T T G C A G C G A
111 C T NA NA NA A C G NA
112 C NA G NA NA NA C G NA
113 C T A C A G C G A
114 C T A C A G C G A
115 C T G C A G C G G
116 T NA G C A G C G G
117 T T G C A G C G A
119 T NA G C A G C G A
122 T T G C A G C G A
123 T T G C A G C G A
125 T T A C A G C G A
126 T T G C A G C G G
127 T T G C A G C G A
128 T T G C A G C G A
130 T NA G C A G C G A
131 C T G C A G C G A
134 T T G C A G C G A
136 T T G C A G C G A
137 T NA G C A G C G A
138 T T G C A G C G A
139 T T G C A G C G A
140 T T G C A G C G A
142 T T G C A G C G NA
143 C T G C A G C G G
144 C T G C G A C G G
145 T T G C A G C G G
146 T T G C A G C G A
148 T T G C A G C G A
149 T T G C A G C G A
151 T T G C A G C G A
152 T T G C A G C G A
153 T C G C A G C G A
154 T T G C A G C G A
155 NA T G C A G C G A
158 NA T G C A G C G G
160 T T G C A G C G A
164 T T G C A G C G A
166 T T G C A G C G G
167 T NA G C A G C G A
168 T T G C A G C G A
169 C T A C A G C G A
172 T T G C A G C G A
173 T T G C A G C G A
174 T T G C A G C G G
201 C T G C A G C G A
202 T T G C A G C G A
203 C T A A G G C G A
204 T T G C A G C G NA
205 T T G C A G C G A
206 T C G C A G C G A
207 C T G C A G C G G
208 T C G C A G C G A
209 T T G C A G C G A
210 T T G C A G C G A
211 C T G C A G C G G
212 C T G C A G C G NA
213 T T G C A G C G A
214 T T G C A G C G A
215 T T G C A G C G G
216 T T G C A G C G G
217 T T G C A G C G G
218 T T A C A G C G A
219 T NA G C A G C G A
220 NA T G C A NA C NA NA
221 T T G C A G C G NA
222 T T G C A G C G G
223 T T G C A G C G A
224 C T G C G G C A A
225 NA T NA C A G C G A
150
Table A.3 (continued)
             SNP           
Line hopExon1_02hopExon4_01hopExon4_02hopExon7_01hopExon7_02hopExon8_01lzExon5_01 lzExon5_02 lzExon5_03
1 G NA NA NA C NA NA NA NA
2 G NA NA NA C NA T NA NA
3 G NA G NA C G NA NA NA
4 G NA G NA C NA T G T
6 G G G NA C G NA NA C
7 G NA G A C NA C NA NA
8 G NA NA NA C NA NA NA NA
9 G NA G A C NA T NA C
10 G NA G NA C G NA NA NA
11 G NA G NA C G NA G NA
12 G NA C NA C G NA NA NA
13 G NA G NA C T NA NA NA
14 G NA G A C NA NA NA NA
15 G G C A C T NA T T
16 A G G A C G C G C
17 A G G A C G T G T
22 A NA G NA C G NA NA NA
23 G G G A C G T NA T
24 G NA G G C NA NA T C
25 G G G G C NA T NA NA
26 G G G A C T NA G C
27 G G G A C G C NA C
28 A G G A C NA T NA T
29 G A C A C G C NA C
31 G G G A C G C NA T
33 G G G A C T NA NA C
34 A G G NA C G NA T C
35 G G C A C T T NA T
36 NA NA G NA C NA NA NA NA
37 G G G A C T C G T
38 A G G A C T C NA T
39 NA G G A C NA C NA C
40 NA NA G NA C G NA G C
41 G NA G NA C NA NA NA NA
42 A NA G NA C NA NA NA NA
43 G NA G NA C T NA NA NA
44 G NA G NA C NA NA NA NA
45 G NA G NA C G NA NA NA
46 G NA G NA C T NA NA NA
47 G NA C NA C G NA G NA
48 NA NA G NA C G NA NA NA
49 G G G NA C T NA G C
50 G NA G NA C T NA G NA
51 NA NA G NA C T NA NA NA
52 G NA G NA C G NA G NA
53 NA NA NA NA C G NA NA C
54 G G G A C G T G T
55 G NA G NA C G NA NA C
56 G NA C NA C T NA NA NA
57 G G G NA C G C NA C
58 A G G A C T T NA C
59 G G G A C G T NA T
60 A G G A C T T NA NA
61 NA G NA A NA NA C NA C
62 G G G A C T T G T
63 G G G A C T C G NA
64 G G G A C G C NA C
65 G G G NA C G NA NA C
68 G G G A C G C G NA
69 G G G A C G C G C
70 G G G G C NA C G C
71 A G G A C G NA NA NA
73 G G G A C T T G T
74 A G G A C G C NA NA
75 A A C A C G T NA T
76 G NA G NA C T NA NA NA
79 G G G A C NA C NA C
80 G G C A C G C NA C
81 A G G A C G C G NA
84 A G G A C G C NA C
86 A G G A C G C G NA
87 G G G G C G C G NA
88 G NA G A C NA NA NA NA
89 G G G A C NA T NA C
90 G A G A C NA NA NA T
91 G G G A C T C NA C
92 G G G A C G C G C
93 A G G A C G T G C
94 G G G A C G NA NA NA
95 G G G A C G C NA T
96 G G G A C G T NA T
97 G G G A C G NA G NA
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Table A.3 (continued)
             SNP           
Line hopExon1_02hopExon4_01hopExon4_02hopExon7_01hopExon7_02hopExon8_01lzExon5_01 lzExon5_02 lzExon5_03
98 A G G A C G C NA C
99 G G G A C G NA NA T
101 G G C A C G T NA T
102 G G G A C NA NA NA C
103 A G G A T G C NA T
104 A G G A C G C NA C
105 G G G A C T T NA T
106 G G G A C G NA NA NA
107 G G G A C G T NA T
108 NA NA G A C T NA NA NA
109 G G NA A C NA NA NA NA
110 G G G A C T T G T
111 G NA G NA C NA NA NA T
112 G NA G NA C NA T NA T
113 G G G A C T C G C
114 A G G A C G T G C
115 G G G A C G T NA C
116 G G C A C NA T NA T
117 G G G A C G C G C
119 G G G A C NA T NA T
122 G G G A C G C G C
123 G A G A C T C G T
125 G G G A C G C G C
126 A G G A C T C G T
127 G G G A C G C G C
128 G G G A T G T G T
130 G A G A C G C NA C
131 G A G A C T C G C
134 G G G A C G C G C
136 G G G A C NA C NA C
137 G A G A C T C NA C
138 G G G A C G C G C
139 A G G A C G C G C
140 G G G A C T T G T
142 G G G A NA G T G T
143 G G G A C G T G T
144 A G G A C G T G T
145 G G C A C NA C NA C
146 A A C A C G C G T
148 G G G A C G C G T
149 G G G A C G T G T
151 G G G A C G C G C
152 G G G A C G T G T
153 G A G A C G T NA T
154 G A G A C G C NA C
155 G A G A C G C G C
158 G G G A C G C NA C
160 G G G A C G C NA C
164 G A G A C G C G C
166 G G G A C G C T C
167 G G G A C NA C NA C
168 G G G A C NA C NA C
169 A G G A C G C G C
172 G G G A C G T G T
173 G G G A C G C NA C
174 G G G G C G C NA C
201 G G C A C G T NA T
202 A G G A C G T NA C
203 G G G A C NA C NA T
204 G G G NA C NA C G NA
205 G G G A C T C G T
206 G G G A C G T G C
207 G G C A C G C G C
208 A G G A C NA T NA T
209 G G G A C NA C NA T
210 G G G A C T C T C
211 G G G A C NA C NA C
212 G NA NA A C G NA NA NA
213 G G G A C G C NA C
214 G G G A C G C G C
215 G G G A C T C G C
216 G G G G C NA C NA C
217 A G G A C G T NA C
218 G G G A C G T G T
219 G A G A C NA T NA T
220 NA G NA A C G NA NA NA
221 NA G NA A NA G T NA NA
222 G G G A C NA T NA T
223 G G G A C G T NA T
224 G G G A C G C T C
225 G G G A C NA C NA C
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Table A.3 (continued)
             SNP           
Line lzIntron1_02mxc5inter_01mxcExon2_01Ntf25inter_01Ntf2Intron1_01osExon1_01 PGRPLE3inter_01phl3UTR_01 phl5UTR_01
1 NA C NA NA NA C C NA NA
2 NA NA A NA NA C NA A NA
3 NA A NA NA NA C G NA NA
4 NA NA NA NA NA C C A NA
6 A C A C G C G NA NA
7 G C A G NA C C G A
8 NA NA NA NA NA C C NA NA
9 A NA T G NA C C NA A
10 NA C NA NA NA C C NA NA
11 NA C NA NA NA C C NA NA
12 NA A NA NA NA C C NA NA
13 NA A NA NA NA C G NA NA
14 NA A T C G C C G A
15 G A T G G C C A A
16 G A T G G C C A A
17 G A T G A C G G G
22 NA A NA NA NA C C NA NA
23 G C A G G A C A G
24 A A T NA A C G A G
25 G A T C G C G A A
26 A A T C G C C G NA
27 G C A G G C C G A
28 G C A G G C C G A
29 G C A G A C C G A
31 G C A G G C C A G
33 A A A G A C C A A
34 A A T C G C C A G
35 A A T G NA C C A A
36 NA A NA NA NA C NA NA NA
37 G NA NA G G C C G A
38 G C A G G C C G A
39 G NA NA G G C NA NA NA
40 NA C A C NA C C G A
41 NA A NA NA NA C G NA NA
42 NA C NA NA NA C C NA NA
43 NA C NA NA NA C C NA NA
44 NA NA NA NA NA C C NA NA
45 NA A T NA NA C C NA NA
46 NA A NA NA NA C C NA NA
47 NA A NA NA NA C C NA NA
48 NA A NA NA NA C NA NA NA
49 G A A NA NA C G A G
50 NA A NA NA NA C G NA NA
51 NA A NA NA NA C C NA NA
52 NA C NA NA NA C C NA NA
53 NA A T NA NA C NA G NA
54 NA C NA G A C C G A
55 NA A T NA NA C C A NA
56 NA A NA NA NA C C NA NA
57 NA A T G G C NA A A
58 A A T G G C G G G
59 G C A C G C C G A
60 G C A G G C NA A A
61 G NA T G NA NA NA A A
62 G C A G G C NA A G
63 G C A C G C NA A A
64 A A A C G C C A G
65 A NA A G NA C NA A A
68 G C A C A C G A A
69 G A T C G C C A G
70 G C A G G C G G A
71 G C A G A C C A A
73 G C A G G C G A G
74 G A A G G C G A A
75 A A T G A C C A A
76 NA A NA NA NA C G NA NA
79 G NA A C G C C A A
80 A C A C G C G G A
81 G C A C G C NA A A
84 G A A G A C C G A
86 G A T G A C C A A
87 G C A G G C C A A
88 NA NA NA NA NA C C NA NA
89 A A T G G C G A A
90 A C A C G C C G A
91 G C A G G C G G A
92 G A A C G C C G G
93 G A T C G C C A A
94 G A T G A C C A A
95 G A A G G C C G A
96 G A T G G C G G A
97 G C A C G C G A G
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Table A.3 (continued)
             SNP           
Line lzIntron1_02mxc5inter_01mxcExon2_01Ntf25inter_01Ntf2Intron1_01osExon1_01 PGRPLE3inter_01phl3UTR_01 phl5UTR_01
98 G A A G G C C A G
99 A A T G G C C A G
101 A C A G A C C A A
102 A A T G A C C NA NA
103 G A A C G C C A A
104 G C A G G C C A G
105 G A T G A C G A A
106 A NA A NA NA C NA A G
107 G NA A G G C G A A
108 NA A T G G C C G NA
109 NA NA NA NA G C NA G A
110 G C A C G C C A NA
111 A C A NA NA C C NA NA
112 NA C A NA NA C G G A
113 G A T C G C G A A
114 G A NA G G C C A A
115 G A T C G C C G A
116 A A T NA G C G G G
117 A A T G G C G G A
119 A NA A G G C NA A A
122 G A T C G C C A G
123 A C A G G C C A A
125 G A A C G C G A G
126 G C A C G C C G A
127 A C A G A C G G G
128 A A T G G C C A A
130 G A T C G C C G A
131 G C A G A A C A A
134 A C A C G C G A A
136 A NA NA NA G C NA A G
137 A NA A C G C C G A
138 G C A C G C C A G
139 G A A C G C C NA NA
140 G C A C G C C G A
142 NA NA NA G G C C NA NA
143 A C A G G C C A A
144 A A T G G C C A A
145 G NA A C G C C A G
146 A A A G A C C A A
148 G C A G G C C A G
149 G C A G A C C A A
151 A C A C G C G A G
152 G A T G A C C A G
153 G A T C G C C A A
154 G A T G A C C A A
155 G A T G A C C A A
158 G C A C G C G A G
160 G A T G G C G A A
164 A A T C G C C A A
166 G C A C G C C G A
167 G A T NA A C NA A G
168 G A T C G C G A G
169 G C A G A C G A A
172 G A T C G C G A A
173 G A A NA G C C G G
174 G C A G G C C G A
201 A C A G G C G A A
202 G C A G A C G G A
203 A C A G G C G A A
204 NA C A G NA C C A A
205 A C A G A C C A A
206 G A T G A C C G A
207 A A A G G C G A A
208 G A T NA G C G A A
209 A A T G A C G A A
210 G C A G A C C A A
211 G C A G G C C A A
212 NA A T G NA C C NA A
213 G A T G G C C A G
214 G C A G A C G A A
215 G C A C G C G A A
216 A C A G G C NA G NA
217 G A A G A C C A G
218 G A T G A A C G A
219 G A T G A C G G A
220 G A NA G NA C G A G
221 G A NA G G C G NA NA
222 G A T G G C G A G
223 G A T G G C C A A
224 A A T G G C G G A
225 A A A C G C NA A A
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Table A.3 (continued)
             SNP           
Line phl5UTR_02 phlExon2_01phlExon2_02phlExon2_03phlExon4_01phlExon4_02phlExon5_01Pvf15UTR_01Pvf15UTR_02
1 NA NA NA NA NA NA NA T C
2 G C G NA T NA G NA NA
3 NA NA NA NA NA NA NA A C
4 G C G G T T A A C
6 G NA G NA T NA A A C
7 G C G G T NA A A NA
8 G NA NA NA NA NA G NA NA
9 G T A G C NA G A C
10 NA NA NA NA NA NA NA A T
11 NA NA NA NA NA NA NA A T
12 NA NA NA NA NA NA NA A T
13 NA NA NA NA NA NA NA A NA
14 A C G G T T A NA NA
15 G T A G C C G NA C
16 G C G G T T A A T
17 G T G G T C G A T
22 NA NA NA NA NA NA NA A C
23 G C G G T T A A C
24 G T G NA T T A A T
25 G T A G C C G A C
26 NA C G G T NA A T C
27 G C G G T T A A T
28 G C G G T T A A T
29 G T G A T C G A T
31 G T G A T C A A C
33 G T A G C C G A C
34 G C G G T T A T C
35 G C G G T T A NA C
36 G T G NA T NA A A C
37 G C G G T T A A NA
38 A C G G T T A A C
39 G T NA NA NA C G NA C
40 G C G G T T A A T
41 NA NA NA NA NA NA NA A C
42 NA NA NA NA NA NA NA A T
43 NA NA G NA T NA A A C
44 NA NA NA NA NA NA NA A NA
45 G T A G C NA G A T
46 NA T NA NA NA NA NA A T
47 NA T A NA C NA NA A T
48 NA NA NA NA NA NA NA A NA
49 G C G G T T A A C
50 NA NA NA NA NA NA NA T C
51 NA NA NA NA NA NA NA NA NA
52 NA NA NA NA NA NA NA A C
53 G NA G NA T T A A C
54 G C G G T T A A C
55 G T G NA T C A NA C
56 NA NA NA NA T NA NA T C
57 G C G G T T A NA NA
58 G T G A T C G NA C
59 G T G A T C G NA NA
60 G T A G C C G A C
61 G C G G T T A NA NA
62 G C G G T T NA A C
63 G T A G C C G NA C
64 G C G G T T A A C
65 G NA NA G NA NA NA A C
68 G T A G T C G A C
69 G C G G T T A A T
70 G C G G T T A NA T
71 G T A G C C G A C
73 G C G G T T A A T
74 G C G G T NA A NA C
75 G C G G T C G A T
76 NA NA NA NA NA NA NA A C
79 G C G G T T A A C
80 G C G G T T A A C
81 G C G G T T A A T
84 G C G G T T A A C
86 G C G G T T A A T
87 G C G G T T A NA C
88 G C NA NA T T NA NA NA
89 G T A G C C G A C
90 G C G NA T T A A C
91 A C G G T T A A C
92 G T G A T C G A C
93 G T A G C C G A C
94 G C G G T T A A C
95 G C G G T T A A C
96 G T A G C C G A NA
97 G T G A T C A A T
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Table A.3 (continued)
             SNP           
Line phl5UTR_02 phlExon2_01phlExon2_02phlExon2_03phlExon4_01phlExon4_02phlExon5_01Pvf15UTR_01Pvf15UTR_02
98 G T G A T T A A C
99 G C G G T NA A A C
101 G T A G C C G T C
102 NA C G G T T A NA C
103 G C G G T T A A C
104 G C G G T T A NA T
105 G C G G T T A A T
106 G C G G T T A A C
107 G C G G T T A NA T
108 G T G G T NA G A C
109 G C G G T NA NA NA T
110 G C G G T T A A NA
111 G C G G T T A A C
112 G T NA G C C NA A C
113 G T A G C C G A C
114 G C G G T T A A C
115 A C G G T T A A C
116 G T G G T C G A C
117 G C G G T T A A T
119 G C G G T T A A NA
122 G C G G T T A A C
123 G C G G T T A A C
125 G C G G T T A A C
126 G C G G T T A A T
127 G T G A T C G A NA
128 G T A G C C G A T
130 G C G G T T A A NA
131 G C G G C C G A T
134 G T A G C C G A T
136 G C G G T T A A T
137 G C G G T T A A C
138 G T G A T T A A T
139 G C G G T T A A C
140 G C G G T T A A C
142 NA C G G T T A A C
143 G C G G T T A A C
144 G C G G C C G A C
145 G C G G T T A A C
146 G T A G C C G A T
148 G T G A T T A A C
149 G C G G T T A A C
151 G T G A T C A A C
152 G C G G T T A A C
153 G T A G C C G A C
154 G T A G C C G A T
155 G C G G T T A A T
158 G C G G T T A A NA
160 G C G G T T A A T
164 G T A G C C G A C
166 G C G G T T A A C
167 G C G G T T A A NA
168 G C G G T C A T C
169 G C G G T T A A T
172 G T A G C C G A T
173 G T G G T T G A NA
174 A C G G T T NA A NA
201 G C G G T T A A T
202 G C G G T T A A T
203 G C G G C C G A T
204 G NA G NA T NA NA A C
205 G C G G T T A A C
206 G C G G T T A A C
207 G C G G T T A A C
208 G T NA G NA NA NA A C
209 G C G G C C G A C
210 G C G G T T A A C
211 G C G G T T A A C
212 G C G G T T A A C
213 G C G G T T A A T
214 G C G G T T A A T
215 G T G A T C G A C
216 G T G G T C NA A C
217 G C G G T T A A C
218 A C G G T T A A T
219 G C G G T T G A T
220 G NA G NA T NA A A T
221 G NA G NA T NA A A C
222 G C G G T T A A T
223 G C G G T T A A T
224 G C G G T T A A C
225 G T A G C C G A C
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Table A.3 (continued)
             SNP           
Line Pvf1Exon1_01Pvf1Exon1_02Pvf1Exon4_01Pvf1Exon4_03Pvf1Exon5_01Pvf1Intron1_01Pvf1Intron1_02Pvf1Intron4_01Rps65inter_01
1 G NA NA C NA NA NA NA NA
2 NA NA NA NA NA NA A A A
3 G NA NA C C G A NA NA
4 NA NA NA C C NA A A NA
6 T NA NA C NA G C A NA
7 NA NA A C C G NA A NA
8 NA NA NA C NA NA A A NA
9 T NA A C NA G A A A
10 G NA NA C C G A NA NA
11 G G NA C C A C NA NA
12 T NA NA C C G A NA NA
13 T A NA C C G A NA NA
14 G NA A C C NA NA A A
15 T NA A C C G C A G
16 T A G C C G A A G
17 G G A C C A A A A
22 G G NA C C G A NA NA
23 G G G C C G A A G
24 G NA NA C C A NA A A
25 T NA NA C C G A A A
26 G NA A C C G NA A G
27 G G A C C G A A A
28 G NA A C C A A A A
29 G G A C C A A A G
31 T NA A C C A A A A
33 G NA NA C C A NA A A
34 G NA A C C G A A A
35 G G A C NA NA A A A
36 G NA NA C NA G A A NA
37 NA NA NA C C G A A G
38 G NA NA C C G A A G
39 T NA G C C G NA A NA
40 G NA NA C C A NA A NA
41 G NA NA C C A NA NA NA
42 G NA NA C C A A NA NA
43 G NA NA C C G A NA NA
44 G G NA C C G A NA NA
45 G G NA C NA G A A NA
46 G G NA C C A NA NA NA
47 G NA NA C NA A NA NA NA
48 NA NA NA C C NA NA NA NA
49 G NA NA C C G A A NA
50 G NA NA C C G A NA NA
51 G NA NA C C NA NA NA NA
52 T NA NA C C A A NA NA
53 G G NA C C NA A A NA
54 T NA NA C C G A A G
55 G NA NA C T G A A NA
56 G NA NA C C G A A NA
57 G G A C C NA A A A
58 T A A C C G NA A A
59 G NA NA NA C NA NA A G
60 G A G C C A NA A A
61 NA NA A NA NA NA NA A A
62 G NA G C C G A A G
63 G NA A C C NA A A G
64 G NA A C C A NA A G
65 G NA NA C C A NA A NA
68 T A A C C G A A G
69 G NA A C C A NA A A
70 G G A C C A NA A A
71 T NA G C NA G NA A A
73 G G A C C G A A G
74 G G G C NA G A A A
75 G G A C C G A A A
76 T A NA C C G A NA NA
79 G NA G C C G A A A
80 T A A C T G A A A
81 T A G C C G A A G
84 T A A C C G A A G
86 G NA A C C G A A A
87 NA NA A C C NA NA A A
88 NA NA NA C C NA NA A NA
89 G G A C C A C A A
90 G G G T C A C A G
91 G NA A C C A A A G
92 T NA A C C G NA A A
93 NA NA G C C G A A G
94 T NA G C NA G A A A
95 G NA G T C A NA A A
96 G NA NA C C NA A A A
97 G NA A C C A C A G
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Table A.3 (continued)
             SNP           
Line Pvf1Exon1_01Pvf1Exon1_02Pvf1Exon4_01Pvf1Exon4_03Pvf1Exon5_01Pvf1Intron1_01Pvf1Intron1_02Pvf1Intron4_01Rps65inter_01
98 T A G C C G A A G
99 T A A C C G C A G
101 G NA A C C G A A A
102 G NA A C NA NA A A A
103 G NA A C C A C A A
104 T A G C C G A A A
105 G G A C C A NA A A
106 T NA NA C C G NA A A
107 G NA A C C A C A A
108 G A NA C C A C A G
109 G NA A C NA A C A NA
110 NA NA NA C C NA C A A
111 G G NA C C G A NA NA
112 NA NA NA C C G A NA A
113 G NA A C C G A A G
114 G G G C C G A A G
115 T NA G C C G C A G
116 NA NA A C C A C A A
117 G NA A C C A C A G
119 NA NA G C C G A A A
122 G A A C C A C A A
123 T A A C T A A G G
125 T A G C C G C A G
126 G NA A C C G A A A
127 G NA G C C G C A G
128 G G A C T G A A A
130 G NA G C C G A A G
131 G NA A C C A NA A A
134 T A G C C G A A A
136 NA NA A T C A NA NA G
137 T NA A NA C G C A G
138 G NA A C C A C A A
139 NA NA NA C C G NA A G
140 T NA G C C G A A G
142 T A A C C G A A A
143 T A A C C G A A A
144 T NA G C C G A A G
145 G NA G C C G A A A
146 G G A C C G A A A
148 T A A C C A A A G
149 G G A C C A NA A A
151 G A A C C G C A A
152 T NA G C C G A A A
153 T NA A C T A A A G
154 G NA A C C A NA A A
155 G NA A C C A NA A A
158 G NA A C C G NA A G
160 G NA G C T A NA A G
164 G NA G C C A NA A G
166 G NA G C C G NA A G
167 G G A T NA A NA G A
168 G G A C C G A A A
169 G NA A C C A NA A G
172 G NA A C C G C A G
173 NA G NA NA NA NA NA NA G
174 T NA G C C G A A A
201 T NA G C C G A A G
202 T NA G C C G A A A
203 NA NA A C C A NA A G
204 NA NA A C C G A A NA
205 G NA A C C A A A G
206 T A G C C G NA A A
207 G NA G C C G A A A
208 G G A C C G A A A
209 T NA G C C G A A A
210 G G A C C A A A G
211 G NA G C C G A A G
212 NA NA NA C C G A A A
213 T NA G C C A A A G
214 G NA A C C A NA A A
215 G A G C C A NA A G
216 T NA A C T G NA A A
217 G NA A C T G A A A
218 G NA A C C A C A A
219 G NA A C C A NA A A
220 G NA G C T A C A NA
221 NA NA A C C G NA A NA
222 T NA A C C G A A A
223 G NA A C C A A A G
224 G A A C C A C A G
225 G NA G C C G A A G
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Table A.3 (continued)
             SNP           
Line Rps6Exon3_01Rps6Intron1_01Ser75inter_01Ser7Exon3_01Ser7Exon3_02Tak15UTR_01Tak1Exon2_01Tak1Exon3_01Tak1Exon4_01
1 T A C A T NA A A C
2 G A C NA T NA NA NA NA
3 G T C A T NA T G NA
4 G T C A T G A NA NA
6 NA NA C A T NA NA G NA
7 G NA C A A NA NA NA NA
8 G NA C A T NA T G NA
9 G A C A A G A A C
10 G A C A T NA T G T
11 G T C A T NA A A T
12 G A C A A NA A A C
13 G A C A T NA A A C
14 G A C A T G A A C
15 G T C A T T T G T
16 G T C C A T T G T
17 G A C A T G A A C
22 G A C A T NA T NA C
23 G T C C T G T A C
24 G A C A T T T NA NA
25 G A C A NA T A A C
26 G A C A T T A A C
27 G A C A T T T G T
28 G A C A T G T G T
29 G NA C C T G A A C
31 G A C A T G A G C
33 G A C A T T A A C
34 G A C A T G A A C
35 G A C A T T A NA NA
36 G NA C A A NA A NA C
37 G T C A T T A NA NA
38 G NA C A T G A NA NA
39 G A C A T T A G T
40 G T C A T G A A C
41 G NA C A T NA A A NA
42 G A C A T NA T G T
43 G NA C A T NA A A C
44 G NA C A T NA A A C
45 G A C A T NA A A C
46 G A C A T NA A A C
47 G NA C A T NA T G T
48 G A C A A NA T NA C
49 G NA C A NA G A A C
50 G A C A T NA T A C
51 G A C A T NA A A C
52 G T C A T NA A G T
53 G A C A NA NA A A C
54 G T C A T G A NA T
55 G A C A A G A G T
56 G A C A T NA A A C
57 G A C A NA NA NA G T
58 G A C A T T T G NA
59 G T C A T T A A C
60 G A C A T G T G C
61 NA NA NA NA NA T NA NA NA
62 G NA C A T G A A C
63 G NA C A A G A A C
64 G T C C A G A A C
65 NA NA C A T T T G NA
68 G A C A T G A A C
69 G A C C A T A A C
70 G A C A A T T NA NA
71 G A C A T G A A C
73 G NA C A T T T G NA
74 G A C A T G A G NA
75 G A C A A G A G C
76 G A C A T NA A A C
79 G A C A A G A A C
80 G A C A A G A G C
81 G NA C A T T A A C
84 G A C A T T A G T
86 G A C A T G A A C
87 G A C A T G A A C
88 G NA C A NA NA T G T
89 G A C NA NA G A A C
90 G NA C C A T T G T
91 G T C A A T A G NA
92 T A C A T G A A C
93 T NA C A T NA A NA NA
94 G A C A A G A A C
95 G A C C T G A G T
96 G A C A T G A NA NA
97 G NA C C T G A G C
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Table A.3 (continued)
             SNP           
Line Rps6Exon3_01Rps6Intron1_01Ser75inter_01Ser7Exon3_01Ser7Exon3_02Tak15UTR_01Tak1Exon2_01Tak1Exon3_01Tak1Exon4_01
98 G T C A T G T A T
99 G T C A T G A A C
101 G A C A T G T G C
102 G A C C A G A G T
103 G A C C T G A A C
104 G A C A T T A G T
105 G A C A T T T G NA
106 NA A C A NA G A G C
107 G A C A T G A A C
108 G T C A T G T G C
109 G NA C A T T NA NA T
110 G A C A T T A A C
111 G A C A T NA A A C
112 G A C A T T A A NA
113 G A C A A G T G T
114 G T C A A G T G T
115 G T C A A T T G T
116 G A NA A T G NA G T
117 G A C A T T T G NA
119 G A C A NA T T G C
122 G A C C A G A A C
123 G T C C T T T G C
125 G T C A A G A G NA
126 G A G A A T T G T
127 G A C A A G A A C
128 G A C C T T A A C
130 G A C A NA G A G T
131 G A C A T G A A C
134 G A C A T T A A C
136 G A C A T NA A A C
137 G T NA A T G NA G T
138 G A C C A G A A C
139 G A C A A G A A C
140 G T C A A T A A C
142 NA A C NA NA T A A C
143 G A C A A G T G C
144 G T C A T G A A C
145 G A C A T T T G T
146 T A C A T G A A C
148 G T C A T G A G C
149 G A C A T G A A C
151 G A C A A G A G NA
152 G A C A T G T G T
153 G T C A A G A A C
154 G A C A A G A G T
155 G A C A A T A A C
158 G A C A A T A A NA
160 G T C A T G A A C
164 G T C A A G A G T
166 G T C C T G A A C
167 G A C A T T A G T
168 G A C A T T T G NA
169 G A C A A G A G NA
172 G T G A A G A A C
173 G A C A A G NA NA C
174 G A C A A G A A C
201 G T C A A T A A C
202 G A C A T G A G NA
203 G T C A T G A A C
204 G NA C NA T G NA G NA
205 G T C C T G A G T
206 G A C A T G A A C
207 T A C A T G A A C
208 G A C A T G NA NA NA
209 G A C A T G T G NA
210 G T C A T G A A C
211 G A G A T T T G T
212 G A NA A NA G A A C
213 G T C C T G A A C
214 G A C A T G A A C
215 G T C A A G A A C
216 G A C A T G A A C
217 G A C A T G A A C
218 G A C C A G A A C
219 G A C A T G A G C
220 G NA C NA T G A G NA
221 G NA C NA T T T G T
222 G A C A T G A A C
223 G T C A NA G T G T
224 G A C A A G A G NA
225 G A C A A G A A C
160
Table A.3 (continued)
             SNP           
Line Tak1Intron1_01Traf25inter_01Traf2Exon1_02Traf2Exon1_03Traf3Exon2_01Traf3Exon3_01Tsf15inter_01Tsf1Exon2_02Tsf1Exon3_01
1 NA NA NA NA C NA NA NA NA
2 NA NA NA NA C NA NA NA T
3 NA NA NA C C NA T NA NA
4 NA NA NA C C NA C C T
6 G G NA C C A C NA T
7 G G G C C G NA C T
8 NA NA NA NA C NA NA NA T
9 NA NA G C C A C NA T
10 NA NA NA NA G NA T NA NA
11 NA NA NA C C NA C NA NA
12 NA NA NA C C NA C NA NA
13 NA NA NA C C NA C NA NA
14 G NA G C C NA NA C NA
15 G G A C C G C C T
16 G A G T C G C C T
17 G NA G C C G C T T
22 NA NA NA C C NA C NA NA
23 T G G C C A T C T
24 NA NA G C C A T C T
25 G NA G NA C A C C T
26 G G G C C NA C C T
27 G G G C C A C C T
28 G G G C C G T C T
29 G G G C C G C C T
31 G G A C C A T C T
33 G G A C C A C C T
34 G NA G C C NA T T T
35 G G G C C NA C C T
36 NA NA G C C NA C NA T
37 G G G C C A C C T
38 G G G C C A C C NA
39 G NA G C C A C C T
40 NA NA G C C A C C T
41 NA NA NA C C NA C NA NA
42 NA NA NA C C NA T NA NA
43 NA NA NA NA C NA T NA NA
44 NA NA NA NA C NA NA NA NA
45 NA NA G C C NA C NA T
46 NA NA NA C C NA C NA NA
47 NA NA NA C C NA C NA NA
48 NA NA NA C C NA C NA NA
49 G A G T C NA C C C
50 NA NA NA C C NA C NA NA
51 NA NA NA NA C NA NA NA NA
52 NA NA NA C C NA C NA NA
53 NA NA G C C NA T NA T
54 G A G T C A C C T
55 NA NA G C C NA C NA T
56 NA NA NA C C NA T NA NA
57 G NA G C C A NA T NA
58 G G G C C G C C T
59 G G G C C NA C C T
60 G G G C C G C C T
61 G G G NA NA A NA C T
62 G A G T C G C C C
63 G A G T C NA C C T
64 G G G C C G T C T
65 G G G C C A C C NA
68 G G G C C G T C T
69 G G G C C A T C T
70 G G G C C A T C T
71 G G G C C A T C T
73 G A G T C A T C T
74 G G G C C A C C T
75 G G G C C G C C T
76 NA NA NA C C NA C NA NA
79 G G G C C G T C T
80 G G G C C G T C T
81 G G G C C NA C C T
84 G NA G C C A C C T
86 G A G T C G T C T
87 G NA G T C A NA C T
88 NA NA NA C C NA NA NA NA
89 G NA G C C A C T C
90 G G G C C A C C T
91 G G G C C G C C T
92 G G G C C G C C T
93 G NA G C C A NA C T
94 G G G C C A C T T
95 G NA G C C G T C T
96 G NA G C C G NA C NA
97 G NA G C C A T C T
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Table A.3 (continued)
             SNP           
Line Tak1Intron1_01Traf25inter_01Traf2Exon1_02Traf2Exon1_03Traf3Exon2_01Traf3Exon3_01Tsf15inter_01Tsf1Exon2_02Tsf1Exon3_01
98 G A G T C A C C T
99 G A G T C A C C T
101 G A G T C A C C T
102 G G G C C A C C T
103 G G G C C A C C T
104 G G G C C A C C T
105 G G G C C G T C T
106 NA G NA C C A T NA T
107 G NA G C C A NA C T
108 G NA G T C A C C T
109 G NA G C C A NA NA T
110 G A G T C G NA C T
111 NA NA NA C C NA T NA NA
112 NA NA NA T C NA T NA NA
113 G G G C C A C T C
114 G G G C C G T NA T
115 G G G C C A C C T
116 G G G C C A NA C C
117 G G G C C G T C T
119 G G G NA C G C C C
122 G G G C C A T C T
123 G G G C C A NA C T
125 G A G T C A T C T
126 G G G C C A C C T
127 G G G C C A T C T
128 G A G T C A T C T
130 G G G C C A C C T
131 G G G C C G T C T
134 G G G C C A NA C T
136 G G G C C A NA C T
137 G G G NA NA A C C T
138 G G G C C A T C T
139 G A G T C G C C NA
140 G A G T C A C T T
142 G G G C C A T C T
143 G G G C C A C C T
144 G G G C C G C C NA
145 G G G C C A NA C T
146 G G G C C G C C T
148 G G G C C A T C T
149 G A G T C G C T C
151 G G G C C A C C C
152 G A G T C A T C T
153 G G G C C A C C T
154 G G G C C A C C T
155 G NA G T C A C C T
158 G G G NA C G C C T
160 G A G T C A NA C T
164 G G A C C A T C T
166 G G G C C G T C T
167 G G G C C A T C T
168 G G G C C A T C T
169 G G G C C G NA C T
172 G G G C C A C C C
173 G NA G NA C NA NA C T
174 G G G C C A C C T
201 G G G C C A C C T
202 G G G C C A T C T
203 G G G C C A T C T
204 G G G C C A NA T C
205 G G G C C A C T C
206 G G G C C A C C T
207 G G G C C A C C T
208 G G G C C A C C T
209 G G G C C A NA C T
210 G NA G T C A T C T
211 G G G C G G T C C
212 G G G C C NA NA C T
213 G G G C C A NA C T
214 G G G C C G C C T
215 G G G C C A C C T
216 G G G C C G C C T
217 G G G C C A C C T
218 G G G C C A C C T
219 G NA G T C G NA C T
220 G G G C C A C C T
221 G G G C C A C NA C
222 G G G C C A T C T
223 G NA G T C A NA C T
224 G G G C C A C C T
225 G G G C C NA C C T
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Table A.3 (continued)
             SNP           
Line Tsf1Exon3_02Tsf1Exon3_03Tsf1Exon3_04upd2Exon1_01upd2Exon3_01upd2Intron1_01upd3Exon1_01upd3Exon2_04upd3Exon3_01upd3Intron1_01
1 NA NA NA NA NA NA G NA G G
2 T C NA NA NA A G NA G NA
3 NA NA T G T NA G NA G G
4 T C NA NA G G G T G G
6 T C NA NA NA NA G T G G
7 NA C NA NA NA NA G T G G
8 T C NA NA NA NA G NA A G
9 T C G G T A G C G G
10 NA NA NA A G NA A NA A T
11 NA NA G G T NA G NA G G
12 NA NA T G G NA G NA G G
13 NA NA NA G T NA G NA G G
14 C C T A G G G T G G
15 T C G G T G G T G G
16 T C T A G G G T G G
17 T C G G G G G T G G
22 NA NA G G G NA G NA G G
23 C C G A G G G C A G
24 C C G G T A G T G G
25 C C NA G T G G T G G
26 T C T G G G G T G G
27 T C G G T A G T G T
28 C C T G NA A G T G G
29 T C T G T A G T G G
31 C C G A G G G T G G
33 C C T G T A G T G G
34 C C T G NA G G T G G
35 T C NA NA G G G T G G
36 T C G NA G NA G NA G G
37 C C T NA NA NA G T G G
38 NA C T G T A G NA G G
39 NA C NA G T A G NA G NA
40 T C G G NA A G T G G
41 NA NA T G T NA G NA G G
42 NA NA T G NA NA G NA G G
43 NA C G A G NA G NA G G
44 NA NA G NA NA NA G NA G G
45 T C G G T A G T G G
46 NA NA G G T NA G NA G G
47 NA C T G T NA G NA G G
48 NA NA T NA G NA G NA G G
49 C C T G NA A G T G G
50 NA NA T G T NA G NA G G
51 NA NA T A G NA G NA G G
52 NA NA G G T NA G NA G T
53 NA C G A G NA G NA G G
54 T C T A G G G C G G
55 T C G G G NA G T G G
56 NA C T G T NA G NA G G
57 C C NA NA T A G NA G G
58 T C T A G G G T G G
59 T C NA NA G G G NA G G
60 T C T G T A G T G G
61 T C NA NA NA G NA NA NA NA
62 C C T G T A G T G G
63 T C NA NA NA NA G T G G
64 C C T A G G G T G G
65 NA C T NA NA NA G NA G G
68 C C G G NA A G T G G
69 T C T G T A G T G G
70 C C G G T A G T G G
71 C C NA G T A G T G G
73 C C T G T A G T G G
74 T C T G T A G T G G
75 T C T G T A G T G G
76 NA NA T A G NA G NA G G
79 C C G NA G G G T G G
80 C C T A G G A C A G
81 C C T G G G G T G G
84 T C G G G G G T G G
86 C C G G T A G T G G
87 T C NA G T NA G T G G
88 NA NA G NA NA NA G NA G G
89 T C G G G G G T G G
90 T C T G G G G C G G
91 T C G A G G G C G G
92 T C T A G G G T G G
93 T C NA NA NA NA G T G G
94 T C G A G G G C G G
95 C C G A G G G T G G
96 NA NA NA NA NA NA NA T G G
97 C C NA G T A G T A G
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Table A.3 (continued)
             SNP           
Line Tsf1Exon3_02Tsf1Exon3_03Tsf1Exon3_04upd2Exon1_01upd2Exon3_01upd2Intron1_01upd3Exon1_01upd3Exon2_04upd3Exon3_01upd3Intron1_01
98 T C T A G G G C G G
99 T C T A G G G T G G
101 T C G A G G G T G G
102 T C G G G G G T G G
103 T C G NA NA A G T G G
104 C C T A G G G C G G
105 T C G G NA A A T G G
106 C C T G T A NA NA NA NA
107 C C NA G NA A G T G G
108 T C G A G G G T G G
109 NA C G G T NA G NA G G
110 NA NA G G T A G T G G
111 NA NA G A G NA G T G G
112 NA NA G G T NA G T G G
113 C NA T A T A G C G G
114 C NA G A G G G T G G
115 T NA G G T A G T G G
116 C NA T A G G G T G G
117 C NA G G T A G T G G
119 C NA T A G G G C G G
122 C NA T A G G G T G G
123 T NA G G T G G T G G
125 C NA T A G G G T G G
126 C NA T G T A G T G G
127 C NA G G T A G C G G
128 C NA T G T G G T G G
130 T NA T G T G G T G G
131 C NA G A G G G T G T
134 C NA T G G G G T G G
136 NA NA NA G T A G T G NA
137 T NA G A G G G C A T
138 T NA T G T A G T G G
139 T NA T NA NA NA G T G G
140 T NA G A G G G T G G
142 C NA G G T A G T G G
143 T NA T G G G G T G G
144 T NA G G T G G T G G
145 C NA G G T A G C G T
146 T NA G G G G G T G G
148 C NA G A G G G T G G
149 T NA G G G G G T G G
151 C NA T G T A G T G G
152 C NA T NA G G G T G G
153 C NA T G T A G T G T
154 T NA G G T A G T G G
155 T NA T A G G G T G G
158 T NA T G T A G C G G
160 T NA G G T A G T G G
164 C NA T A G G G C G G
166 C NA G G T A G T G G
167 T NA G G T A G C G T
168 C NA G G T A G C G G
169 C NA T A G G G C G G
172 C NA T A G G G C G G
173 NA NA NA NA NA NA G NA G NA
174 T NA G G T A G T G G
201 T NA G G G G G T G G
202 C NA T G G G G T G G
203 C NA G G T A G C G T
204 C NA G A NA G G C G G
205 C NA G G T A G T G G
206 T NA G G T A G T G G
207 C NA G G T A G C G T
208 T NA G A G G G T G G
209 T NA T G T A G T G G
210 C NA T G T A G C G T
211 C NA T G T A G T G T
212 NA NA NA G NA NA G T G G
213 T NA G G T A G T G G
214 T NA G G T A G T G G
215 T NA G G T A G T G T
216 T NA T G T A G T G G
217 T NA G G G G G T G G
218 T NA G G T A G C G T
219 C NA G G T A G C G G
220 T NA G G T A G T G G
221 NA NA NA NA NA NA G T G G
222 T NA G G T A G C G T
223 T NA G A G G G T G G
224 T NA G G T A G T G G
225 T NA T G T A G C G G
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Table A.4 TaqMan Primer and Probe Sequences
Gene Sequence
Def MGB probe AGGATGCCCACCAGGA
forward primer GAGGATCATGTCCTGGTGCAT
reverse primer TCGCTTCTGGCGGCTATG
DptA MGB probe TTTGCAGTCCAGGGTC
forward primer GCGGCGATGGTTTTGG
reverse primer CGCTGGTCCACACCTTCTG
Mtk MGB probe GCTGGGTGTGATGG
forward primer AACTTAATCTTGGAGCGATTTTTCTG
reverse primer ACGGCCTCGTATCGAAAATG
PGRP-SA MGB probe CGAAGGCACTGGTTG
forward primer TCGGCAACGATGGTATCGTA
reverse primer GGCACCGCGCAATCC
Tsf1 MGB probe AGTGCCGCCTTCC
forward primer GAACGCAGCAGGACAAGGA
reverse primer CTGCTGCAGGGTGCGAAT
RpL32 MGB probe AGCTGTCGCACAAAT
forward primer AGGCCCAAGATCGTGAAGAA
reverse primer GACGCACTCTGTTGTCGATACG
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APPENDIX B
SUPPLEMENTARY INFORMATION FOR CHAPTER 3
Table B.1 Genes Included on BeadChips
Category FBgn Symbol Function Category FBgn Symbol Function
immunity FBgn0012042 AttA effector other FBgn0058370 CG40370 \N
immunity FBgn0041581 AttB effector other FBgn0025628 CG4199 \N
immunity FBgn0041579 AttC effector other FBgn0036639 CG4229 \N
immunity FBgn0038530 AttD effector other FBgn0034761 CG4250 \N
immunity FBgn0000165 Bc effector other FBgn0031405 CG4267 \N
immunity FBgn0002022 Catsup effector other FBgn0034741 CG4269 \N
immunity FBgn0000276 CecA1 effector other FBgn0035589 CG4618 \N
immunity FBgn0000277 CecA2 effector other FBgn0027584 CG4757 \N
immunity FBgn0000278 CecB effector other FBgn0028514 CG4793 \N
immunity FBgn0000279 CecC effector other FBgn0039434 CG5468 \N
immunity FBgn0034539 CG11159 effector other FBgn0034364 CG5493 \N
immunity FBgn0028526 CG15293 effector other FBgn0034160 CG5550 \N
immunity FBgn0032773 CG15825 effector other FBgn0034290 CG5773 \N
immunity FBgn0035743 CG15829 effector other FBgn0038930 CG5778 \N
immunity FBgn0029765 CG16756 effector other FBgn0040582 CG5791 \N
immunity FBgn0034538 CG16799 effector other FBgn0038682 CG5835 \N
immunity FBgn0034162 CG6426 effector other FBgn0032973 CG6675 \N
immunity FBgn0034092 CG7798 effector other FBgn0030086 CG7033 \N
immunity FBgn0035813 CG8492 effector other FBgn0031941 CG7211 \N
immunity FBgn0038465 CG8913 effector other FBgn0031940 CG7214 \N
immunity FBgn0000422 Ddc effector other FBgn0031723 CG7251 \N
immunity FBgn0010385 Def effector other FBgn0038631 CG7695 \N
immunity FBgn0000486 Dox-A2 effector other FBgn0033596 CG7738 \N
immunity FBgn0000487 Dox-A3 effector other FBgn0032025 CG7778 \N
immunity FBgn0004240 Dpt effector other FBgn0038576 CG7940 \N
immunity FBgn0034407 DptB effector other FBgn0033234 CG8791 \N
immunity FBgn0010388 Dro effector other FBgn0035208 CG9184 \N
immunity FBgn0052279 dro2 effector other FBgn0032069 CG9468 \N
immunity FBgn0052283 dro3 effector other FBgn0036659 CG9701 \N
immunity FBgn0052282 dro4 effector other FBgn0032472 CG9928 \N
immunity FBgn0035434 dro5 effector other FBgn0039593 CG9989 \N
immunity FBgn0052268 dro6 effector other FBgn0035636 Cralbp \N
immunity FBgn0010381 Drs effector other FBgn0010383 Cyp18a1 \N
immunity FBgn0052274 Drs-l effector other FBgn0015032 Cyp4c3 \N
immunity FBgn0029167 Hml effector other FBgn0035964 Dhpr \N
immunity FBgn0034329 IM1 effector other FBgn0037977 Ect3 \N
immunity FBgn0033835 IM10 effector other FBgn0005660 Ets21C \N
immunity FBgn0025583 IM2 effector other FBgn0000715 Fmrf \N
immunity FBgn0034328 IM23 effector other FBgn0000721 for \N
immunity FBgn0040736 IM3 effector other FBgn0037724 Fst \N
immunity FBgn0040653 IM4 effector other FBgn0001112 Gld \N
immunity FBgn0004425 LysB effector other FBgn0035167 Gr61a \N
immunity FBgn0004426 LysC effector other FBgn0001230 Hsp68 \N
immunity FBgn0004427 LysD effector other FBgn0020416 Idgf1 \N
immunity FBgn0004428 LysE effector other FBgn0020415 Idgf2 \N
immunity FBgn0004429 LysP effector other FBgn0020414 Idgf3 \N
immunity FBgn0004430 LysS effector other FBgn0026415 Idgf4 \N
immunity FBgn0004431 LysX effector other FBgn0001281 janB \N
immunity FBgn0014865 Mtk effector other FBgn0003358 Jon99Ci \N
immunity FBgn0005626 ple effector other FBgn0020638 Lcp65Ag1 \N
immunity FBgn0003162 Pu effector other FBgn0020637 Lcp65Ag2 \N
immunity FBgn0011722 Tig effector other FBgn0040104 lectin-24A \N
immunity FBgn0028396 TotA effector other FBgn0016675 Lectin-galC1 \N
immunity FBgn0038838 TotB effector other FBgn0020278 loco \N
immunity FBgn0044812 TotC effector other FBgn0051092 LpR2 \N
immunity FBgn0044811 TotF effector other FBgn0002565 Lsp2 \N
immunity FBgn0031701 TotM effector other FBgn0013987 MAPk-Ak2 \N
immunity FBgn0044810 TotX effector other FBgn0002869 MtnB \N
immunity FBgn0044809 TotZ effector other FBgn0011672 Mvl \N
immunity FBgn0022355 Tsf1 effector other FBgn0013305 Nmda1 \N
immunity FBgn0036299 Tsf2 effector other FBgn0034509 Obp57c \N
immunity FBgn0034094 Tsf3 effector other FBgn0046878 Obp83cd \N
immunity FBgn0041710 yellow-f effector other FBgn0037589 Obp85a \N
immunity FBgn0038105 yellow-f2 effector other FBgn0013307 Odc1 \N
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Table B.1 (continued)
Category FBgn Symbol Function Category FBgn Symbol Function
immunity FBgn0033301 CG12780 recognition other FBgn0002997 ome \N
immunity FBgn0034511 CG13422 recognition other FBgn0037590 Or85b \N
immunity FBgn0051217 CG31217 recognition other FBgn0026192 par-6 \N
immunity FBgn0031547 CG3212 recognition other FBgn0035089 Phk-3 \N
immunity FBgn0015924 crq recognition other FBgn0003328 scb \N
immunity FBgn0010435 emp recognition other FBgn0015808 ScpX \N
immunity FBgn0040323 GNBP1 recognition other FBgn0051069 spn-D \N
immunity FBgn0040322 GNBP2 recognition other FBgn0003511 Sry-beta \N
immunity FBgn0040321 GNBP3 recognition other FBgn0031506 Tdp1 \N
immunity FBgn0028430 He recognition other FBgn0011584 Trp1 \N
immunity FBgn0035975 PGRP-LA recognition other FBgn0017456 Ubc84D \N
immunity FBgn0037906 PGRP-LB recognition other FBgn0003961 Uro \N
immunity FBgn0035976 PGRP-LC recognition other FBgn0011737 wee \N
immunity FBgn0035635 PGRP-LD recognition other FBgn0015565 yin \N
immunity FBgn0030695 PGRP-LE recognition other FBgn0010501 Dcp-1 apoptosis
immunity FBgn0035977 PGRP-LF recognition other FBgn0028381 decay apoptosis
immunity FBgn0030310 PGRP-SA recognition other FBgn0000477 DNaseII apoptosis
immunity FBgn0043578 PGRP-SB1 recognition other FBgn0015946 grim apoptosis
immunity FBgn0043577 PGRP-SB2 recognition other FBgn0035049 Mmp1 apoptosis
immunity FBgn0043576 PGRP-SC1a recognition other FBgn0027609 morgue apoptosis
immunity FBgn0033327 PGRP-SC1b recognition other FBgn0011706 rpr apoptosis
immunity FBgn0043575 PGRP-SC2 recognition other FBgn0023076 Clk circadian
immunity FBgn0035806 PGRP-SD recognition other FBgn0025680 cry circadian
immunity FBgn0014033 Sr-CI recognition other FBgn0023094 cyc circadian
immunity FBgn0020377 Sr-CII recognition other FBgn0023178 Pdf circadian
immunity FBgn0020376 Sr-CIII recognition other FBgn0016694 Pdp1 circadian
immunity FBgn0041183 TepI recognition other FBgn0003068 per circadian
immunity FBgn0041182 TepII recognition other FBgn0014396 tim circadian
immunity FBgn0041181 TepIII recognition other FBgn0039298 to circadian
immunity FBgn0041180 TepIV recognition other FBgn0016076 vri circadian
immunity FBgn0004364 18w signaling other FBgn0002626 RpL32 control
immunity FBgn0000097 aop signaling other FBgn0028683 spt4 control
immunity FBgn0022131 aPKC signaling other FBgn0000094 Anp effector
immunity FBgn0000173 ben signaling other FBgn0039628 CG11841 effector
immunity FBgn0038928 BG4 signaling other FBgn0031560 CG16713 effector
immunity FBgn0000212 brm signaling other FBgn0037678 CG16749 effector
immunity FBgn0000229 bsk signaling other FBgn0036024 CG18180 effector
immunity FBgn0000250 cact signaling other FBgn0032639 CG18563 effector
immunity FBgn0032832 CG10662 signaling other FBgn0050088 CG30088 effector
immunity FBgn0027930 CG1102 signaling other FBgn0031562 CG3604 effector
immunity FBgn0039666 CG11501 signaling other FBgn0030449 CG4349 effector
immunity FBgn0039102 CG16705 signaling other FBgn0039495 CG5909 effector
immunity FBgn0037515 CG3066 signaling other FBgn0036969 CG6663 effector
immunity FBgn0030925 CG6361 signaling other FBgn0027563 CG9631 effector
immunity FBgn0030774 CG9675 signaling other FBgn0038211 CG9649 effector
immunity FBgn0014141 cher signaling other FBgn0015222 Fer1HCH effector
immunity FBgn0011274 Dif signaling other FBgn0015221 Fer2LCH effector
immunity FBgn0000462 dl signaling other FBgn0030092 fh effector
immunity FBgn0034738 Dnr1 signaling other FBgn0020906 Jon25Bi effector
immunity FBgn0020306 dom signaling other FBgn0031654 Jon25Bii effector
immunity FBgn0043903 dome signaling other FBgn0031653 Jon25Biii effector
immunity FBgn0020381 Dredd signaling other FBgn0001285 Jon44E effector
immunity FBgn0010269 Dsor1 signaling other FBgn0035667 Jon65Ai effector
immunity FBgn0000533 ea signaling other FBgn0035664 Jon65Aiv effector
immunity FBgn0028436 ECSIT signaling other FBgn0039778 Jon99Fi effector
immunity FBgn0003731 Egfr signaling other FBgn0019929 Ser7 effector
immunity FBgn0020497 emb signaling other FBgn0019928 Ser8 effector
immunity FBgn0014179 gcm signaling other FBgn0028988 Spn1 effector
immunity FBgn0019809 gcm2 signaling other FBgn0028987 Spn2 effector
immunity FBgn0010303 hep signaling other FBgn0028986 Spn3 effector
immunity FBgn0004864 hop signaling other FBgn0028985 Spn4 effector
immunity FBgn0013983 imd signaling other FBgn0028984 Spn5 effector
immunity FBgn0024222 ird5 signaling other FBgn0038412 Zip3 effector
immunity FBgn0001291 Jra signaling other FBgn0000210 br hematopoiesis
immunity FBgn0001297 kay signaling other FBgn0000463 Dl hematopoiesis
immunity FBgn0041205 key signaling other FBgn0001981 esg hematopoiesis
immunity FBgn0001319 kn signaling other FBgn0040206 krz hematopoiesis
immunity FBgn0015763 lic signaling other FBgn0002440 l(3)mbn hematopoiesis
immunity FBgn0010602 lwr signaling other FBgn0015544 spag hematopoiesis
immunity FBgn0002576 lz signaling other FBgn0017645 Ank2 insecticide
immunity FBgn0026207 mbo signaling other FBgn0000120 Arr1 insecticide
immunity FBgn0024329 Mekk1 signaling other FBgn0000121 Arr2 insecticide
immunity FBgn0024326 Mkk4 signaling other FBgn0045761 CG10618 insecticide
immunity FBgn0015765 Mpk2 signaling other FBgn0030484 CG1681 insecticide
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Table B.1 (continued)
Category FBgn Symbol Function Category FBgn Symbol Function
immunity FBgn0010909 msn signaling other FBgn0027590 CG16936 insecticide
immunity FBgn0015770 MstProx signaling other FBgn0035113 CG17142 insecticide
immunity FBgn0005639 mxc signaling other FBgn0050019 CG30019 insecticide
immunity FBgn0033402 Myd88 signaling other FBgn0038878 CG3301 insecticide
immunity FBgn0004647 N signaling other FBgn0034354 CG5224 insecticide
immunity FBgn0002930 nec signaling other FBgn0031327 CG5397 insecticide
immunity FBgn0011676 Nos signaling other FBgn0034888 CG5431 insecticide
immunity FBgn0031145 Ntf-2 signaling other FBgn0035906 CG6673 insecticide
immunity FBgn0010660 Nup214 signaling other FBgn0033728 CG8505 insecticide
immunity FBgn0004956 os signaling other FBgn0033679 CG8888 insecticide
immunity FBgn0024846 p38b signaling other FBgn0034807 CG9897 insecticide
immunity FBgn0003079 phl signaling other FBgn0038681 Cyp12a4 insecticide
immunity FBgn0010441 pll signaling other FBgn0053503 Cyp12d1-d insecticide
immunity FBgn0003118 pnt signaling other FBgn0050489 Cyp12d1-p insecticide
immunity FBgn0030926 psh signaling other FBgn0033982 Cyp317a1 insecticide
immunity FBgn0004210 puc signaling other FBgn0034053 Cyp4aa1 insecticide
immunity FBgn0030964 Pvf1 signaling other FBgn0015037 Cyp4p1 insecticide
immunity FBgn0031888 Pvf2 signaling other FBgn0033302 Cyp6a14 insecticide
immunity FBgn0031889 Pvf3 signaling other FBgn0015714 Cyp6a17 insecticide
immunity FBgn0032006 Pvr signaling other FBgn0033979 Cyp6a19 insecticide
immunity FBgn0010333 Rac1 signaling other FBgn0000473 Cyp6a2 insecticide
immunity FBgn0003205 Ras85D signaling other FBgn0033980 Cyp6a20 insecticide
immunity FBgn0003231 ref(2)P signaling other FBgn0033981 Cyp6a21 insecticide
immunity FBgn0014018 Rel signaling other FBgn0013773 Cyp6a22 insecticide
immunity FBgn0004922 RpS6 signaling other FBgn0033978 Cyp6a23 insecticide
immunity FBgn0004197 Ser signaling other FBgn0013772 Cyp6a8 insecticide
immunity FBgn0030018 slpr signaling other FBgn0013771 Cyp6a9 insecticide
immunity FBgn0026170 smt3 signaling other FBgn0025454 Cyp6g1 insecticide
immunity FBgn0028990 Spn27A signaling other FBgn0033696 Cyp6g2 insecticide
immunity FBgn0003495 spz signaling other FBgn0033697 Cyp6t3 insecticide
immunity FBgn0003507 srp signaling other FBgn0033065 Cyp6w1 insecticide
immunity FBgn0016917 Stat92E signaling other FBgn0015040 Cyp9c1 insecticide
immunity FBgn0004837 Su(H) signaling other FBgn0010387 Dbi insecticide
immunity FBgn0026323 Tak1 signaling other FBgn0011202 dia insecticide
immunity FBgn0041582 tamo signaling other FBgn0029175 Ext2 insecticide
immunity FBgn0026760 Tehao signaling other FBgn0028433 Ggamma30A insecticide
immunity FBgn0022073 Thor signaling other FBgn0027657 glob1 insecticide
immunity FBgn0003717 Tl signaling other FBgn0034334 GstE10 insecticide
immunity FBgn0032095 Toll-4 signaling other FBgn0034340 GstE6 insecticide
immunity FBgn0036494 Toll-6 signaling other FBgn0034343 GstE9 insecticide
immunity FBgn0034476 Toll-7 signaling other FBgn0010226 GstS1 insecticide
immunity FBgn0036978 Toll-9 signaling other FBgn0004784 inaC insecticide
immunity FBgn0029114 Tollo signaling other FBgn0023077 inaF insecticide
immunity FBgn0026319 Traf1 signaling other FBgn0002645 Map205 insecticide
immunity FBgn0026318 Traf2 signaling other FBgn0003036 para insecticide
immunity FBgn0030748 Traf3 signaling other FBgn0004244 Rdl insecticide
immunity FBgn0003882 tub signaling other FBgn0003250 Rh4 insecticide
immunity FBgn0035601 Uev1A signaling other FBgn0026314 Ugt35b insecticide
immunity FBgn0030904 upd2 signaling other FBgn0040256 Ugt86Dd insecticide
immunity FBgn0003963 ush signaling other FBgn0040252 Ugt86Dh insecticide
immunity FBgn0021895 ytr signaling other FBgn0000251 cad local response
metabolism FBgn0012034 AcCoAS \N other FBgn0026252 msk local response
metabolism FBgn0000024 Ace \N other FBgn0020510 Abi phagocytosis
metabolism FBgn0010100 Acon \N other FBgn0000042 Act5C phagocytosis
metabolism FBgn0025115 Acyp \N other FBgn0000047 Act88F phagocytosis
metabolism FBgn0000055 Adh \N other FBgn0000083 AnnIX phagocytosis
metabolism FBgn0010379 Akt1 \N other FBgn0010380 Bap phagocytosis
metabolism FBgn0000064 Ald \N other FBgn0025724 beta'Cop phagocytosis
metabolism FBgn0038742 Arc42 \N other FBgn0034179 CG6805 phagocytosis
metabolism FBgn0013749 Arf102F \N other FBgn0030993 CG7635 phagocytosis
metabolism FBgn0020236 ATPCL \N other FBgn0036043 CG8177 phagocytosis
metabolism FBgn0027348 bgm \N other FBgn0000319 Chc phagocytosis
metabolism FBgn0041342 Cct1 \N other FBgn0000308 chic phagocytosis
metabolism FBgn0035231 Cct2 \N other FBgn0010434 cora phagocytosis
metabolism FBgn0010350 CdsA \N other FBgn0015926 dah phagocytosis
metabolism FBgn0037440 CG1041 \N other FBgn0028969 deltaCOP phagocytosis
metabolism FBgn0035679 CG10467 \N other FBgn0026721 fat-spondin phagocytosis
metabolism FBgn0029969 CG10932 \N other FBgn0038475 Keap1 phagocytosis
metabolism FBgn0033246 CG11198 \N other FBgn0011653 mas phagocytosis
metabolism FBgn0037643 CG11963 \N other FBgn0020269 mspo phagocytosis
metabolism FBgn0037386 CG1208 \N other FBgn0015624 nej phagocytosis
metabolism FBgn0037356 CG12170 \N other FBgn0036101 ninA phagocytosis
metabolism FBgn0035811 CG12262 \N other FBgn0033247 Nup44A phagocytosis
metabolism FBgn0033856 CG13334 \N other FBgn0044826 Pak3 phagocytosis
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Table B.1 (continued)
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metabolism FBgn0037988 CG14740 \N other FBgn0020255 ran phagocytosis
metabolism FBgn0027580 CG1516 \N other FBgn0041781 SCAR phagocytosis
metabolism FBgn0037762 CG16905 \N other FBgn0013733 shot phagocytosis
metabolism FBgn0030239 CG17333 \N other FBgn0003475 spir phagocytosis
metabolism FBgn0039856 CG1774 \N other FBgn0024273 WASp phagocytosis
metabolism FBgn0038973 CG18594 \N other FBgn0000075 amd phenoloxidase
metabolism FBgn0032955 CG2201 \N other FBgn0039759 CG9733 phenoloxidase
metabolism FBgn0051075 CG31075 \N other FBgn0037396 CG11459 protease
metabolism FBgn0027571 CG3523 \N other FBgn0039629 CG11842 protease
metabolism FBgn0032114 CG3752 \N other FBgn0038250 CG3505 protease
metabolism FBgn0029890 CG4095 \N other FBgn0032638 CG6639 protease
metabolism FBgn0028479 CG4389 \N other FBgn0038299 CG6687 protease inhibitor
metabolism FBgn0035006 CG4563 \N other FBgn0031973 CG7219 protease inhibitor
metabolism FBgn0036784 CG5103 \N other FBgn0015737 Hmu recognition
metabolism FBgn0031912 CG5261 \N other FBgn0043364 cabut signaling
metabolism FBgn0032237 CG5362 \N other FBgn0031114 cactin signaling
metabolism FBgn0026576 CG5991 \N other FBgn0030909 CG15062 signaling
metabolism FBgn0033844 CG6016 \N other FBgn0030910 CG5963 signaling
metabolism FBgn0036182 CG6084 \N other FBgn0033483 egr signaling
metabolism FBgn0039476 CG6271 \N other FBgn0028633 ik2 signaling
metabolism FBgn0029689 CG6428 \N other FBgn0040513 kappaB-Ras signaling
metabolism FBgn0039184 CG6432 \N other FBgn0034118 Nup62 signaling
metabolism FBgn0033879 CG6543 \N other FBgn0014001 Pak signaling
metabolism FBgn0038293 CG6904 \N other FBgn0025574 Pli signaling
metabolism FBgn0031948 CG7149 \N other FBgn0003256 rl signaling
metabolism FBgn0036762 CG7430 \N other FBgn0026178 scrib signaling
metabolism FBgn0036691 CG7842 \N other FBgn0040271 Sulf1 signaling
metabolism FBgn0038587 CG7998 \N other FBgn0030941 wgn signaling
metabolism FBgn0037607 CG8036 \N other FBgn0000556 Ef1alpha48D wounding
metabolism FBgn0035203 CG9149 \N other FBgn0000639 Fbp1 wounding
metabolism FBgn0034618 CG9485 \N other FBgn0002564 Lsp1gamma wounding
metabolism FBgn0036857 CG9629 \N reproduction FBgn0027080 Aats-tyr \N
metabolism FBgn0000303 Cha \N reproduction FBgn0002855 Acp26Aa \N
metabolism FBgn0024248 chico \N reproduction FBgn0002856 Acp26Ab \N
metabolism FBgn0027842 CPTI \N reproduction FBgn0015583 Acp29AB \N
metabolism FBgn0043044 desat1 \N reproduction FBgn0023415 Acp32CD \N
metabolism FBgn0004568 Dgk \N reproduction FBgn0023414 Acp33A \N
metabolism FBgn0020930 Dgkepsilon \N reproduction FBgn0011559 Acp36DE \N
metabolism FBgn0040212 Dhap-at \N reproduction FBgn0034152 Acp53C14a \N
metabolism FBgn0000472 dm \N reproduction FBgn0034153 Acp53C14b \N
metabolism FBgn0000536 eas \N reproduction FBgn0015584 Acp53Ea \N
metabolism FBgn0000579 Eno \N reproduction FBgn0020509 Acp62F \N
metabolism FBgn0029172 Fad2 \N reproduction FBgn0015585 Acp63F \N
metabolism FBgn0020440 Fak56D \N reproduction FBgn0003034 Acp70A \N
metabolism FBgn0032820 fbp \N reproduction FBgn0015586 Acp76A \N
metabolism FBgn0038197 foxo \N reproduction FBgn0002863 Acp95EF \N
metabolism FBgn0001075 ft \N reproduction FBgn0013745 Acp98AB \N
metabolism FBgn0026718 fu12 \N reproduction FBgn0003863 alphaTry \N
metabolism FBgn0001091 Gapdh1 \N reproduction FBgn0003884 alphaTub84B \N
metabolism FBgn0001092 Gapdh2 \N reproduction FBgn0012037 Ance \N
metabolism FBgn0005198 gig \N reproduction FBgn0016123 Aph-4 \N
metabolism FBgn0004507 GlyP \N reproduction FBgn0019644 ATPsyn-b \N
metabolism FBgn0001124 Got1 \N reproduction FBgn0016120 ATPsyn-d \N
metabolism FBgn0001125 Got2 \N reproduction FBgn0011211 blw \N
metabolism FBgn0001128 Gpdh \N reproduction FBgn0011723 byn \N
metabolism FBgn0025592 Gyk \N reproduction FBgn0004781 Ccp84Ac \N
metabolism FBgn0001186 Hex-A \N reproduction FBgn0035294 CG1017 \N
metabolism FBgn0001187 Hex-C \N reproduction FBgn0037441 CG10284 \N
metabolism FBgn0015234 HLH106 \N reproduction FBgn0034638 CG10433 \N
metabolism FBgn0001205 Hmgcr \N reproduction FBgn0032833 CG10664 \N
metabolism FBgn0010611 Hmgs \N reproduction FBgn0031865 CG10806 \N
metabolism FBgn0001248 Idh \N reproduction FBgn0034195 CG10956 \N
metabolism FBgn0044051 Ilp1 \N reproduction FBgn0030520 CG10990 \N
metabolism FBgn0036046 Ilp2 \N reproduction FBgn0038067 CG11598 \N
metabolism FBgn0044050 Ilp3 \N reproduction FBgn0040341 CG11664 \N
metabolism FBgn0044049 Ilp4 \N reproduction FBgn0028944 CG11864 \N
metabolism FBgn0044048 Ilp5 \N reproduction FBgn0039313 CG11892 \N
metabolism FBgn0044047 Ilp6 \N reproduction FBgn0025618 CG12311 \N
metabolism FBgn0044046 Ilp7 \N reproduction FBgn0035373 CG1241 \N
metabolism FBgn0001258 ImpL3 \N reproduction FBgn0037213 CG12581 \N
metabolism FBgn0036816 Indy \N reproduction FBgn0035545 CG12607 \N
metabolism FBgn0038770 Indy-2 \N reproduction FBgn0032789 CG13083 \N
metabolism FBgn0013984 InR \N reproduction FBgn0035933 CG13309 \N
metabolism FBgn0034589 king-tubby \N reproduction FBgn0037627 CG13318 \N
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metabolism FBgn0026708 l(1)G0030 \N reproduction FBgn0031691 CG14034 \N
metabolism FBgn0027291 l(1)G0156 \N reproduction FBgn0038147 CG14375 \N
metabolism FBgn0028336 l(1)G0255 \N reproduction FBgn0033046 CG14470 \N
metabolism FBgn0028325 l(1)G0334 \N reproduction FBgn0037928 CG14713 \N
metabolism FBgn0010609 l(2)44DEa \N reproduction FBgn0030469 CG15745 \N
metabolism FBgn0022160 l(2)k05713 \N reproduction FBgn0037763 CG16904 \N
metabolism FBgn0023496 Lip1 \N reproduction FBgn0032275 CG17097 \N
metabolism FBgn0023495 Lip3 \N reproduction FBgn0032281 CG17107 \N
metabolism FBgn0029155 Mdh \N reproduction FBgn0032285 CG17108 \N
metabolism FBgn0004797 mdy \N reproduction FBgn0034877 CG17280 \N
metabolism FBgn0002719 Men \N reproduction FBgn0033776 CG17575 \N
metabolism FBgn0011361 mtacp1 \N reproduction FBgn0038919 CG17843 \N
metabolism FBgn0010352 Nc73EF \N reproduction FBgn0032274 CG18284 \N
metabolism FBgn0032482 Pect \N reproduction FBgn0038347 CG18522 \N
metabolism FBgn0003067 Pepck \N reproduction FBgn0033241 CG2915 \N
metabolism FBgn0003071 Pfk \N reproduction FBgn0040499 CG30171 \N
metabolism FBgn0004654 Pgd \N reproduction FBgn0050404 CG30404 \N
metabolism FBgn0003074 Pgi \N reproduction FBgn0029804 CG3097 \N
metabolism FBgn0003075 Pgk \N reproduction FBgn0051163 CG31163 \N
metabolism FBgn0014869 Pglym78 \N reproduction FBgn0051199 CG31199 \N
metabolism FBgn0003076 Pgm \N reproduction FBgn0051200 CG31200 \N
metabolism FBgn0033075 Pld \N reproduction FBgn0051645 CG31645 \N
metabolism FBgn0013955 PR2 \N reproduction FBgn0051872 CG31872 \N
metabolism FBgn0026379 Pten \N reproduction FBgn0051999 CG31999 \N
metabolism FBgn0020385 pug \N reproduction FBgn0031436 CG3214 \N
metabolism FBgn0003178 PyK \N reproduction FBgn0052473 CG32473 \N
metabolism FBgn0003217 rdgA \N reproduction FBgn0052521 CG32521 \N
metabolism FBgn0016724 RfaBp \N reproduction FBgn0052642 CG32642 \N
metabolism FBgn0037105 S1P \N reproduction FBgn0052952 CG32952 \N
metabolism FBgn0033656 S2P \N reproduction FBgn0053171 CG33171 \N
metabolism FBgn0015806 S6k \N reproduction FBgn0038463 CG3534 \N
metabolism FBgn0033052 SCAP \N reproduction FBgn0036642 CG4169 \N
metabolism FBgn0004888 Scsalpha \N reproduction FBgn0038376 CG4225 \N
metabolism FBgn0017539 Scs-fp \N reproduction FBgn0034132 CG4439 \N
metabolism FBgn0021765 scu \N reproduction FBgn0029891 CG4523 \N
metabolism FBgn0014028 SdhB \N reproduction FBgn0038745 CG4538 \N
metabolism FBgn0024291 Sir2 \N reproduction FBgn0034229 CG4847 \N
metabolism FBgn0030300 Sk1 \N reproduction FBgn0038984 CG5315 \N
metabolism FBgn0052484 Sk2 \N reproduction FBgn0032476 CG5439 \N
metabolism FBgn0033170 sPLA2 \N reproduction FBgn0030853 CG5703 \N
metabolism FBgn0010591 Sply \N reproduction FBgn0038508 CG5866 \N
metabolism FBgn0029118 Sucb \N reproduction FBgn0039492 CG6051 \N
metabolism FBgn0033782 sug \N reproduction FBgn0039418 CG6069 \N
metabolism FBgn0025352 Thiolase \N reproduction FBgn0036154 CG6168 \N
metabolism FBgn0021796 Tor \N reproduction FBgn0036970 CG6289 \N
metabolism FBgn0003738 Tpi \N reproduction FBgn0033875 CG6357 \N
metabolism FBgn0027560 Tps1 \N reproduction FBgn0032284 CG7294 \N
metabolism FBgn0003748 Treh \N reproduction FBgn0032283 CG7296 \N
metabolism FBgn0004889 tws \N reproduction FBgn0036749 CG7460 \N
metabolism FBgn0035978 UGP \N reproduction FBgn0037146 CG7470 \N
metabolism FBgn0042627 v(2)k05816 \N reproduction FBgn0040793 CG7630 \N
metabolism FBgn0016078 wun \N reproduction FBgn0033584 CG7737 \N
metabolism FBgn0041087 wun2 \N reproduction FBgn0030087 CG7766 \N
metabolism FBgn0040064 yip2 \N reproduction FBgn0039737 CG7920 \N
metabolism FBgn0004057 Zw \N reproduction FBgn0033999 CG8093 \N
other FBgn0010339 128up \N reproduction FBgn0032945 CG8665 \N
other FBgn0028550 A3-3 \N reproduction FBgn0031745 CG8965 \N
other FBgn0023129 aay \N reproduction FBgn0031746 CG9029 \N
other FBgn0014454 Acp1 \N reproduction FBgn0034497 CG9090 \N
other FBgn0020765 Acp65Aa \N reproduction FBgn0036878 CG9283 \N
other FBgn0026602 Ady43A \N reproduction FBgn0038181 CG9297 \N
other FBgn0025186 ari-2 \N reproduction FBgn0032897 CG9336 \N
other FBgn0035715 CG10103 \N reproduction FBgn0036451 CG9425 \N
other FBgn0035695 CG10226 \N reproduction FBgn0031810 CG9511 \N
other FBgn0032836 CG10680 \N reproduction FBgn0003060 CG9757 \N
other FBgn0034289 CG10910 \N reproduction FBgn0039589 CG9986 \N
other FBgn0039268 CG11819 \N reproduction FBgn0039597 CG9997 \N
other FBgn0039624 CG11833 \N reproduction FBgn0004629 Cys \N
other FBgn0039644 CG11897 \N reproduction FBgn0024381 Dup99B \N
other FBgn0039837 CG12114 \N reproduction FBgn0000566 Eip55E \N
other FBgn0030041 CG12116 \N reproduction FBgn0035849 ERR \N
other FBgn0028504 CG12182 \N reproduction FBgn0000592 Est-6 \N
other FBgn0040371 CG12470 \N reproduction FBgn0001337 Exp6 \N
other FBgn0033926 CG12505 \N reproduction FBgn0020439 fau \N
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Table B.1 (continued)
Category FBgn Symbol Function Category FBgn Symbol Function
other FBgn0035513 CG1259 \N reproduction FBgn0011205 fbl \N
other FBgn0033521 CG12896 \N reproduction FBgn0025519 fidipidine \N
other FBgn0033511 CG12907 \N reproduction FBgn0020303 fok \N
other FBgn0032810 CG13077 \N reproduction FBgn0001114 Glt \N
other FBgn0032140 CG13117 \N reproduction FBgn0001120 gnu \N
other FBgn0033788 CG13323 \N reproduction FBgn0013972 Gycalpha99B \N
other FBgn0033789 CG13324 \N reproduction FBgn0042712 HBS1 \N
other FBgn0033857 CG13335 \N reproduction FBgn0014857 His3.3A \N
other FBgn0032037 CG13394 \N reproduction FBgn0004167 kst \N
other FBgn0036419 CG13482 \N reproduction FBgn0011296 l(2)efl \N
other FBgn0034695 CG13503 \N reproduction FBgn0011013 l(3)s1921 \N
other FBgn0033394 CG13740 \N reproduction FBgn0040098 lectin-29Ca \N
other FBgn0031937 CG13795 \N reproduction FBgn0040093 lectin-46Ca \N
other FBgn0035112 CG13877 \N reproduction FBgn0040092 lectin-46Cb \N
other FBgn0035176 CG13905 \N reproduction FBgn0005278 M(2)21AB \N
other FBgn0031032 CG14204 \N reproduction FBgn0029870 Marf \N
other FBgn0031033 CG14219 \N reproduction FBgn0024211 mfas \N
other FBgn0032900 CG14401 \N reproduction FBgn0002741 Mhc \N
other FBgn0037131 CG14564 \N reproduction FBgn0002772 Mlc1 \N
other FBgn0037126 CG14567 \N reproduction FBgn0002773 Mlc2 \N
other FBgn0037123 CG14569 \N reproduction FBgn0002789 Mp20 \N
other FBgn0037288 CG14661 \N reproduction FBgn0004414 msopa \N
other FBgn0035797 CG14837 \N reproduction FBgn0011668 Mst57Da \N
other FBgn0035412 CG14957 \N reproduction FBgn0011669 Mst57Db \N
other FBgn0030927 CG15046 \N reproduction FBgn0011670 Mst57Dc \N
other FBgn0040734 CG15065 \N reproduction FBgn0004657 mys \N
other FBgn0034331 CG15067 \N reproduction FBgn0019957 ND42 \N
other FBgn0034394 CG15096 \N reproduction FBgn0017566 ND75 \N
other FBgn0040729 CG15126 \N reproduction FBgn0005322 nmd \N
other FBgn0037398 CG15580 \N reproduction FBgn0014366 noi \N
other FBgn0034647 CG15678 \N reproduction FBgn0020386 Pk61C \N
other FBgn0029766 CG15784 \N reproduction FBgn0003149 Prm \N
other FBgn0032835 CG16772 \N reproduction FBgn0033518 Prx2540-2 \N
other FBgn0037713 CG16790 \N reproduction FBgn0004368 Ptp4E \N
other FBgn0040735 CG16836 \N reproduction FBgn0014009 Rab2 \N
other FBgn0040972 CG16978 \N reproduction FBgn0030986 RhoGAP18B \N
other FBgn0039045 CG17119 \N reproduction FBgn0010406 RNaseX25 \N
other FBgn0031488 CG17265 \N reproduction FBgn0003279 RpL4 \N
other FBgn0046763 CG17278 \N reproduction FBgn0011834 Ser6 \N
other FBgn0028394 CG17834 \N reproduction FBgn0025803 SNF4Agamma \N
other FBgn0034512 CG18067 \N reproduction FBgn0003464 sol \N
other FBgn0042120 CG18779 \N reproduction FBgn0024293 Spn43Ab \N
other FBgn0027544 CG2217 \N reproduction FBgn0028983 Spn6 \N
other FBgn0050076 CG30076 \N reproduction FBgn0023477 Tal \N
other FBgn0051638 CG31638 \N reproduction FBgn0023479 Tequila \N
other FBgn0052074 CG32074 \N reproduction FBgn0004117 Tm2 \N
other FBgn0052214 CG32214 \N reproduction FBgn0039668 Trc8 \N
other FBgn0052412 CG32412 \N reproduction FBgn0001402 trol \N
other FBgn0040368 CG32859 \N reproduction FBgn0003964 usp \N
other FBgn0053047 CG33047 \N reproduction FBgn0045823 vsg \N
other FBgn0058192 CG40192 \N
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APPENDIX C
SUPPLEMENTARY INFORMATION FOR CHAPTER 4
Table C.1 Transcribed Genes Classified Among Immune Functional Groups
FBgn Symbol FBgn Symbol FBgn Symbol
FBgn0041579 AttC FBgn0033301 CG12780 FBgn0029512 Aos1
FBgn0000276 CecA1 FBgn0032808 CG13079 FBgn0000173 ben
FBgn0000277 CecA2 FBgn0034511 CG13422 FBgn0000229 bsk
FBgn0000278 CecB FBgn0050148 CG30148 FBgn0000250 cact
FBgn0035734 CG14823 FBgn0040322 GNBP2 FBgn0039666 CG11501
FBgn0028526 CG15293 FBgn0028430 He FBgn0030925 CG6361
FBgn0034330 CG18107 FBgn0054003 nimB3 FBgn0014141 cher
FBgn0025827 CG6421 FBgn0028939 nimC2 FBgn0011274 Dif
FBgn0034092 CG7798 FBgn0035976 PGRP-LC FBgn0020306 dom
FBgn0000487 Dox-A3 FBgn0030695 PGRP-LE FBgn0043903 dome
FBgn0004240 Dpt FBgn0035977 PGRP-LF FBgn0028436 ECSIT
FBgn0034407 DptB FBgn0030310 PGRP-SA FBgn0014179 gcm
FBgn0010388 Dro FBgn0043575 PGRP-SC2 FBgn0022787 Hel89B
FBgn0052279 dro2 FBgn0014033 Sr-CI FBgn0010303 hep
FBgn0052283 dro3 FBgn0020376 Sr-CIII FBgn0041205 key
FBgn0052268 dro6 FBgn0041183 TepI FBgn0001319 kn
FBgn0010381 Drs FBgn0041180 TepIV FBgn0015765 Mpk2
FBgn0029167 Hml FBgn0031145 Ntf-2
FBgn0034329 IM1 FBgn0032680 Ntf-2r
FBgn0025583 IM2 FBgn0004956 os
FBgn0034328 IM23 FBgn0040294 POSH
FBgn0040736 IM3 FBgn0032006 Pvr
FBgn0004425 LysB FBgn0003231 ref(2)P
FBgn0004428 LysE FBgn0026170 smt3
FBgn0004429 LysP FBgn0041184 Socs36E
FBgn0004431 LysX FBgn0039102 SPE
FBgn0014865 Mtk FBgn0052382 sphinx2
FBgn0005626 ple FBgn0030051 spirit
FBgn0003162 Pu FBgn0026323 Tak1
FBgn0028396 TotA FBgn0041582 tamo
FBgn0044812 TotC FBgn0022073 Thor
FBgn0031701 TotM FBgn0032095 Toll-4
FBgn0044809 TotZ FBgn0026319 Traf4
FBgn0003882 tub
FBgn0029113 Uba2
FBgn0035601 Uev1A
FBgn0027603 Ulp1
FBgn0038134 wntD
Effector Recognition Signaling
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APPENDIX D
SUPPLEMENTARY INFORMATION FOR CHAPTER 5
Table D.1 Mutant D. melanogaster stocks used in crosses
Gene
Exelixis 
Stock
Genetic 
Background
spz XP d00069 w1118
MyD88 XP d09821 w1118
Tub RB e03259 w1118
Pll RB e01040 w1118
Dif XP d05062 w1118
Cact XP d10397 w1118
PGRP-LC XP d04396 w1118
imd XP d00066 w1118
BG4 WH f02804 w1118
DREDD EP 1412 w1118
ird5 DrosGDP* y1w67c23;ry506
key PB c02831 w1118
Rel XP d03528 w
1118
  stock Bl-14684
*Dros. Gene Disruption project,
Table D.2 Primer and Probe Sequences for Dpt Pyrosequencing
Primer Sequence
forward - 5' biotinylated CAGCACTTGGGAGGACCATA
reverse TGTAGGTGCTTCCCACTTTCC
probe GGTGCTTCCCACTTT
